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Determination of bowel viability in patients undergoing bowel resection is essential 
in gastrointestinal surgery. One of the most common operations in gastrointestinal 
surgery is bowel resection for patients who have different kinds of bowel cancer 
or any other occlusion in which anastomosis has to be carried out following the 
removal of an unhealthy segment of the bowel. Monitoring blood flow in 
abdominal surgery especially intraoperatively would be a valuable tool for 
prevention of a postoperative anastomosis complication (e.g. anastomotic leak, 
which is the main complication after colorectal resection). 
 
The development of a continuous method for monitoring perfusion of bowel tissue 
would assist in early detection of inadequate blood supply which then help to 
reduce the occurrence of an anastomosis complication. Although various 
monitoring techniques have been proposed to assess intestinal viability 
intraoperatively, none of these techniques have proved to be reliable enough to 
replace visual observation. Therefore, to date there is no widely accepted and 
readily available intraoperative technique to reliably assess the viability of bowel 
tissue.  
 
The aim of this study was to combine the established techniques, laser Doppler 
flowmetry (LDF) and Photoplethysmography (PPG), into one probe intended for 
assessment of perfusion in abdominal tissue during bowel resection 
intraoperatively. In PPG, changes in transmission of light through tissue due to 
pulsation of small arteries can be monitored whereas in LDF microcirculatory 
blood cell velocity and flux can be studied. Such a probe could alert the surgeon 
immediately of any compromise in blood flow so further investigation and, if 
necessary, therapeutic steps can be applied immediately to prevent severe 
consequences. Therefore, custom reflectance PPG along with LDF sensor was 
designed and built in the form of a probe to investigate the changes in blood 
volume, blood flow and arterial oxygen saturation in patients undergoing bowel 
resection.  
 
                                                                                            ABSTRACT 
 3 
The instrumentation was designed successfully and the data was saved for the 
further analysis. Twenty-four patients undergoing bowel resection were recruited 
for monitoring of perfusion and blood flow intraoperatively; twenty had undergone 
laparoscopy and the remainder had a laparotomy operation. Eight different 
measurements were performed during each trial. The results revealed that the 
probe could be an indicator of evaluating perfusion and blood flow changes at 
different stages of the surgery. The results also suggest that laser Doppler is more 
sensitive to artefact compared to PPG. Differences in amplitude of PPG between 
different measurements reveal that the sensor does detect changes in blood 
volume and flow confirming that it has the ability to verify that pulsatile flow is 
being preferentially preserved at the last step of the resection procedure (at the 
edges of the anastomosis sites after anastomosis is been constructed).  
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AC              Alternating Current    
BZ               Biological Zero 
DAQ            Data Acquisition 
DC              Direct Current 
ECM           Electronic Contractility Meter  
Hb              Haemoglobin (also referred to as deoxyhaemoglobin) 
HbO2          Oxyhaemoglobin  
HGC           Hydrogen Gas Clearance  
IR Infrared light 
IVM             Intravital Microscopy  
LED             Light Emitting Diode 
LDF             Laser Doppler Flowmetry 
LDPI            Laser Doppler Perfusion Imaging 
LDPM          Laser Doppler Perfusion Monitoring 
LFA             Laser Fluorescence Angiography  
NIRS           Near Infrared Spectrophotometry  
PCB            Printed Circuit Board 
pCO2          Carbon dioxide partial pressure 
PPG            Photoplethysmography 
PtO2           Tissue Oxygen Tension  
R                 Red light 
SaO2 Arterial Oxygen Saturation measured using a haemoximeter 
SpO2                 Arterial blood Oxygen Saturation 
StO2              Tissue Oxygen Saturation 
VI                Virtual Instrument 
VLS             Visible Light Spectrophotometry  
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Introduction 
Having a continuous method for monitoring perfusion of bowel tissue is very 
important and desirable in gastrointestinal surgery since it can assist in the early 
detection of inadequate blood supply, which can help to reduce the complication 
and the length of the hospital stay after an operation and also to reduce 
postoperative morbidity and mortality (1, 2). Several techniques and monitoring 
devices have been applied for assessing bowel tissue perfusion intraoperatively 
however each of them have their limitations, some of these limitations include; 
not easy to use for the operator, are time consuming, invasive and/or expensive. 
These limitations prevent their routine application in clinical practice for 
monitoring perfusion in bowel operation. Therefore, to date there is no widely 
accepted and readily available intraoperative technique to reliably assess the 
viability of bowel tissue. 
 
This project sets out to develop a new technique for the continuous monitoring of 
bowel viability. A new processing system was developed utilising the combination 
of two techniques, photoplethysmography (PPG) along with laser Doppler 
flowmetry (LDF), suitable for intraoperative monitoring of bowel perfusion, a new 
combined PPG/LDF sensor was also designed. The goal of this work is to 
demonstrate that this novel probe may have the capability of continuously and 
noninvasively monitoring the perfusion of bowel tissue intraoperatively by 
detecting any changes in volume of arterial blood pulsating and estimating the 
oxygen saturation using PPG along with estimating the blood flow (the flux) using 
LDF.  
 
This thesis describes the design, construction and evaluation of the combined 
system. In vivo evaluation was performed in 24 patients at The Royal London 
Hospital. The methodology of the clinical trials is described. The results from the 
trials in all patients undergoing bowel resection are presented.  
                                                                                                 CHAPTER ONE 
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1.1 Thesis Outline 
A brief summary of each of the chapters contained in this thesis is presented 
below. 
 
Chapter 2 presents a review of the anatomy and physiology of the 
gastrointestinal tract; an emphasis has been given to the intestine, as it is the 
main part of investigation for this project. The blood supply of the intestine is also 
presented in detail to give a better explanation of the perfusion of the intestine, 
which would provide a better understanding of intraoperative measurements in 
bowel resection. 
 
Chapter 3 presents the different kinds of bowel resection. Bowel obstruction in 
both small and large intestine is described and more attention has been given to 
the main large bowel obstruction, colorectal cancer. Surgical treatments for 
colorectal cancer are presented in more detail, as this was the main focus of this 
study. And different types of surgical operations for bowel colorectal cancer are 
presented as well. 
 
Chapter 4 describes a review of the basic principles of photoplethysmography 
and pulse oximetry. The technology of the pulse oximeter has been explained 
along with principle of operation, applications of the technique; also limitation of 
the technique is presented in brief. The two probe configurations utilised in pulse 
oximetry are described as well. 
 
Chapter 5 covers the basic principle of laser Doppler flowmetry (LDF) technique. 
Types of perfusion measurements, limitation of the system and LDF application in 
the gastrointestinal area is also presented.  
 
Chapter 6 discusses which techniques for monitoring the bowel have been taken 
from the earliest recorded study in 1976 until now. Past and current techniques 
for intraoperative determination of intestinal viability have been presented, which 
is the main focus of this project, an overview of the technique is provided for 
each, followed by the advantages and limitations associated with its use. 
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Chapter 7 describes the design and development of a new combined sensor for 
perfusion monitoring of the intestine intraoperatively. The design considerations, 
construction and optical component selection of a combined dual-wavelength 
photoplethysmography and LDF are set out in this chapter. Since the sensor will 
be introduced in theatre to patient’s abdomen, sterilisation issues of the probe 
prior to each trial, which was very important, are also discussed. The two 
evaluations that were conducted in the laboratory on healthy volunteers are 
presented as well. These experiments are: (1) Investigation of the optical 
interference between LDF and PPG, (2) Evaluation of the system’s ability to 
differentiate between states of normal and compromised perfusion. 
 
Chapter 8 goes on to describe the development of a new processing system, 
which compromises two techniques, photoplethysmographic (PPG) and LDF. 
Details of the schematic design, choice of components and the construction of 
the circuits are reviewed. The evaluation has been performed and the results 
presented as well.  
 
Chapter 9 describes the developed virtual instrument for use in conjunction with 
the new combined sensor. The LabVIEW software described is used to acquire, 
display and store the obtained PPG and LDF signals. Details of the algorithms 
used for estimating SpO2 values are also covered in this chapter. 
 
Chapter 10 presents the results obtained from all clinical trials on 24 patients 
undergoing bowel resection performed in The Royal London Hospital. These 
results include the PPG and LDF amplitude analysis along with the outcome of 
SpO2 calculations from all patients.  
 
Chapter 11 presents the conclusions drawn from these studies along with 
suggestions for future work. 
 
 26 
 
 
 
 
 
Review Of Anatomy And Physiology Of 
Gastrointestinal Tract 
2.1 Overview of the gastrointestinal tract  
The human gastrointestinal (GI) tract refers to all the structures from the mouth to 
the anus. In fact, the GI starts with the mouth and proceeds to the pharynx, 
oesophagus, stomach, duodenum, jejunum, intestines (small and large), rectum 
and finally the anal canal (Figure 2.1). This muscular tube is about 9 m in length 
(in an adult) and it is under control of the autonomic nervous system (3). 
 
 
Figure 2.1: Picture of the gastrointestinal (GI) tract starts from the mouth and 
proceeds to the pharynx, oesophagus, stomach, duodenum, jejunum, intestines 
(small and large), rectum and finally the anal canal (4). 
 
The responsibility of the GI tract is the breakdown of the food, digestion and 
absorption of nutrients, and excretion of solid waste. Ingested food cannot be 
absorbed into the body, in fact food need to break down physically then larger 
                                                                                                 CHAPTER TWO 
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molecules (e.g. starches) has to be converted to nutrients in order to be absorbed 
into the blood and then the nutrients are carried to cells throughout the body. This 
is the initial role of the GI system. So when food is eaten, it moves through each 
part of the GI tract and then the various digestive fluids and enzymes will mix with 
it. The salivary glands begin secreting as soon as food is inserted into the mouth, 
and as the food passes throughout the GI, enzymes secrete in the stomach, 
small intestine, pancreas and the liver in order for the digestion to continue. The 
small and large intestines play important roles in digestion with different 
functions. The most important part of digestion occurs in the small intestine while 
the responsibility of the large intestine is to absorb water and the excretion of 
solid waste material (5, 6). 
 
2.2 Peritoneum  
The peritoneum is a thin semi-transparent membrane and is multi-layered. It 
coats the abdominal wall, pelvic cavity and the organs within it. The peritoneum 
has a shiny surface and secrets a lubricative liquid known as serous fluid. The 
peritoneum is in two parts: The parietal peritoneum, which lines the abdominal 
wall and the visceral peritoneum that covers the external surface of internal 
organs (viscera). A lot of blood vessels, lymph vessels and nerves supply the 
peritoneum. The peritoneum forms ligaments, mesenteries, omenta, pouches, 
pits, and folds while it passes from one organ to another organ and from the 
organs to the body wall (7). 
 
The mesentery is a fold of two peritoneal layers and is the part of the visceral 
membrane that connects a membrane-encapsulated organ to the abdominal wall 
or to another organ (7). 
 
2.3 Stomach  
The stomach is one of the main organs of digestion. It has a sac-like shape; and 
is located between the oesophagus and the intestines (8). It can be seen in 
Figure 2.2. 
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Four layers make up the stomach wall, from outer to inner including: the serous 
(peritoneal), muscular, submucous and mucous coats. The serous, or the 
peritoneal coat, is a thin layer of loose connective tissue made up by the 
peritoneum. It is attached to the subjacent muscular coat which is located just 
under the peritoneal coat and has three layers of non-striated muscles, consisting 
of outer longitudinal, middle circular and inner oblique layers respectively from 
outer to inner (8, 9). The internal structure of stomach can be seen in Figure 2.3. 
 
 
Figure 2.2: Picture of the major abdominal organs including stomach, small and 
lare intestines (10). 
 
2.4 Small Intestine  
The longest section of the gastrointestinal (GI) tract is the small intestine (or small 
bowel). Although it is referred to as small, in fact it is a lot longer than the large 
bowel (4.3 meter on average). It is thin (or narrow) compared to the large bowel 
and about 20 mm in diameter. The small bowel is a convoluted tube and a vital 
organ involved in nutrient absorption, starts from the pylorus and ends at the colic 
valve. Its length is approximately 7 meters but it diminishes in size.  As it can be 
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seen in Figure 2.4 the small bowel is placed in the central and lower part of the 
abdominal cavity surrounded by the large intestine (11).  
 
 
Figure 2.3: The internal structure of stomach, from outer to inner including: the 
serous (peritoneal), muscular, submucous and mucous coats (12). 
 
 
Figure 2.4: Picture of small and large intestine, the small bowel is placed in the 
central and lower part of the abdominal cavity surrounded by the large intestine 
(10). 
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The small intestine wall is made up of four coats (in fact, most of the GI tract is 
similarly composed of these four layers): serous, muscular, areolar, and mucous.  
The mucosal and submucosal layers of the small intestine are modified and 
consist of many glands known as the intestinal glands. The small intestine wall is 
protected from the action of acid by gastric juice secreted by the intestinal glands. 
The surface of mucosa has millions of villi giving it a soft velvety appearance. Villi 
(singular: villus) are microscopic finger-like projections, helping nutrients in the 
food absorb more efficiently into the body. There are about 20–40 villi per square 
millimetre. The serous coat, the external layer, is originated from peritoneum and 
the entire surface of the small bowel is coated with that. The muscular layer is 
located under the serous layer comprised of two distinct layers of muscle fibres: 
an outer longitudinal and an inner circular (11).  
 
2.4.1 Duodenum, Jejunum and Ileum 
The small intestine is divided into three segments including the duodenum, 
jejunum and ileum. The smallest segment of the small intestine, the duodenum, is 
approximately 25 cm long and starts from the pylorus and ends at the duodenal 
jejunal flexure. This area connects the rest of the intestine to the stomach and it 
can be anatomically divided into four parts: superior, descending, horizontal, and 
ascending. It curves around the head of the pancreas and is also the most 
immobile part of the small bowel (13).  
 
Jejunum is the middle segment of the small intestine, which is wider and thicker 
than the duodenum. The jejunum is about 2.5 m long and the ileum, which is the 
last segment of the small intestine, is about 3.6 m long (14). The mesentery, an 
extensive fold of peritoneum, attaches itself to the posterior abdominal wall and 
allows jejunum and ileum to have the greatest motion (13). The ileum ends with 
the ileocecal valve (sphincter) and enters into the wall of the large intestine. The 
ileocecal valve regulates the movement of chyme into the large intestine and 
prevents backward flow of the contents from the large intestine. No structural or 
functional margin exists between the three segments of small intestine (15). 
Figure 2.5 shows the structure of villi in the small intestine. 
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Figure 2.5: The structure of villi: microscopic finger-like projections. Villi help 
nutrients in the food absorb more efficiently into the body (16). 
 
While food is passed from the small intestine to the large intestine all of its 
nutrients along with most of the water are extracted from the food (11). 
2.5 Large Intestine 
When all nutrients have been absorbed in the small intestine via the villi, the 
watery waste then enters the last part of the gastrointestinal tract, the large 
intestine. In fact, the key function of the large intestine is to absorb water from the 
waste and compresses it into a form so that it’s easy to discharge from the body. 
As the chyme slowly passes through the colon, the water is removed and it is 
mixed with mucus and bacteria and at the end is converted into faeces (11). 
 
The large intestine has two sections including the colon and rectum. The colon is 
the longest part of the large bowel, which is sub-divided into four sections 
including: the ascending colon, the transverse colon, the descending colon and 
the sigmoid colon. The last segment of the colon is known as the rectum (11). 
See Figures 2.4 and 2.6. 
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Figure 2.6: Parts of large intestine including Ascending Colon, Descending Colon, 
Sigmoid and Rectum (17). 
 
2.6 Blood Supply of the stomach and intestine 
The stomach has a rich blood supply; five main arteries are left gastric, right 
gastric, right gastro-epiploic, left gastro-epiploic and short gastric (18) as shown 
in Figure 2.7. 
 
Three branches from abdominal aorta provide blood supply to the intestine, which 
include the celiac artery, superior mesenteric artery (SMA), inferior mesenteric 
artery (IMA), and branches of the intestinal iliac artery (IIA) (18). See Figure 2.8. 
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Figure 2.7: The arterial blood supply of stomach including five main arteries: left 
gastric, right gastric, right gastro-epiploic, left gastro-epiploic and short gastric 
(19). 
 
This research project focuses on the intestines, so blood supply for the small and 
large intestines will be described in more detail.  
 
2.6.1 The Celiac Artery 
The celiac artery or trunk, which is very short about 1 cm to 2 cm long, comes 
from the aorta through a diaphragm. This artery supplies the foregut and it has 
three terminal branches including: the left gastric, splenic, and hepatic arteries 
(20).  
 
2.6.2 Superior Mesenteric Artery (SMA) 
Superior mesenteric artery is the main blood vessel in the digestive system, 
which branches off from the abdominal aorta. This artery supplies the pancreas 
and the lower parts of the intestine including the distal part of duodenum, the 
jejunum, ileum, cecum, appendix, ascending colon, and the transverse colon 
(20).  
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Figure 2.8: Arterial blood supply to the colon including: the celiac artery, superior 
mesenteric artery (SMA), inferior mesenteric artery (IMA), and branches of the 
intestinal iliac artery (IIA) (21). 
 
2.6.3 Inferior Mesenteric Artery (IMA) 
The inferior mesenteric artery provides the blood supply to the left third segment 
of the transverse colon, descending colon, sigmoid colon, rectum and also the 
upper half of the anal canal. The IMA then branches into the left colic, the 
superior rectal arteries, and the sigmoid branches (22). 
 
2.6.4 Marginal Artery  
The anastomoses of the connected branches of the colic artery form a 
continuous arterial loop or arcade near the inner border of the large intestine 
known as the marginal artery (23).  See Figure 2.9. 
 
2.6.5 Griffiths’ Point and Sudeck's point 
A watershed is a weak point in the colonic blood supply, which results from 
incomplete anastomoses of the marginal arteries. Several watershed areas can 
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be seen in the colonic blood supply and they are frequently susceptible to 
ischemia. These areas include Griffiths' point at the splenic flexure and Sudeck's 
point at the sigmoid colon (24) (Figure 2.9, indicated by shaded area). 
 
Griffiths' point is at the splenic flexure and at the junction of the SMA and IMA 
territories.  Anastomoses (the connections between the blood vessels) here might 
be weak or even absent, therefore the marginal artery at this area are poorly 
developed along the right side of the colon, explaining the reason that the splenic 
flexure is susceptible to ischaemia (25). 
 
The point of origin of the last sigmoidal artery, originated from the inferior 
mesenteric artery (IMA) is called Sudeck's critical point (26). 
 
 
Figure 2.9: Marginal arteries and Griffith’s along with Sudeck’s points that is 
indicated by shaded areas (27). 
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2.7 Veins 
The portal venous system is the system of veins containing multiple veins and 
tributaries, which drains blood from the greater sections the gastrointestinal tract 
(28). 
 
2.7.1 Portal Vein 
The portal vein is the vein of the gut that brings blood from the abdominal part of 
the gastrointestinal tract from the lower third of esophagus to halfway down the 
anal canal including: spleen, pancreas and gall bladder then delivers it to the liver 
(28). The portal vein is an important vein, about 8 cm long and made up by the 
union of superior mesenteric vein and splenic vein at the back of the neck of the 
pancreas (29) (Figure 2.10). It runs to the right behind the first part of the 
duodenum then inserts into the lesser omentum. After entering through the porta 
hepatis it then divides into two terminal branches: right and left branches. Further 
these terminal branches break up into a system of microscopic vessels known as 
sinusoids. After adding nutrients to the blood or removing them from it, then 
hepatic veins collect the blood from the sinusoid (29).  
 
2.7.2 The tributaries of the portal vein  
There are a few direct tributaries of the portal vein including: Splenic veins, 
Inferior mesenteric vein, Superior mesenteric vein, Left gastric vein, Right gastric 
and Cystic veins. Figure 2.11 shows all these veins (28). 
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Figure 2.10: Formation of portal vein behind neck of pancreas made up by the 
union of superior mesenteric vein and splenic vein (28). 
 
 
 
Figure 2.11: Veins of portal circulation including: Splenic veins, Inferior 
mesenteric vein, Superior mesenteric vein, Left gastric vein, Right gastric and 
Cystic veins (28). 
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2.8 Differences between the small and large intestine 
The small and large intestines are important sections of the human digestive 
system. Although there is continuity between both there are some noticeable 
differences between them, some of the main differences are explained below. 
Some of these differences have been shown in Figure 2.12. 
 
Mobility: The mobility of the small and large intestine are not the same in fact; 
most segments of the small intestine (apart from of duodenum) are mobile, while 
most of the colon is fixed in place by mesenteric (30). 
 
Calibre: The calibre of the small intestine when full is normally less than the 
caliber of the large intestine when full (28). 
 
Longitudinal muscle: In the small intestine a continuous layer has been formed 
around the intestine with the longitudinal muscle. But the longitudinal muscle in 
the large bowel is seen as three separate bands known as teniae coli (30). 
 
Fatty tags: On the wall of large intestine there are fat filled tags called the 
appendices epiploicae, however these fatty tags are not present in the small 
intestine (28). 
 
Smoothness: The small intestine wall has a smooth outer surface, but that of the 
large intestine becomes sacculated (having sac-like expansion) (31). 
 
2.9 Internal Differences 
Mucous membrane: The mucous sheath of the small intestine (see Figure 2.4) 
contains plicae circulars. These are not seen in the large intestine; instead 
occasional incomplete folds can be seen (30). 
 
Villi: The mucous sheath of small intestine (see Figure 2.5) is characterised by 
the presence of numerous villi. However, the large intestine has no villi (30). 
 39 
Lymphoid tissue: Throughout the mucous sheath of the small intestine (see 
Figure 2.4) masses of lymphoid tissue can be seen known as Peyer’s patches. 
Cells and organs that form the lymphatic system (like white blood cells, bone 
marrow etc.) are called lymphoid tissue. These are not present in the large 
intestine (31). 
 
Figure 2.12: some external and internal differences beween the small and large 
intestine (28). 
 
Different kinds of bowel resection will be discussed in the following chapter.  
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Bowel Resection 
3.1 Definition of the bowel resection   
Resection is another name for any operation that removes tissue or part of an 
organ. Bowel resection is a surgical procedure to remove part of, or the entire 
bowel (32). It is carried out when part of the small or large bowel is blocked, 
damaged or diseased. The goal of bowel resection is to treat the condition while 
preserving normal bowel function. Proctocolectomy is the removal of the entire 
colon and the rectum while in subtotal colectomy, part or all of the colon but not 
the rectum is removed (33). 
 
3.1.1 Small Bowel Resection 
Small bowel resection may be recommended for blockage of the small intestine 
(small intestinal obstruction) due to scar tissue, hernia or other causes, bleeding, 
infection or ulcers due to inflammation of the small intestine (regional ileitis, 
regional enteritis, Crohn's disease), injuries, cancer, precancerous polyps 
(nodes), carciniod tumour and ischaemia (34).  
 
3.1.2 Large Bowel Resection 
This operation is also known as colectomy, colon removal, colon resection, or 
resection of part of the large intestine. Some of the conditions that can be treated 
with large bowel resection include blockage in the large intestine (large intestinal 
obstruction) due to scar tissue or other causes, colon cancer, Crohn's disease, 
ulcerative colitis, precancerous polyps (nodes), familia polyposis, ischaemia (35). 
Since bowel obstructions are more common than other causes for bowel 
resection in both small and large intestine, they will be discussed in Section 3.2 in 
more detail.  
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3.2 Bowel Obstruction (BO) 
When a bowel obstruction (also known as intestinal obstruction) occurs, a 
blockage inhibits the contents (food, fluids, and gas) of the intestines to pass 
freely through the digestive tract. There are two types of intestinal obstructions, 
mechanical; which means there is a physical obstruction and non-mechanical 
(functional). A mechanical bowel obstruction might be a partial or complete 
blockage depending on whether any bowel contents can pass normally through 
the obstructed area (32). Mechanical obstructions can have many causes 
including tumours, scar tissues (adhesion), or twisting or narrowing of the 
intestines etc. Treatment for mechanical obstruction is mostly carried out by 
removing the source of the blockage (36). Examples of blockage in the small and 
large bowel are shown in Figure 3.1. 
 
BO can happen in any section along the small intestine or large intestine (colon), 
which will be discussed in Sections 3.2.1 and 3.2.2 respectively. 
 
Figure 3.1: Left side: a blockage in the small intestine as a result of scar tissue 
(adhesions) Right side: a partial blockage in the colon caused by a tumour (cancer) (37). 
 
3.2.1 Small Bowel Obstruction (SMO) 
Small bowel obstruction (SBO) is a common clinical condition requiring 
hospitalisation and surgical consultation, which is a reason for approximately 
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20% of surgical admissions of patients with acute abdominal conditions (38). 
SMO can occur partially or completely and prevents normal transit of the contents 
and blood flow through the small bowel (39, 40). In Table 3.1 the most common 
causes of small bowel obstruction with their incidence percentage is listed and 
some will be discussed. Intestinal obstructions are more common in the small 
intestine and they can cause severe pain. 
 
Table 3.1 Causes of Small Bowel Obstruction (41). 
Cause        Incidence 
Adhesion 60% 
Malignant tumour 20% 
Hernia 10% 
Inflammatory bowel disease 5% 
Volvulus 3% 
Others 2% 
 
Adhesions — the main cause of bowel obstruction is adhesions caused by scar 
tissue, which is usually related to prior laparotomy. Abdominal adhesions are 
bands of fibrous scar tissue; they can form on part of tissue inside the abdomen, 
causing the tissues to bind to each other or to the wall of the abdomen. See 
Figure 3.2. Sometimes this condition of adhesions blocks the intestines either 
completely or partially. If this obstruction happens it might lead to death in about 
5% of cases (42). 
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Figure 3.2: One example of blockage in the small and large bowel (43). 
 
Hernia – hernia reports account for 10% of small bowel obstructions (44), which 
can twist or narrow the intestine. A hernia might happen when there is a 
structural weakness in the tissue of the abdominal wall, in which a segment of the 
small intestine may stick out through this weakened area. It can appear as a lump 
under the skin. This segment of intestine is called a hernia, which can block the 
small intestine and the blood supply might be cut off as well (44). A sample of 
hernia has been shown in Figure 3.3. Hernia can occur in many areas in the body 
but it mostly happens in the small intestine (44). 
 
Figure 3.3: Hernia in small bowel in which a segment of the small intestine sticks out 
through this weakened area (43). 
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Tumours – Cancerous tumours can cause small bowel obstruction although it 
accounts for a small percentage of all small bowel obstructions. Growing within 
the wall of the intestine they might gradually block its inner passageway after 
some time (46). 
 
3.2.2 Large Bowel Obstruction (LBO) 
The obstruction can be complete or partial like in small obstruction. LBO can 
occur due to many causes, most often as a result of primary carcinoma, volvulus 
or diverticulitis (47).  
 
Colorectal Cancer – between 10 % and 30 % of patients with colorectal cancer 
present large bowel obstruction. Colorectal cancer is the reason for about half of 
all large bowel obstructions. If colon and also rectal cancer is not diagnosed this 
may lead to the gradual narrowing of the large intestine's inner passageway. 
Single-staged operation including resection and anastomosis are common 
procedures to be performed on an obstructed segment of the bowel (48). In 
Figure 3.4 LBO can be seen as a result of colorectal cancer. Since this study has 
been performed on patients undergoing bowel resection for colorectal cancer, the 
main focus will be on this, and the procedure will be discussed separately in more 
detail in the following sections.  
 
 
Figure 3.4: Large bowel obstructions are caused by colorectal cancer (43). 
 
Volvulus – Colon Volvulus (CV) is an abnormal twisting or rotation of a segment 
of intestinal around itself, which produces a closed loop of bowel with a pinched 
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base, this causes intestinal obstruction and vascular compromise (see Figure 
3.5). CV is a frequent condition that happens in people over the age of 65 (49). 
 
 
Figure 3.5: Large bowel obstructions are caused by volvulus in which a segment of 
intestinal twists around itself (50). 
 
Diverticular disease – Diverticula, are small bags that may protrude from the 
wall of the intestine. Having these pouches called diverticulosis, is more common 
in elderly people. About half of all people over age 60 might experience this 
disease. If the pouches become inflamed or infected then it is called diverticulitis. 
It might cause a blockage in the colon by gradually narrowing the intestine (51). 
 
3.3 Colorectal Cancer (CRC) 
Colorectal cancer (CRC) is a kind of cancer that forms in either the large intestine 
(colon) or the rectum (end of the colon) (52).  Worldwide, It is the third most 
common cancer, which affects more than 940,000 patients annually (53). In the 
UK it’s the second biggest cancer killer, and around 40,000 people are diagnosed 
with colorectal cancer in men and women each year. About two thirds of all CRCs 
occur in the colon and one third is located in the rectum. Caught early, it is often 
curable. Colorectal cancer can begin in either the tissues of any of sections of the 
colon or the rectum. When cells that line either of these organs become abnormal 
and grow out of control, a cancerous tumour forms. This cancer in most cases 
develops slowly over a period of several years (54, 55). 
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It is more common in people over the age of 50, and the risk increases with age. 
Also people more likely to get it if they have: polyps - growths inside the colon 
and rectum that may become cancerous, a diet high in fat and meat, high alcohol 
intake, family history or personal history of colorectal cancer, ulcerative colitis or 
Crohn’s diseases (55, 56).  
 
Symptoms 
Symptoms may include blood in the stool, narrower stools, change in bowel habit, 
abdominal pain and tenderness in the lower abdomen, weight loss and general 
stomach discomfort. Colonoscopy and sigmoidoscopy are screening tests for 
colorectal cancer (56). 
  
Treatment 
Treatment for CRC depends mostly on the stage and location of the cancer, 
however surgery is usually the most common treatment for all stages of 
colorectal cancer. Especially if detected early, surgery is often effective. The goal 
of bowel resection is to take out the affected part of the colon or rectum. 
Additional treatments are sometimes indicated including chemotherapy, 
radiotherapy and biotherapy or a combination of these (56). 
 
3.4 Bowel Resection for Colorectal Cancer 
In CRC, the tumour and part of the colon or rectum on either side is removed by 
a bowel resection procedure. After removal of the diseased part, the healthy ends 
of the colon or rectum are re-joined together (see Figure 3.6) with the aim of 
restoring normal function to the colon. 
Bowel resection plays an important role in colorectal cancer. In early-stage 
cancer, surgery is done to remove as much cancer as possible to give the 
greatest chance of survival. And in cases of advanced colorectal cancer when it 
has spread (metastasized) to other parts of the body, bowel resection is still 
required to remove tumours that are blocking the intestine or causing bleeding 
(57, 58). 
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Treatment after bowel resection may include radiotherapy, which uses high-
energy radiation, usually X-rays to kill cancerous cells, and also chemotherapy, 
which uses drugs, given either as pills or through injection, to selectively destroy 
them. Follow-up care is essential because colorectal cancer may come back after 
surgery, especially if it was not discovered in the early stages. 
 
3.5 Surgical Techniques for Bowel Resection  
Bowel resection surgery can be performed by one of two techniques: 1) 
laparoscopy or 2) open laparotomy.  
 
3.5.1 Laparoscopic and Laparotomy Procedures 
The first attempt to laparoscopic colectomy for cancer was made in the early 
1990s (59). Laparoscopy, also known as keyhole or minimally invasive surgery, is 
a method that requires 5-6 small incisions in the abdomen, one for a laparoscopic 
camera and the rest for other tools, along with a small incision of 35–45 mm for 
the anastomosis (60). While in laparotomy, the operation is carried out through a 
large incision on the abdomen. Laparoscopic operations have become extremely 
popular recently, and have been widely employed for almost all kind of resection 
operations in patients with different stages of colorectal cancer (60, 33). 
 
Laparoscopic operations have been of more interest than open laparotomy, this 
is due to the benefits of laparoscopy which include; less pain from the incisions 
after the operation, faster return of the normal bowel function, quicker healing of 
the wound, less scarring on the bowel and shorter stay in hospital (61). Also 
during the operation a magnified perspective of the operation can be viewed on a 
monitor by the surgical team leading to safer surgery, while in laparotomy the 
surgical team is not able to view the entire surgical field for the whole time of the 
surgery (62). As a result laparoscopic surgery is the most common procedure 
performed in the clinical area for bowel operation. 
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Even in laparoscopy, the anastomosis has to be performed while that part of the 
colon is out of the bowel through an abdominal incision (the one made at 35-45 
mm), which the surgeon creates prior to the anastomosis (63).  
These two procedures were performed for bowel resection for the patients that 
were included in this study, with the majority having colon cancer, out of them, 20 
of the patients were treated laparoscopically, and for the remaining 4, open 
laparotomy was performed. 
 
3.5.2 Anastomosis 
The creation of a joint between two ends of the bowel is called anastomosis, 
which is needed after removing the dead/diseased part. In fact, an anastomosis 
is a surgical procedure between two structures and can refer to a connection that 
is created between any tubular structures including intestine or blood vessels 
(55). 
 
The construction of an anastomosis depends on the kind of the resection. 
Different kinds of anastomosis can be performed, such as end-to-end, side-to-
end and side-to-side anastomosis in which different staplers can be used to 
create the desired anastomosis (64). Figure 3.6 shows an end-to-end 
anastomosis as an example. 
 
The following sections will discuss and outline the general principles in bowel 
resection operations. 
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Figure 3.6: An example of anastomosis, an end-to-end anastomosis, in which the ends 
of the bowel are joining together to create an anastomosis using the stiches (64). 
 
3.6 Types of Surgical Operation for Bowel Resection for CRC 
A colectomy is the name of an operation in which part of the colon has to be 
removed. As mentioned in Chapter 2, the colon has several parts (Figure 2.5). 
Depending on where the tumour is, one or more specific parts may be removed. 
Table 3.2 describes the type of different resections according to their location in 
the bowel (59). Each cancer operation is aimed to remove all the cancer along 
with enough part of the healthy normal tissue around it, to ensure that the risk of 
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the cancer returning in that area is as low as possible. Colectomy is performed to 
treat one of these bowel cancers: 
 
Table 3.2: Types of colorectal resection (59) 
Type of Operation Location of Tumour 
Right Hemi-Colectomy Caecum, right colon, hepatic flexure 
Extended Right Hemi-Colectomy Transverse colon or splenic flexure 
Transverse Colectomy Transverse colon 
Left Hemi-Colectomy Splenic flexure or left colon 
Sigmoid Colectomy Sigmoid colon 
High Anterior Resection Recto-sigmoid, upper third rectum 
Low Anterior Resection Middle third rectum 
Abdominoperineal Resection Distal third rectum 
 
The next sections explain different types of colorectal resection. 
 
3.7 Surgical Treatment for Colon Cancer 
3.7.1 Right Hemi-Colectomy 
A right hemi-colectomy is the usual operation when the tumour is in the right side 
of the colon, so the right side of the colon has to be removed, which is called right 
hemi colectomy. The first step in all bowel resection is mobilisation of the colon 
and its mesentery, and then ligation of the appropriate vessels at their origin has 
to be performed. Since right colic vessels are the vessels that supply the right 
part of the colon, these specific vessels have to be ligated (Chapter 2). With the 
colon mobilised and after the ligation, the segment of the colon to be resected is 
ready to be removed and anastomosis can be constructed. For that, the ends of 
the remaining parts of the colon are re-joined to each other. Anastomosis 
(Section 3.5.2) can be performed with hand sutures or using staples (59). Figure 
3.7 shows a right hemi-colectomy and the anastomosis. 
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Figure 3.7: A right hemi-colectomy, A: tumour in cecum, B: ileocolic anastomosis (65). 
 
3.7.2 Extended Right Hemi-Colectomy 
When the tumour is in the mid transverse colon or splenic flexure, the treatment 
can be managed by an extended right hemi-colectomy (Figure 3.8). This 
operation will remove the terminal ileum, cecum, ascending colon, hepatic flexure 
and a portion of the transverse colon. When the tumour is in the transverse colon, 
the middle colic artery, which comes from superior mesenteric artery, has to be 
ligated. And if the tumour is in splenic flexure, the left colic artery, which comes 
from the inferior mesenteric artery (IMA) has to be ligated (59).  
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Figure 3.8: Extended right colectomy, A: tumour in splenic flexure, B: ileocolic 
anastomosis (65). 
 
3.7.3 Transverse Colectomy 
If the middle part of the bowel is removed (the transverse colon), it is called a 
transverse colectomy. In which the middle colic artery has to be ligated then two 
ends of the remaining colon (the ascending and descending colon) can be 
rejoined to create the anastomosis (66). See Figure 3.9. 
 
Figure 3.9: Transverse colectomy, A: tumour in transverse colon, B:  anastomosis of 
ascending and descending colon (65). 
 
 
 
53 
3.7.4 Left Hemi-Colectomy 
This operation is performed for tumours of the descending colon, in which the left 
colic artery has to be ligated, the splenic flexure and descending colon should be 
removed and the rest of the colon (the transverse and upper sigmoid colon) can 
be rejoined to create the anastomosis (67). See Figure 3.10. 
 
 
Figure 3.10: Left hemi-colectomy, A: tumour in descending colon, B: anastomosis of 
transverse and sigmoid colon (65). 
 
3.7.5 Sigmoid Colectomy  
If the sigmoid colon is removed it is called a sigmoid colectomy. After removal of 
the cancerous segment the upper rectum and descending colon can be rejoined 
to make the anastomosis (68). In some patients a colostomy needs to be 
performed for drainage of waste through an opening in the abdomen (stoma) 
(69). A colostomy is considered in some cases to divert digestive waste away 
from the affected areas of the colon allowing them a greater chance of healing. 
Once the areas are healed the anastomosis can be treated (59). See Figure 3.11.  
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Figure 3.11: Sigmoid colectomy, A: tumour in sigmoid colon, B: anastomosis of the upper 
rectum and descending colon (65). 
 
3.8 Surgical Treatment for Rectal Cancer 
3.8.1 High Anterior Resection 
Anterior resection is performed for treatment of rectal tumours, high anterior 
resection involves the removal of the sigmoid colon, the upper rectum and a 
variable portion of the left colon. For anterior resection the sigmoid artery, which 
comes from the inferior mesenteric artery has to be ligated after the bowel is 
mobilised (70). 
 
3.8.2 Low Anterior Resection 
To treat rectal cancer and cancers in the upper third of the rectum low anterior 
resection is considered. After removing the cancerous part of the rectum, the 
colon can be reattached to the remaining part of the rectum (71). See Figure 
3.12. 
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Figure 3.12: Low anterior resection: A: tumour in rectum, B: anastomosis of the anus and 
the rest of sigmoid colon (65). 
 
3.8.3 Abdominoperineal Resection 
Abdominoperineal resection  (APR) is a standard surgical treatment for patients 
with a tumour in the distal third of the rectum (i.e. when the cancer is located very 
low in the rectum or anus). For this treatment the anus, rectum and sigmoid colon 
have to be removed leading to a permanent iliac colostomy. Ligation of the 
superior rectal artery has to be performed before resection (72). See Figure 3.13. 
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Figure 3.13: Abdominoperineal resection, A: tumour in rectum, B: colostomy (65). 
 
 
The next chapter presents a summary of previous research in intra-operative 
determination of intestinal viability.         
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Intraoperative Determination of Intestinal 
Viability 
4.1 Introduction 
As mentioned in Chapter three, one of the most common operations in 
gastrointestinal surgery is bowel resection for patients who have different kinds of 
bowel cancer or any other occlusion in which anastomosis has to be carried out 
following the removal of an unhealthy segment of the bowel. The most common 
complication after the anastomosis is anastomotic leakage, which unfortunately 
has remained a problem (73). Despite some developments in techniques like new 
stapling methods for anastomosis and modalities in bowel operation, anastomotic 
leakage after bowel resection is still a major concern and the occurrence has not 
decreased significantly over the last decade (74). In order to avoid anastomotic 
leak or any other complications like intestinal ischemia or necrosis, which can 
happen in any bowel surgery, intraoperative viability of the bowel must be 
evaluated regularly during any gastrointestinal operation. In order to have 
successful healing of an anastomosis, a sufficient blood supply is needed, which 
then helps to decrease the anastomotic leakage, intestinal ischemia and necrosis 
(75, 76). Having a successful anastomosis greatly improves the patient’s recovery 
stay in hospital after an operation and also reduces postoperative morbidity and 
mortality. The incidence of anastomotic leakage has been reported between 1.2% 
and 19.2%, nearly 32% of these patients die due to postoperative complication 
(77). Unfortunately in clinical practice it is not easy to judge whether the intestine 
remains viable after the procedure, and determination of the bowel viability has 
remained a dilemma for surgeons (78-81). In many cases, second-look operation, 
decided by the surgeon, is carried out to be sure the surgery was a success (82, 
83). This procedure has become more common in some mesenteric surgery 
especially when uncertain intestinal viability is observed during the primary 
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surgery. Some surgeons believe that the second-look laparotomy is a gold 
standard for determining future bowel viability (84).   
 
Intestinal microcirculation and viability in the clinical site is usually estimated on 
the basis of clinical findings such as the intestinal colour tone of the serosal 
surface (Chapter 2), the presence of bowel peristalsis (muscle contractions), 
arterial pulsation and also bleeding from the marginal arteries. These clinical 
features of the bowel viability do not relate consistently to bowel survival, and also 
they are subjectively based on the experience of the surgeon (78, 75), so human 
error is possible. For example a dark colour does not always indicate a serious 
problem, as the bowel might be in fact viable; the reason for the dark colour may 
be due to transient venous insufficiency. The colour may seem normal in early 
arterial occlusion. Absence or lack of mesenteric pulsation does not necessarily 
mean that the tissue is not viable; hypotension or spasm might be a reason for 
this. Also even in a totally ischemic bowel, peristalsis may continue. Therefore 
visual signs are unreliable indicators for assessment of intestinal microcirculation 
and should not be the sole basis for clinical decision making. As a result, there is 
a need to have a more reliable method for determination of intestinal viability (78, 
85) during gastrointestinal operations. To address this need, a wide variety of 
methods have been proposed, each having advantages and disadvantages. 
Studies to assess the intra-operative and/or peri-operative intestinal blood flow 
using sensors have a long history, dating back to 1976. To date just a few of these 
methods are applicable in surgical practice for use in tissue of doubtful viability, 
although none of them are employed routinely in clinical practice (78).  
 
Some methods have been shown to increase the accuracy of intestinal viability 
assessment and have been the subject of research studies. These techniques 
have shown potential to be of some value, although they are subject to certain 
drawbacks and limitations.  
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4.2 Monitoring Methods for the Detection of Intestinal Viability 
As mentioned, to date, various methods have been proposed to assess intestinal 
blood flow or intestinal viability, most of which are discussed below. 
All methods for the detection of monitoring of the bowel have been divided into 
two groups based on old and new techniques with some still under research: 
 
First Group: methods, which are old or no longer in use. 
Second Group: methods, which are new or have been of great interest in the last 
decade. 
  
In the following sections, all the monitoring methods will be described according to 
these two groups. 
 
4.3 First Group 
This group of monitoring methods comprises of all methods involving those, which 
are no longer employed or of no interest at present, either in clinical use or in 
research. 
 
4.3.1 Polagraphic Measurement of Oxygen Tension 
Tissue oxygen tension (PtO2), measures the local partial pressure of oxygen in a 
specific tissue in the body using a Clark electrode (86). There is some controversy 
regarding the usefulness of employing this method in the intestinal tissue. One 
study showed that the decreased PtO2 level in intestinal tissue can predict 
anastomotic leakage (87), while another study showed that no increase in 
anastomotic leakage was associated with a decrease in PtO2 (88).  A result of 
these conflicting findings has been a decline in the use of the technique. 
 
4.3.2 Doppler Ultrasound 
In earlier studies it was believed that intraoperative Doppler ultrasound of the 
marginal arteries was a reliable method for predicting the intestinal viability 
intraoperatively, an economical and easy to use technique (89). In a study in 1979 
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by Cooperman, Doppler ultrasound was used successfully to determine the 
adequacy of blood supply at the edge of anastomosis of resection for patients 
undergoing intestinal resection (90). In a more recent study in patients undergoing 
colorectal resections, only 1% incidence of anastomotic leakage at the edge of the 
resected site was observed when they were assessed with Doppler ultrasound 
(91).  
 
The drawbacks of Doppler ultrasound for assessing bowel viability have been 
discussed widely and include being sensitive to the signals from nearby large 
vessels and requiring tissue contact, which can impair local blood flow (92). Also 
Rotering et al. in a comparison study in 1982 demonstrated that laser Doppler has 
superior sensitivity, ease of use and objectivity compared to ultrasound (93). In 
1988, Lynch TG et al. presented a comparison study between Doppler ultrasound, 
laser Doppler, and perfusion fluorometry in bowel ischemia, results have revealed 
that the sensitivity of Doppler ultrasound in detecting intestinal viability is 86% 
which is significantly lower than that of two other methods (the sensitivity of laser 
Doppler index was 94%, and of perfusion fluorometry was 95%) (94). 
 
4.3.3 Hydrogen Gas Clearance (HGC) 
Hydrogen gas clearance (HGC) was applied for assessment of microcirculation in 
intestinal studies in earlier experimental studies, which were mostly studied 
between 1964 and 1990 (95). This technique is based on the method of inserting 
a positively polarised electrode into the tissue of interest, administering hydrogen 
gas (H2) which can be done by respiration or intra-arterially, allowing the H2 to be 
cleared from arterial blood, and at the end the exponential clearance rate of H2 
from the target tissue, can be monitored.  
 
A 1980 review article concluded that HGC was a valid and important method for 
monitoring blood flow, despite some drawbacks (96). HGC has been performed 
for measuring blood flow in different organs, in fact any tissue in which a small 
electrode can be implanted, however this technique is not used routinely in clinical 
application for evaluation of intestinal blood flow mostly because of its 
invasiveness, inconvenience and inadequate reliability (75, 97). 
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4.3.4 Radioisotope Studies 
Radioisotope methods have been used in earlier studies in human and animal 
research to monitor blood perfusion at anastomotic or ischemic sites. In these 
methods, injections of radioisotopes were applied to monitor blood flow in regions 
where ischemia was suspected. These methods have some disadvantages, the 
main one being exposure to radiation for both the patient and medical personnel. 
Also storage and disposal of radioisotopes are expensive and impractical.  
Therefore these techniques are no longer in clinical or research use at present 
(98, 99). These studies were mostly performed between 1976 and 1985. 
 
4.3.5 Bowel Wall Contractility Measurements 
In 1986, a new method called the electronic contractility meter (ECM) was 
proposed to measure contractile activity of the ischemic part of the bowel. This 
technique comprises two main components including a special probe and an 
electronic control part. The probe was clipped to the surface of the bowel and the 
electromyogram (tracing representing electrical activity in muscle) reflecting 
peristalsis (muscle contractions) of the small intestine, was measured in millivolts 
using a computer algorithm. Low values of electromyography (EMG) are attributed 
to ischemic damage of the site under study (100). In a later study by Brolin et al. it 
was observed that the electronic contractility meter (ECM) is capable of providing 
a quantitative assessment of ischemic damage in the bowel and that EMG was a 
sensitive indicator of ischemic damage (81). However this technique did not find a 
wider clinical acceptance mostly due to the complexity of the technique. 
 
4.4 Second Group 
This group of monitoring methods covers all methods involving those which have 
been of more interest in the last decade, and still are of interest today in clinical 
practice or research area. 
 
4.4.1 Pulse Oximetry 
DeNobile et al. and Erikoglu et al. measured the oxygen saturation of the bowel 
using pulse oximetry in 1990 and 2005 respectively. The results of both studies 
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concluded that using pulse oximetry for intraoperative evaluation of intestinal 
viability could provide an idea of the degree of the pathological changes in the 
investigation area (78). Also MacDonald et al. in 1993 suggested that a pulse 
oximeter is capable of being used in intestinal blood flow assessment 
intraoperatively (101). One year later in 1994, Gardner et al. using reflectance 
pulse oximetry in an animal model showed that pulse oximetry can be a useful 
and a simple method for continuously monitoring the blood flow of the distal colon 
intraoperatively and might also be useful when there is doubt about the adequacy 
of blood flow to the distal colon (102). In 2001 a study suggested that pulse 
oximetry can help preserve bowel of doubtful viability (103). In a study in 2008, 
Phillips et al. introduced a novel reflectance pulse oximetry method for 
intraoperative measurements of SpO2 in the oesophagus and large bowel and 
suggested that this method is able to measure SpO2 continuously in patients with 
compromised peripheral perfusion (104).  
 
Although pulse oximetry is widely accepted there are some limitations. Hadley and 
Mars in 2003 stated that although pulse oximeters measure oxygen saturation 
and give an indication of perfusion, they do not measure blood flow or tissue 
viability (105). Also Dyess et al. in 1991 believed that by using pulse oximetry, 
there is a high rate of false-negative and false-positive evaluations (106). 
 
4.4.2 Near Infrared and Visible Light Spectrophotometry (NIRS & VLS) 
The principle of spectrophotometry is based on the amount of light absorbed or 
transmitted as it passes through the target tissue in order to measure the 
concentrations of different types of haemoglobin and/or ‘tissue oxygen saturation’ 
(StO2). Visible light spectrophotometry (VLS) relies on locally absorbed, shallow-
penetrating visible light of 475-625 nm for monitoring microvascular hemoglobin 
oxygen saturation (StO2) in small thin tissue volumes and has a penetration of 
about 2 mm into the tissue. NIRS with wavelengths typically beginning at 700-730 
nm can penetrate more deeply compared to visible light. Unlike pulse oximetry, 
these techniques do not use photoplethysmography to discriminate between the 
pulsating arterial blood and the other blood components. Near Infrared 
Spectrophotometry (NIRS) therefore provides assessment of oxygenation in all 
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vascular compartments including arterial, venous and capillary, while VLS 
generally is able to measure the StO2 in the capillaries due to its shallower 
penetration depth (107).  
 
VLS and NIRS have been employed recently in some studies. Benaron et al. in 
2005 suggested that VLS is a suitable method for monitoring the localized 
subsurface hemoglobin oxygen saturation in the microvascular tissue (108). In 
2006 Hirano et al. successfully measured bowel StO2 using NIRS at the 
anastomosis site of the bowel in patients undergoing colorectal resection. They 
demonstrated that low StO2 on the anastomosis site could be a warning of an 
increased risk of anastomosis complications (109). Recently the evaluation of the 
estimated value of VLS for anastomotic leakage has been performed for the colon 
and rectum by Karliczek et al. in 2010. According to the result of this study on 
patients undergoing colorectal resections, StO2 levels in colonic tissue were stable 
and reproducible while these values increased at the anastomotic site of the 
bowel after the creation of the anastomosis. An increase in the value of StO2 was 
interpreted as a sign of leakage in the anastomosis (110). 
 
It is believed that one advantage of VLS is the shallow penetration of the light in 
this technique, which is considered more appropriate than NIRS for the 
measurements of bowel wall oxygenation (102). Although the most important 
advantage of VLS compared to other techniques like polarographic (or tonometry 
measurements), NIRS or laser Doppler flowmetry (LDF) is that there is no need 
for tissue contact since the instrument corrects for an uneven baseline and the full 
light spectrum is analysed (110). 
 
There are some drawbacks, for example the specific level of StO2 that can lead to 
intestinal ischemia has not yet been defined.  Also there is a lack of reproducibility 
in StO2 values measured by different algorithms by different oximetry systems. 
Another drawback is that presence of solids (like stool and food) inside the 
intestine can affect the results. Also the probe needs to be held perpendicular to 
the tissue surface, a different angle can affect the accuracy of the measurements. 
In colorectal anastomoses, measurements are not easily performed, and finally, 
spectrophotometry systems are expensive. However it seems that VLS is an 
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auspicious method for bowel oxygenation measurement and has been recently 
the main subject of the majority of studies in this area. 
 
4.4.3 Intravital Microscopy (IVM) 
Intravital microscopy (IVM) is one of the most recent developments and has been 
recommended as a gold standard in 2008 by Duchs and Fiotzik in a study for 
microcirculatory research, since it can directly visualise and quantify changes in 
blood flow at the capillary level (111). In an animal study by Yasumura et al. this 
method showed that it could be a useful indicator of bowel viability. However the 
technique has not yet been applied to human studies, mostly due to the time 
consuming nature of the method (78). 
 
4.4.4 Fluorometry and Laser Fluorescence Angiography 
Fluorescence methods, namely perfusion fluorometry and laser fluorescence 
angiography (LFA), have both been performed in the evaluation of intestinal 
viability. Lynch et al. in 1988 in a comparison study between Doppler ultrasound, 
laser Doppler and perfusion fluorometry in bowel ischemia showed that the 
sensitivity of perfusion fluorometry in detecting intestinal viability is 95%, which 
was the greatest of these three methods (94). Later in 1992, Horgan mentioned in 
his work that perfusion fluorometry is a reliable technique for assessing areas of 
particularly doubtful viability (112). 
 
The main disadvantage of fluorometry is that the measurements are not 
repeatable as the fluorescein remains in the tissue of interest for a significant 
period following injection (113). Also the results show a large standard deviation. 
Some believe that the viability of the tissue cannot be measured directly by this 
method, moreover it can also give a false prediction of non-viability and might lead 
to unnecessary secondary surgery (78). 
 
Recently laser fluorescence angiography (LFA) has been applied for intestinal 
microcirculation assessment, which is based on intravenous injection of 
fluorescent dye (indocyanine green). In this technique the target tissue is then 
illuminated using laser light. The system in this technique has been proved to be 
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reliable and the measurements are repeatable, which is an advantage compared 
to conventional perfusion fluorometry (114).  
 
4.4.5 Infrared Imaging 
Small differences in the temperature between adjacent structures can be 
measured by thermal or infrared imaging, which has been used for assessment of 
the intestinal blood flow in some studies.  
 
The first study dates back to 1978 when Moss et al. were working on reactive 
hyperemia (the transient increase in blood flow in tissue following haemostasis).  
They demonstrated that thermographic assessment could be of value in 
assessing bowel viability during surgery (115). Later in 2000, Brooks et al. 
introduced thermal imaging for detection of bowel ischemia intraoperatively (116). 
They compared thermal imaging with three other methods including visual 
inspection, Doppler ultrasound and fluorescence. All techniques showed a higher 
sensitivity to detect differences between vascularized and devascularized bowel 
than visual inspection. Also in 1997 another study by Robert et al. concluded that 
infrared imaging is a good method for localising anatomic structures. They also 
showed in an animal model that this technique is useful in tissue viability 
assessment during laparoscopy procedures (117). Later Cadeddu et al. in 2001 
(118), Nishikawa et al. in 2006 (119), Shussman et al. in 2011 (120), found that 
intraoperative thermal imaging provided useful information regarding bowel 
viability. 
 
The limitation of infrared imaging is that this technique is not a direct indicator of 
the blood perfusion and oxygenation; also the measurements depend on ambient 
temperature (121).  
 
4.4.6 Laser Doppler Flowmetry 
In this technique direct information about oxygen, nutrient or waste metabolite 
exchange in the adjacent tissue could not be obtained. Many researchers have 
employed LDF in their studies. Vignali et al. in 2000 concluded that LDF 
measurements can be a valuable tool intra-operatively in predicting the 
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occurrence of anastomotic leak in patients with colorectal cancer (122). Their 
study shows that LDF can show blood flow reduction during different stages of 
large bowel resection. In 2002, Nakatsuka used LDF and gastric tonometry to 
measure colonic tissue blood flow and gastric mucosal pH respectively to 
compare which of these methods is more reliable in reflecting changes in 
intestinal microcirculation (123). In this comparison study the results proved that 
LDF is a better method in preventing postoperative ischemia. In another study by 
Seike et al. in 2007, the colonic blood flow was measured intraoperatively in large 
bowel resection (124). In this study using LDF blood flow measurements showed 
a significance decrease by clamping the arteries. LDF measurements have also 
been applied by others in cancer of the rectum and sigmoid colon, also for 
assessing bowel serosal and mucosal oxygenation in colon surgery. It has been 
proved that LDF measurements can be a valuable technique in the detection of 
ischemia from the serosal surface of the bowel (125). Recently in 2012, Kaser et 
al. showed that laser Doppler flowmetry and spectrometry have an important role 
on clinical outcome since they are potentially valuable methods in order to assist 
the surgeon to make the right decision in critical venous mesenteric perfusion 
(126). 
 
However, like every other technique there are some limitations for LDF: it is a time 
consuming method, movement artefacts affect the results, the perfusion units are 
subjective and rather qualitative, large standard deviation can be observed in 
measurements of the bowel surface and the cut-off level of flow indicative of 
intestinal ischemia is not specific (in different studies it was not the same). Also 
measurements require tissue contact, which might affect the local blood flow (78). 
 
4.4.7 pH Monitoring 
Tonometry, a noninvasive technique to measure pH using a tonometer, is a 
method for monitoring the changes in intramucosal pH (pHi) after ischemia. A 
tonometer is a balloon catheter filled with a isotonic sodium chloride solution, 
which is placed into the lumen (the inside space of the intestine) allowing the free 
diffusion of carbon dioxide (CO2).  After an equilibration period, pCO2 inside the 
balloon is proportional to the intestinal mucosal pCO2 so using the Henderson-
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Hasselbach equation, the intramucosal pH can be calculated (127, 128). 
According to the study of Hernandez et al. in 1996 pH monitoring is a valuable 
method to detect early ischemia, they believe that fast and significant changes in 
pHi occurs after arterial and venous ischemia (129). Millan, in 2006 demonstrated 
that pHi<7.28 is associated with the high risk of anastomotic leak, the study was 
performed on 90 patients who underwent colorectal resections (130). One year 
later in 2007, Kamiya et al. used tonometry to observe pHi levels in the intestinal 
lumen intra and postoperatively on 35 patients (131). According to the results from 
this study there was a good conection between intramucosal pH and ischemic 
occurrences. Furthermore, using pHi measurements with tonometry was useful for 
finding vascular problems in the intestine.  
 
4.4.8 Microdialysis 
Microdialysis is a well-known method for measuring metabolism in various tissues 
such as the brain, muscle and the subcutis during different circumstances. The 
possibility of using this method in the digestive system has been reported. In a 
study in 1999 by Tenhunen et al. it was confirmed that by monitoring metabolic 
markers like measurements of glucose, lactate and glycerol from the jejunal wall, 
intestinal microdialysis can be used as an indicator of intestinal ischaemia (132) 
with high sensitivity and specificity (133). In another study in 2008 a microdialysis 
analyser was applied to measure glucose and lactate levels intraoperatively in the 
bowel tissue of several subjects when they were been resected, the results from 
this study showed this technique in clinical practice is feasible (134). 
 
4.5 Discussion 
The survivability of the gastrointestinal serosal (refer to Chapter 2) in an abnormal 
condition is of great importance, for that reason methods enabling measurement 
of gastric blood flow are of great interest. One important factor in a successful 
gastro-surgical program is to have an effective method of monitoring blood 
perfusion (135).  
 
As discussed in this chapter, quantitative evaluation of intestinal viability through 
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objective measurement has been attempted, using various methods to find an 
easy and reliable method of monitoring bowel viability, probably dating back to the 
first study in 1976. Subsequent investigations have continuously been introduced 
to new methods in the hope of finding an ideal monitoring technique in the 
assessment of bowel viability. To date however, no ideal monitoring method has 
been found, since none of the mentioned methods can fulfil the criteria of the ideal 
monitoring method for bowel viability; some are invasive and others are time 
consuming or unreliable. The ideal bowel monitoring method should be reliable, 
fast, easy to use, accurate with least false negative results, be non-invasive, safe, 
cheap, objective and reproducible.  
 
Among various monitoring techniques to date, just a few have found wide 
acceptance and clinical applicability including laser Doppler flowmetry. Good 
correlation has been obtained between the LDF signal and intestinal blood flow. 
The laser Doppler flowmeter still is a promising technique for studying gastric 
perfusion during operation and endoscopy (158). LDF has been employed as one 
of the two techniques in this study. The other technique is pulse oximetry. So in 
order to investigate a potentially ideal method for monitoring bowel viability 
intraoperatively a combined PPG/LDF probe was proposed. 
 
Several studies investigated the combination of laser Doppler flowmetry (LDF) 
and photoplethysmography (PPG) measurements. Examples include the 
characterisation of scleroderma and primary Raynaud's phenomenon by Rosato 
et al. (136), pressure ulcer research by Bergstrand (137), assessment of 
peripheral blood flow at different vascular depths by Hagblad (138) and detection 
of colonic ischaemia in dogs by Avino et al. (139). 
 
The following chapter presents the basic principle of photoplethysmography and 
pulse oximetry.  
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Photoplethysmography and Pulse Oximetry 
5.1 Introduction 
Measurement of arterial blood oxygen saturation is one of the most important factors 
in clinical physiological monitoring. The oxygen saturation describes the percentage 
of haemoglobin binding sites in the bloodstream occupied by oxygen. 
Photoplethysmography is an optical technique that provides a means to measure the 
oxygen saturation noninvasively, namely pulse oximetry (140). The pulse oximeter is 
now an indispensible monitoring device in anaesthesia, critical care and other areas 
of medicine (141). 
 
5.2 Photoplethysmography 
Photoplethysmography (PPG) is a non-invasive electro-optical method developed by 
Hertzman (142). PPG can provide information on the blood volume changes in the 
body, caused by cardiovascular pulsations in the target tissue (143). A 
photoplethysmogram, is achieved by illuminating a portion of the living tissue of 
interest and detecting the reflected or transmitted light. Photoplethysmography 
requires two basic forms of optoelectronic components: one for emitting visible or 
near-infrared light into tissue and the other for detecting the intensity of the 
transmitted or reflected (backscattered) light, i.e. the portion of light that is not 
absorbed by tissue and blood. Variation in the signal correlates to pulsatile changes 
in blood volume, from which blood flow may be inferred (144). 
  
Various ranges of tissue depths can be investigated using suitable combinations of 
distances between the light source and the photo detector and suitable choice of 
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wavelength. By using a short distance from a green LED (560 nm) to a photo 
detector, a shallow penetration depth can be achieved. On the other hand, using 
near-infrared light (810 nm) placed at a further distance from the sensor, e.g. 25 
mm, can measure a deeper penetration (145, 146). 
 
5.3 History of Photoplethysmography 
In 1937, Alrick B. Hertzman et al. (147) demonstrated that blood volume changes 
when it is induced by exercise or exposure to cold. In 1940 Hertzman and Dillon 
(148) separated the pulsatile and static components using separate electronic 
amplifiers and used them to monitor vasomotor activity. Hertzman believed that 
movement of the measurement probe against the skin could be avoided; which lead 
to the development of elaborate positioning devices. To create this device, Hertzman 
used a battery powered torch lamp, which was not ideal due to its relatively wide 
spectrum, and the widespread illumination. Moreover, using the torch lamp, constant 
light intensity could not be guaranteed. The improvements in optoelectronics and 
also medical instrumentation led to the development of photoplethysmography 
equipment, which was small, reliable, low-cost and user friendly (140, 146). 
Considerable improvements in the size, sensitivity, reliability and reproducibility of 
PPG recording and the design of PPG sensors were possible due to development in 
semiconductor technology. Computer-based digital signal processing and pulse 
wave analysis have since undergone significant developments.  All these 
developments have contributed to the adoption and success of pulse oximetry as a 
clinical tool (149). 
 
5.4 The Photoplethysmographic Waveform 
The PPG signal consists of two components: a static DC part and a pulsatile AC part 
(Figure 4.1). The AC component is a periodic waveform, which represents the 
pulsing of the blood in the arteries while the DC component, which dominates the 
total signal, is produced by the partial transmission or backscattering of light from the 
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non-pulsing arterial blood, the venous and capillary blood and also other tissues. 
The AC part may be separated from the DC part using a high pass filter and 
amplifier stage. Since a large portion of light from the source, passes through the 
tissue without any contact with blood vessels, the DC part is bigger compared to the 
very small AC components (produced as a result of light passing through arterial 
blood vessels). Immediately after systole, the amount of blood in the arteries 
increases leading to an increase of the absorbance of light by the blood (which is 
highly absorbing due to the high concentration of haemoglobin present), and as a 
result, the intensity of light reaching the photo detector is reduced. During diastole, 
the amount of blood in the arteries decreases, resulting in an increase in the light 
transmission (143, 150). Thus the part of the detected signal due to the arterial blood 
appears pulsatile in nature, synchronous with the heart rate, as shown in Figure 5.1. 
  
Figure 5.1: PPG: The origin of the signal (AC, DC) and absorbed light (151). 
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5.5 Photoplethysmography Operation 
LEDs and the detector can be placed in one of two configurations. In transmission 
mode operation, the target tissue (e.g. fingertip) is placed between the light source 
and the photo detector, while in reflection mode operation, the light source and the 
detector are placed next to each other as shown in Figure 5.2 (152).  
 
In order to decrease the possible motion artefact, the PPG sensor needs to be held 
in place avoiding movement. Other sources of artefact including ambient light 
interference must be considered. Artefact can be minimised in several ways 
including using a suitable probe attached to the skin, shielding of the measurement 
site from ambient light and using electronic filtering (153). 
 
Figure 5.2: Two main operations of sending light, (right) Transmission method, (left) 
Reflectance method (154). 
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5.6 Pulse Oximetry 
Measurement of oxygen saturation using the optical principles dates back to the 
1930s, when it was demonstrated by Karl Matthes, that red light passes readily 
through oxyhaemoglobin but reduced haemoglobin absorbs it more strongly (155).  
Karl Matthes constructed the first device to measure blood oxygen saturation in vivo 
continuously. Two wavelengths of light were used in his device, one sensitive to 
oxygen saturation and the other, in the infrared range, was used to compensate for 
changes in tissue thickness and light intensity. This method was useful in following 
trends in saturation, but it was difficult to calibrate, thus limiting its application. In the 
early 1940s, Millikan developed an instrument named an “oximeter” to measure 
arterial oxygen saturation from the ear of World War II pilots (156). Since his ear 
oximeter was not calibrated Millikan had to guess the normal saturation for each 
case. Then Goldie, Wood and Geraci worked on Millikan’s ear oximeter which 
resulted in important subsequent improvements of the device (157). 
 
In 1949, the monitoring of SaO2 (arterial oxygen saturation measured using a 
haemoximeter) was described by Brinkman and Zijlstra, which was based upon skin 
reflectance spectroscopy from the forehead. Their idea was based on using light 
reflection instead of tissue transillumination, resulted in monitoring of SaO2 from 
almost any part of the body (158). Their idea was followed by a more advanced 
photoelectric method suggested by Sekelj et al. for SaO2 determination (159). Later 
the fiber optic catheter oximeter was proposed by Polanyi and Hehir (160), which is 
in fact the basis for the modern oximeter. Others like Robert Shaw in 1964 and 
Hewlett-Packard in the early 1970s worked to improve the ear oximeters (161). They 
tried to mount a sensor in the ear and light delivered via a fibreoptic cable with a 
heating element in order to keep the tissue locally perfused with blood. Significant 
progresses were added by Cohen and Wardsworth by a non-invasive reflectance 
oximetry (162). 
 
In 1972 Takuo Aoyagi designed the modern two-wavelength pulse oximetry while he 
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was working on an experiment to measure the light passing through the earlobe, 
instead he noticed that light transmitting through the earlobe was able to show 
pulsatile variations. He tried to eliminate or remove these variations, and then he 
realized that the ratio of pulsatile signals measured at two different wavelengths 
could be related to oxygen saturation in the arterial blood. Later the OLV-5100, the 
first pulse oximeter, was presented by him and his team in March 1974. The number 
of wavelengths necessary for the measurement of arterial oxygen saturation 
reduced from eight (used in the HP instrument) to two (163). However, all these 
early instruments suffered from a number of disadvantages including lack of suitable 
calibration method, difficulty in distinguishing tissue, arterial blood and venous blood 
or error due to unknown optical path length (164). 
 
In the late 1970s, several scientific groups began working on refinements to pulse 
oximetry. Advances in semiconductor technology, solid state devices such as LEDs, 
photodiodes and microprocessors led to the development of modern pulse oximetry. 
LEDs emit a very narrow band of wavelengths that can massively improve the signal 
quality and therefore the accuracy of pulse oximeters. In 1981, two companies, 
Nellcor and Ohmeda, presented commercial pulse oximeters using LEDs and a 
photodiode. These LEDs and photodiode were small in size and both can be 
mounted directly on the sensor probe applied to the patient’s finger (165). Many 
manufacturers currently produce pulse oximeters that give clinicians high levels of 
confidence in the readings of oxygen saturation.  
 
On the 1st January 1990, the American Society of Anesthesiologists (ASA) made 
pulse oximetry a standard for use intraoperatively. Since then, pulse oximetry has 
become the standard method for monitoring oxygenation during sedation, 
anaesthesia, post anaesthesia intensive care including neonatal intensive care, and 
recovery from anaesthesia (166). 
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5.7 Pulse Oximeter and Blood Oxygen Saturation 
As described in the last section, a pulse oximeter is a routine medical device that 
estimates the oxygen saturation of a patient's arterial blood noninvasively (since it 
measures oxygen saturation without the need of a blood sample) using a dual 
wavelength spectrophotometer by transmitting light through a pulsating arterial 
vascular bed. It is the most common method to measure and display oxygenation in 
the human body. The pulse oximeter displays the oxygen saturation (SpO2), the 
percentage of hemoglobin in the arterial circulation that is bound to oxygen (141). 
 
A pulse oximeter can be a useful device in any situation where normal oxygenation 
is doubtful, unstable or at risk, including intensive care, surgery, recovery, 
emergency and hospital ward settings, for general assessment of a patient's 
oxygenation, and also to determine if supplemental oxygen is needed (140).  
 
Pulse oximeters operate in two modes, either by reflection or transmission, the mode 
determining the design of the sensor or probe. The accuracy of pulse oximetry may 
be compromised by dyshaemoglobinaemias, poor peripheral pulse and other 
physiological states, and it is not reliable at low saturation level. Despite these 
limitations, pulse oximetry is perhaps the most significant recent development in 
clinical physiological monitoring (141). A typical portable commercial oximeter is 
shown in Figure 5.3. 
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Figure 5.3: Pulse Oximeter device. 
 
5.8 Light Emitting Diodes (LEDs) 
A light emitting diode is a light source that produces and emits light when an electric 
current is applied in the forward bias direction of the device. The principle of pulse 
oximetry is based on the emission of light by two LEDs with different wavelengths as 
light sources usually red and infrared (the wavelength for red is around 660 nm, and 
for infrared, typically are 905, 910, or 940 nm) through the cutaneous vascular beds 
in peripheral regions such as the finger, toe or earlobe. A photo detector in the probe 
detects the reflected or transmitted light. The absorption spectrum of 
oxyhaemoglobin varies significantly from that of deoxyhaemoglobin as can be seen 
in Figure 5.4. The extinction coefficient of deoxyhemoglobin is much higher than for 
that of oxyhaemoglobin in the red region of the spectrum (around 660 nm), 
meanwhile at 940 nm, oxyhemoglobin has a higher absorption. Once the absorption 
levels are detected, the ratio of absorption between oxyhemoglobin and 
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deoxyhemoglobin can be determined (152, 167 and 168). Melanin and other skin 
pigments absorb a great amount of light at wavelengths shorter than 600 nm, while 
water strongly absorbs wavelengths longer than 1 µm. Since the light absorption of 
oxyhaemoglobin and deoxyhaemoglobin are not the same at red and infrared, the 
amplitudes of the red and infrared AC signals (Section 5.3) are sensitive to changes 
in SpO2 (144). 
 
 
Figure 5.4: Absorption levels of oxygenated and deoxygenated (169). 
 
From the normalised amplitude ratios (AC/DC) for each wavelength, SpO2 can be 
estimated. The absorbance of oxyhemoglobin and deoxyhemoglobin is equal for the 
wavelengths of 590 and 805 nm (isosbestic point); in some earlier oximeters these 
wavelengths were used for correction of hemoglobin concentration. The monitored 
signal is synchronous with the heart beat due to arterial blood vessels expanding 
and contracting in response to periodic variations in blood pressure over the cardiac 
cycle (143).  
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5.9 Photodetector 
The photodetector is used to convert light energy into an electrical current. There are 
many types of photodetectors such as photodiodes, phototransistors and 
photoresistors. The photodiode has been chosen as a photodetector for many 
reasons including: it has an excellent linearity of output current as a function of 
incident light, it is sensitive, has fast response times and has a spectral response 
from 190 nm to 1100 nm (170). 
 
5.10 Principles of Pulse Oximetry 
The principle of pulse oximetry is based on the fact that oxygenated and 
deoxygenated haemoglobin absorb the red (R) and infrared (IR) light at different 
wavelengths with different absorption levels. Haemoglobin (Hb) absorbs relatively 
more light at 660 nm than oxyhaemoglobin (HbO2), while HbO2 absorbs more light at 
940 nm than Hb. Thus comparisons of the absorbencies at different wavelengths 
allow the estimation of the relative concentrations of HbO2 and Hb (i.e. 
saturation)(171). The detector measures the intensity of the transmitted light at each 
wavelength and the changes in light absorption during the arterial pulsatile flow can 
be analysed, and the arterial oxygen saturation (SpO2) is derived by the ratio 
between the red light and the infrared light (172). 
 
With each heartbeat the left ventricle contracts and pumps blood into the systemic 
arterial system, this leads to a pressure increase in the arteries (systolic pressure) 
followed by a decrease in pressure (diastolic pressure). As a result the blood volume 
in the arteries including the peripheral arteries will increase leading to more light 
absorption during systole. The photoplethysmographic signal recorded by the pulse 
oximeter at a peripheral site resembles the shape of a peripheral arterial pressure 
waveform. The pulsatile waveform consists of AC and DC components as can be 
seen from Figure 5.5 (140).  
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Figure 5.5: Pulsatile signals observed during pulse oximetry (173). 
 
In order to find the percentage of blood oxygen saturation, the ratio of ratios RR is 
used (169). AC and DC components from each of the wavelengths need to be 
measured and taken as a ratio as follows: 
 
�! =
!!"
!!"
!"!"
!"!"
                                                        Equation 5.1 
 
   
Where RAC and IRAC are the AC components of red and infrared light sources, 
respectively, while, RDC and IRDC are DC components of red and infrared light 
sources, respectively. The SpO2 values can be obtained using the following formula:  
 
���! = 110− 25  �!                                                                                Equation 5.2 
 
Normal arterial oxygen saturation values in a healthy individual are 95% to 99% 
(174). 
 
5.10.1 Beer-Lambert law 
The intensity It of light transmitted through a medium is given by the Beer-Lambert 
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law: 
�! = �!��� � � ��                                                              Equation 5.3 
 
Where I0 is the intensity of incident light that enters the medium, α λ  is a 
wavelength-dependent absorbance coefficient, l is the distance the light travels 
through the media and c is molar concentration of the absorbing species (see Figure 
5.6) (175).  
 
Figure 5.6: light of intensity I0 enters the medium and is transmitted with intensity It, l is the 
path with the path length through the medium. 
 
5.11 Typical Photoplethysmographic Waveform  
A typical PPG signal is shown in Figure 5.7.  The PPG signal contains additional 
information in its shape, height, timing, some of which may be used to extract 
clinically useful information. A recognizable feature is the “dicrotic notch” which is a 
sudden drop in pressure after systolic contraction. The dicrotic notch represents the 
closure of the aortic valve after the end of systole (176). The period of the waveform 
can be used to calculate the heart rate. 
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Figure 5.7: Dicrottic notch in a normal arterial pulsation waveform. 
 
5.12 Calibration of Pulse Oximeters 
The first pulse oximeters, manufactured in the early 1980s, used Equation 5.2 to 
calibrate the value of SaO2, which is based on the Beer-Lambert law. However all 
manufactures use the empirical calibration as right conditions for using Beer-
Lamberts law since the Beer-Lambert law does not consider the multiple scattering 
of light by the red blood cell. 
 
There are two definitions for oxygen saturation: functional oxygen saturation and 
fractional oxygen saturation (175). Functional saturation considers only haemoglobin 
species capable of binding with oxygen:  
 
Functional �!�! =
!"!!
!"!!!!"
×!""%                                                         Equation 5.4 
 
Fractional saturation includes dysfunctional haemoglobins, the most common being 
carboxyhaemoglobin (HbCO) and methaemoglobin (MetHb) (175): 
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Fractional �!�! =
!"!!
!"!!!!"!!"#$!!"#$%
×!""%                             Equation 5.5 
 
5.13 Pulse Oximetry Limitations 
There are some factors that interfere with accurate determination of SpO2 and 
should be considered with its use. These factors include ambient light, body 
movement, skin pigmentation, hypoperfusion, administration of vasopressors and 
hypothermia and more (177). Table 5.1 shows factors that have an affect on pulse 
oximetry (178). 
 
Table 5.1 Factors that affect pulse oximetry 
Factors Effect on Pulse Oximetry 
Emergent  
Cardiac arrest Poor signal 
Respiratory arrest Poor signal 
Shock Poor signal 
Physiologic  
Jaundice No interference 
Anemia No interference 
Cardiac arrhythmia Poor signal 
Environmental  
Bright light or sunshine False increase in signal (overreading) 
Shivering, tremors, rigors, motion Poor signal 
Electrical frequencies Interference with signal 
Mechanical interference with Poor signal 
circulation (blood pressure cuff, tourniquet, 
arterial line) 
Poor signal 
 
 
The following chapter presents the principle of laser Doppler flowmetry (LDF) 
technique.  
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Laser Doppler Flowmetry 
6.1 Introduction 
The Austrian physicist Christian Doppler was the first to describe in 1842 the 
apparent shift in frequency of sound waves when their source is approaching or 
receding from an observer. When a source of waves and the receiver are 
approaching each other, the frequency of the detected waves increases and the 
wavelength is shortened; sounds are detected with higher pitch and, in the case 
of light waves, light appears bluer. On the other hand if the sender and receiver 
are moving apart, detected sounds become lower pitched and light appears 
redder. The apparent frequency shift is known as the Doppler effect (179). 
 
The Doppler effect is employed in laser Doppler flowmeters for measuring 
microvascular blood flow. In brief, a beam of laser light, transferred by a fibre-
optic probe, interacts with moving components of tissue such as red blood cells 
and is Doppler shifted while light interacting with static objects is unchanged (see 
Figure 6.1) (179). The light is then scattered and partially absorbed by the tissue 
under investigation. A returning fibre picks up the light, converts into an electrical 
signal and the output signal provides an estimation of blood flow. The ‘flux’ is 
commonly used in order to describe the blood flow measured by the laser 
Doppler technique. And it is the product of the velocity and the number of red 
cells in the volume of tissue interrogated by the probe (180). The principle of LDF 
will be presented in the next section. 
  
In 1955 Forrester et al. (181) was the first to determine the basis for LDF and 
tried to improve his theory later (182), then this principle for LDF was developed 
by Cummins and Swinney (183) during the 1960s. Later in 1975 Stern 
successfully introduced LDF into the field of biomedical engineering by presenting 
in vivo measurements (184). After that LDF progressed rapidly with 
improvements like introducing the first fibre-optic based laser Doppler perfusion 
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monitoring (LDPM) by Holloway and Watkins in 1977 (185). Again in 1980 this 
was improved by Nilsson et al. (186). Continuous improvements were made in 
later years (187, 188), the first imaging system was also introduced in 1989 by 
Nilsson et al. (189), these techniques will be discussed in Section 6.4. 
 
 
Figure 6.1: Principles of operation in laser Doppler flowmetry. A laser beam is directed 
into a target tissue. Light waves are reflected and scattered after contacting with moving 
objects like red blood cells. The backscattered light (both unshifted and Doppler shifted) 
then can be detected and received by a photodetector (190). 
 
Various methods for measuring skin blood flow have been studied; such as 
fluorescent traces, thermography, laser Doppler flowmetry, Doppler ultrasound 
etc. Of these techniques, laser Doppler flowmetry (LDF) has been of great 
interest in studies and research as well as clinical settings. Generally speaking, 
the main advantage of this technique is its non-invasiveness, the ability to 
measure the microcirculation of the tissue and the ability to resolve small 
changes very quickly. Since the commercialisation of the technique (in 1980), 
LDF has undergone a lot of improvement in perfusion monitoring. 
 
Since then the number of peer-reviewed articles, which have used LDF in their 
research has increased (191). Although, like most monitoring techniques, LDF 
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has some drawbacks, which will be discussed later. The principle of LDF is 
discussed in the following section. 
 
6.2 Principle of LDF 
Laser Doppler flowmetry (LDF) is a method for estimating the measurement of 
microvascular red blood cells (or erythrocytes) perfusion in tissue including 
capillaries, arterioles, venules and shunting vessels. The technique is based on 
the emission of laser light carried by a fibre-optic probe attached to or inserted 
into the target tissue. Laser light from this fibre, transmits photons into the tissue, 
which then are scattered and reflected within the tissue and eventually some are 
scattered back to the probe. Another optical fibre collects the backscattered light 
from the target tissue (see Figure 6.1). At which stage the photodiode receives 
the photons and converts them into current. Every photon that encounters a 
moving red blood cell (RBC) or any other moving particle undergoes a shift in 
frequency, the magnitude of which depend on the velocity of the moving cells 
(192), this small frequency shift is the basics of LDF theory (190, 191). Figure 6.2 
shows a laser beam of single frequency fi colliding with a single object as a RBC 
moving at velocity � at an angle �! in the direction of �, and scattered by the 
RBC in different directions. The frequency of this light differs from fi in the 
direction of the detector with the angel defined as �!. This small frequency shift 
∆� can be obtained using Equation 6.1 (179). 
 
∆� = � (cos�! − cos�!)
!
!
                                                               Equation 6.1 
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Figure 6.2: The Doppler effect: The frequency of the light scattered by the moving 
objects (RBC) with velocity � in the direction defined by �! is shifted in frequency by an 
amount ∆� compared to that of the light of frequency fi, which hits the RBC at an angle 
�!(179). 
 
The backscattered light from the target tissue is analysed to retrieve information 
about the blood flow in the microcirculation, by analysing the frequency shift of 
the backscattered light, conclusions about the amount and velocity of the blood 
flow can be illustrated (193). The principle of LDF shown in Figure 6.1 and Figure 
6.3 shows a laser Doppler perfusion monitoring system. 
 
The flux is proportional to the average velocity (proportional to the beat 
frequency) and number of red blood cells in the area of investigation (proportional 
to the intensity of the Doppler shifted light), which can be calculated using 
Equation 6.2 (179).  
 
���� = �×�×���                                                                          Equation 6.2 
 
Where k is proportionality constant, � is the mean speed of the RBCs in the 
sampling volume (proportional to the mean ∆�) and Vol is the concentration of 
moving RBCs in this volume. 
 
 
� 
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Figure 6.3: Laser Doppler perfusion monitoring system (194). 
 
LDF is a non-invasive technique for assessment the blood perfusion in the 
microcirculation that has been proven as a useful measurement in most organ 
systems (195, 196). LDF is currently used in a variety of fields in medicine, 
especially in biomedical research and clinical settings including wound healing 
(197), assessment of burn wound depth (198), skin tumour characterisation 
(199), amputation level determination (200, 201), neurosurgery (202), and breast 
reconstruction (203). Other clinical researches such as cerebral monitoring, flap 
transfer surgery, transplantation surgery and vital organ monitoring, 
pharmacology, and also peripheral vascular disease research have been used by 
the means of LDF  (194). A list of laser Doppler applications is provided in Table 
6.1.  
 
Laser Doppler flowmetry has some limitations: the tissues’ optical properties 
might have an affect on the perfusion signal, noise caused by motion artefact, 
lack of knowledge of the depth of measurement, lack of quantitative units for 
perfusion and also the biological zero signal (perfusion measured when there is 
no flow condition)(191). Also it is impossible to determine exact measurements of 
blood flow because the plasma component of blood is not detected and so does 
not contribute to the Doppler shift. Since LDF cannot give the absolute 
measurement of blood perfusion, this limits its application in the clinical setting. 
The direction of movement of the blood cells relative to the probe is also not 
known, as the frequency difference between Doppler shifted and un-shifted light 
is always positive, regardless of whether the actual frequency shift is positive or 
negative (194). Although, regardless of all these limitations, LDF remains in high 
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demand for monitoring microcirculatory blood flow, is routinely used in some 
areas of medicine and has found application in many areas of research such as 
monitoring small-vessel perfusion in kidneys, liver, muscles, intestines, brain and 
heart (191). Some of these limitations will be discussed in details in Section 6.6. 
 
Table 6.1: Laser Doppler applications 
Angiogenesis 
Burn depth assessment 
Cardiovascular monitoring 
Dentistry 
Dermatology 
Gastroenterology 
Impotence 
Ischemia 
Neurology/cerebral blood flow 
Oncology 
Ophthalmology 
Otology 
Rheumatology 
 
6.3 Light Source 
The incident laser light beam used in LDF must be monochromatic (light of a 
specific wavelength). It has a penetration depth of approximately 1 mm however 
in blood-rich organs like the kidney or the liver, the measuring depth will be 
considerably decreased to less than one millimetre. If the blood supply to a region 
is limited for any reason, the measuring depth will increase due to the lack of 
blood permits increased passage of light in the area. The penetration depth of 
light is influenced by the path that light takes through the skin. The penetration 
depth is limited by some factors, like absorption and scattering effects of the area 
of tissue. The measuring depth depends also on the structure of the capillary 
beds and their density, oxygenation, etc. The wavelength of the laser light and 
the distance between the sending and receiving fibres in the laser Doppler probe 
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used, also affects on the measurement depth (203). The volume of light 
penetration is generally 1 mm3 or smaller (194) (Figure 6.4).  
 
 
Figure 6.4: The volume of light penetration is generally 1 mm3 or smaller (193).  
 
Although laser Doppler has undergone significant improvement since it was first 
introduced, there is still no current LDF instrument that can provide absolute 
perfusion values (e.g. ml/min/100 gram tissue). Measurements are stated as 
Perfusion Units (PU), which are arbitrary, as the laser Doppler instrument cannot 
show blood flux in absolute values (203). 
 
The actual frequency of the light is too high to be measured using low cost 
electronics (being of the order of 1014 Hz), instead the Doppler shifted light 
interferes with light scattered from static objects to produce a modulation (‘beat’ 
frequency) equal to the difference in frequency between the frequency shifted 
and incident light. The beat frequency is typically in the range 0-8 kHz, so may be 
readily measured using simple circuitry (194). 
 
The techniques of laser Doppler are presented in the following section. 
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6.4 LDF Techniques 
As mentioned earlier in this chapter, typically there are two kinds of perfusion 
measurements, single point (LDPM) and imaging (LDPI) systems. Laser Doppler 
perfusion monitoring (LDPM) measures the perfusion in just one point of sample 
tissue. On the other hand laser Doppler perfusion imaging (LDPI) instruments is 
able to provide perfusion monitoring for a larger area in which the laser beam is 
scanned over the area of interest (191, 205). In this section, the special 
characteristics of these systems, as well as an advanced type of imaging systems 
based on fast CMOS cameras, are described. LDPM and LDPI instruments are 
both commercially available. 
 
6.4.1 Laser Doppler Perfusion Monitoring (LDPM) 
In laser Doppler perfusion monitor, a fibre optic probe with one multimode fibre 
has been used, which delivers the laser light to the target tissue. Another 
multimode fibre is used to detect the back-scattered photons (Figure 6.5 (a)). In 
this technique the perfusion of one point of target tissue in real time is recorded. 
The wavelength and the fibre separation used in the instrument indicate the 
measurement depth and sampling volume. According to this the measuring depth 
in normal skin with a probe fibre separation 0.25 mm (which is a standard probe 
separation) and 780 nm wavelengths is between 0.5 to 1 millimetre and the 
measurement volume is about 1 mm3 (191).  
 
For laser Doppler instruments the main manufacturers are Perimed AB 
(Stockholm, Sweden), Moor Instruments Ltd. (Axminster, UK), Transonic 
Systems Inc. (Ithaca, New York, USA), Oxford Optronix Ltd (Oxford, UK) and 
LEA Medizintechnik (Giessen, Germany). The wavelengths typically used by 
these manufactures are mostly 630 nm, 780 nm and 830 nm, with approximately 
fibre-to-fibre distances of 0.25 mm, 0.5 mm and 0.78 mm (apart from the 
instruments by LEA) (191).  
 
There are many different types of probes available for different applications such 
as fibre probe systems (206) and integrated probe systems (207). 
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The advantage of LDPM compared to other monitoring methods in the 
measurement of microvascular blood perfusion is the fact that it is able to 
recognize even small changes in local blood perfusion very quickly (less than 0.1 
s), making it useful for continuous perfusion monitoring. Another advantage is 
that it is non-invasive since the probe does not need to touch the surface of the 
tissue and as a result the normal physiological state of the microcirculation won’t 
be affected. Furthermore, the small dimension of the probe means it can be used 
in experimental environments that are hard to access (191). 
 
This technique has its limitations. Since it has been designed to record tissue 
perfusion at a single point over time, any information regarding the surrounding 
perfusion area is not gathered (208, 209). Another issue with this technique is 
that the results of the measurements are proportional to blood flow and since the 
factor of proportionality are not the same for different tissues and tissues sites 
means that the system does not present exact measurements of blood flow. The 
flux measured in commercial LDPM systems is generally referred to by the 
manufacturers as ‘perfusion’, and expressed in Perfusion Units (PU), or similar 
(191). 
 
6.4.2 Laser Doppler Perfusion Imaging (LDPI) 
The need to study perfusion over larger tissue areas was the next evolvement in 
laser Doppler, which led to the construction of LDPI, in which a laser Doppler 
perfusion imaging instrument is able to map the perfusion from a larger area in 
which the laser beam is scanned over the area of interest to form an image. The 
scanning procedure lasts for a couple of minutes to form an entire image of the 
tissue, since in each scanning position for each pixel value the perfusion value 
has to be calculated and transformed to form an entire image (191). In Figure 
6.5(b) the schematic of a scanning laser Doppler perfusion imager is shown. Like 
LDPM it’s a non-invasive technique, however it provides the perfusion for a larger 
area, with this the average perfusion in heterogeneous tissue can be provided in 
one measurement (191). Another advantage is that this technique is non-contact 
so it can be used in clinical situations with hard accessible tissue (191).  
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This technique has some advantages over the single-probe technique; one is that 
the blood flow is measured over an area rather than at a single site as in DLPM, 
so it can remove some of the difficulties that arise in the LDPM technique such as 
movement artefacts and site-to-site perfusion variations due to the 
heterogeneous nature of tissue. This technique has special limitations, one is the 
length of time taken to complete a full scan is extensive; examining a rapid 
change in blood flow cannot be done over short periods (191). However some 
studies have been made to reduce these limits. Also the distance between the 
imager and the tissue might affect the measurements, as in if this distance 
changes between the subsequent measurements it can affect the results (210). 
 
Perimed AB and Moor Instruments Ltd are the major manufacturers of laser 
Doppler perfusion imagers. 
  
 
 
Figure 6.5: A diagram of (a) LDPM and (b) LDPI geometries on a tissue model. LD laser 
diode, PD photodetector (191). 
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6.4.3 CMOS Imager 
As mentioned, LDPI system have some drawbacks, one is that it is slow, and the 
other is the estimated perfusion value is affected by the spot size of 
backscattered light. To address these drawbacks a new generation LDPI system, 
suggested by Serov et al, was presented, which is based on fast CMOS cameras 
to make imaging procedure faster (211-213). The complementary metal oxide 
semiconductor (CMOS) technology was introduced and a new generation laser 
Doppler perfusion imaging (214, 215) in which the backscattered light is focused 
on a detector array. In this system every pixel in the array is used to calculate a 
perfusion value from the part of the tissue that the pixel sees (Figure 6.6c). So by 
simultaneously illuminating the whole target tissue, the pixels in the complete 
image will be obtained simultaneously and the tissue can be mapped using the 
processing signal obtained by each pixel in time, faster than scanning the area 
point to point like in LDPI. Movement artefacts can be avoided in this new 
system, as there is no scanning in the system (191). The disadvantage of this 
system is that the cameras are not yet fast enough (205). 
 
   
Figure 6.6: Schematic illustrations of the various LDF modalities, LDPM (a), LDPI (b), 
and CMOS imager (c). 
 
 
 
(a) (b) (c) 
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6.5 Limitations of LDF  
6.5.1 Calibration Standards 
The laser Doppler perfusion signal is a comparative measure of flux, so the 
measurements need to be standardised. A proper calibration system has been 
under investigation from the early days of introducing LDF. 
To date there is no gold standard available for calibration of LDF in relation to 
absolute blood flow per unit volume of tissue, due to the varied and 
heterogeneous distribution of blood vessels in the tissue. Several studies have 
been performed in the hope of designing and developing a calibration device but 
the use of these devices has been limited to research. Therefore an ideal 
calibration system is still under investigation and seems rather difficult to realise 
(191). 
 
6.5.2 Biological Zero  
When a laser Doppler probe is used with tissue in which haemostasis has been 
applied (e.g. by applying a tight tourniquet to a limb), a residual flux signal is still 
reported, even when there is no blood flow. Tenland et al. (210) was first to 
suggest that this signal should be called “biological zero” (BZ) and needs to be 
subtracted from the total output signal. The origin of BZ probably arises from 
several sources including small involuntary muscle movement, and random 
movement of red cells and other tissue partly due to Brownian motion (218, 219). 
 
In some clinical applications, the BZ is measured in each experiment and the 
value subtracted from the normal perfusion value, this might be more important 
especially when there is very low perfusion in the tissue (220–222). Some studies 
have been performed to a better understanding of BZ, according to the result of 
Fagrell and Nilsson (223), the BZ is caused by residual movement of entangled 
blood cells and other moving components of living tissue, such as vessel wall 
activity, hair follicles and sweat gland production. In another study by Kernick et 
al. (224), they strongly suggest that since BZ changes with temperature in both in 
vivo and in vitro measurements, the original BZ signal in the measurement of the 
skin comes from the Brownian motion of the tissue structure and macromolecules 
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in the interstitial spaces. Although Kernick et al. had shown that temperature 
might affect BZ, the accuracy of the idea is still under question (191, 224). 
 
6.5.3 Motion Artefacts 
One of the important drawbacks of LDF is that the movement artefact has affect 
on the output signals. Tissue movement or fibre movement both might cause the 
motion artefact. It has been suggested by Gush and King that some modifications 
of fibre-optic probes can reduce the movement artefacts. They believe that by 
using small aperture fibres and keeping the fibre close to the skin can reduce the 
motion artefacts to some extent (225).  
 
The effect of tissue movement on the blood flow signal in laser Doppler devices 
was studied by Öberg (225). The results of his study showed that by increasing 
the tissue movement, the flow signal increases linearly. Other study suggests that 
motion artefacts have more effect when the measurement device is not in contact 
with the tissue (like LDPI) compared to the devices that their probe can be fixed 
on the target tissue (227). 
 
6.5.4 Multiple Doppler Shifts: a theoretical limitation 
The theoretical model of laser Doppler perfusion monitors and imagers is based 
on single Doppler shifted photons for the calculation of blood flow; however, in 
reality, many of photons might interact with more than one moving object, this 
might happen mostly in the tissue with high perfusion (191).  
 
These limitations of the laser Doppler technique were addressed by the 
researchers and many improvements have been obtained. However, some of 
these limitations given still need to be considered. Although there are still some 
unsolved limitation, LDF techniques is still of great interest for microcirculatory 
blood flow measurements. 
 
The design and development of this new combined sensor for intraoperative 
perfusion monitoring of the intestine will be presented in the next chapter. 
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Development of a Combined PPG/LDF 
Optical Probe 
7.1 Introduction 
A new combined PPG/LDF system has been developed to detect and pre-
process the red and infrared photoplethysmographic (PPG) along with Laser 
Doppler Flowmetry (LDF) signals. Chapter 8 presents the details of the 
construction of the PPG/LDF instrumentation. This chapter outlines the various 
stages taken in the design and development of the combined PPG/LDF sensor, 
which include the choice of components for the PPG probe, the choice of LDF 
probe, the dimensions and configuration of the sensor, the mechanical 
construction and also infection control considerations. Finally, evaluation tests 
were carried out in the laboratory to determine the effectiveness of the sensor as 
a means of transmitting and receiving light for PPG and LDF measurement. 
 
7.2 Combined Sensor: Design and Construction for the PPG 
probe 
In this study the optical components for the PPG probe were configured in the 
reflectance mode.  This mode was chosen instead of transmission mode to 
measure the PPG signals from the bowel (refer to Chapter 4 for an explanation of 
reflectance and transmission modes), since in transmission mode the tissue 
needs to be placed between the light sources and the photo detector, which 
would have restricted the choice of monitoring site. A schematic of the combined 
PPG/LDF probe, based on a printed circuit board design, is shown in Figure 7.1.  
 
                                                             CHAPTER SEVEN 
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Figure 7.1: A schematic of the combined PPG/LDF probe, including the photodiode, two 
LEDs and laser Doppler with 8 mm outside diameter. 
 
The shape of the sensor was designed in a rectangular shape and small enough 
(a width of 12 mm) to be inserted into the Trocar (a sharp-pointed surgical 
instrument that is placed through the abdomen during laparoscopic surgery as a 
portal for the subsequent placement of other instruments, such as graspers, 
scissors, staplers, etc.) for the measurements during the operation. The 
combined sensor is connected to the processing system by a multicore cable.  
 
7.2.1 PPG Sensor 
The PPG part of the sensor consists of a central photo detector surrounded by 
two light sources for PPG and also incorporates an LDF fibre tip that can be 
placed on the bowel surface. Details of the choice of light sources and 
photodetector used will be discussed in the following sections.  
 
Light sources (LEDs) 
In order to measure the blood oxygen saturation by oximetry, two wavelengths 
(usually red and near infrared) are required (Section 4.8). LEDs are ideal for 
pulse oximeters as light sources as they are cheap (so can be used even in 
disposable probes), very compact (can fit into very small probes), emit light in a 
narrow range of wavelengths and do not produce excessive amounts of heat 
during use (so they do not damage the tissue) (228). 
 
 
 
 
 
!
LDF 
Place 
Photodiode 
Pads LED Pads 
Cable connecting 
pads 
32 mm 
12 mm 
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A combination of wavelengths of light sources was used in this study, and both 
sources were mounted the same distance from the photo detector (7 mm). 
Surface mounted ceramic type red LED (CR 60 R, PerkinElmer, Inc., USA) was 
used with a peak emission wavelength of 628 nm. The dimensions of the LED 
were 3.00 mm x 1.27 mm x 0.60 mm. The optical and electronics characteristics 
are shown in Table 7.1. 
 
Table 7.1: R LED specifications and electrical/optical characteristics (229). 
Parameter Value Unit 
LED Colour Red  
Light Emission Angle 100 ° 
Continuous Forward Current  60  mA 
LED Mounting SMD  
Lens Shape Rectangular  
Peak Emission Wavelength  628  nm 
Forward Voltage  2.0  V 
Luminous Intensity Min 100  Mcd 
Luminous Intensity Type 140  Mcd 
Operating Temperature Max 80 °C 
Operating Temperature Min -20 °C 
Soldering Temperature  240 °C 
Reverse Leakage Current Max 10 µA 
 
The infrared LED used in this study was a surface mounted ceramic device 
(AP2012F3C, Kingbright, USA) with a peak emission wavelength of 940 nm. The 
dimensions of the LED was 2.00 mm x 1.25 mm x 1.1 mm. The optical and 
electronics characteristics are shown in Table 7.2. 
 
Table 7.2: IR LED specifications and electrical/optical characteristics (230). 
Parameter Value Unit 
Peak Wavelength 940 nm 
Forward Current If (AV) 20 mA 
Radiant Intensity 3 mW/Sr 
Viewing Angle 120 ° 
Forward Voltage VF Max 1.6 V 
Operating Temperature Min -40 °C 
Operating Temperature Max 85 °C 
Operating Temperature 
Range 
-40 to +85 °C 
Weight  0.000003 kg 
 
The two LEDs chosen for the sensor are shown in Figure 7.2. Each LED was 
mounted on the PCB board manually. 
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Figure 7.2: Left R LED (229) and Right IR LED (230). 
 
Photo-detector 
The detector used in this sensor to detect the backscattered light from bowel 
tissue is a surface mounted silicon PIN photodiode (BPW 34 S) sensitive to light 
in the 400 nm to 1100 nm range. This wide range of detection allows detection of 
both LED wavelengths using a single photo detector.  The radiant sensitive area 
is 7 mm2 with the dimension of 4.5 mm × 4.0 mm × 1.2 mm. Figure 7.3 shows a 
picture of the photodiode while Table 7.3 presents characteristic and maximum 
rating of the photodiode used in this study. 
 
 
Figure 7.3: The photodiode used for the PPG part (BPW 43 S) (231). 
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Table 7.3: Characteristic and maximum rating of the photodiode used on the PPG part 
(BPW 43 S) (231). 
Parameter Value Unit 
Operating and storage temperature 
range 
-40…. +100 °C 
Reverse Voltage 32 V 
Total power dissipation 150 mW 
Wavelength of max. sensitivity 850 nm 
Spectral range of sensitivity 400_110 nm 
Dimension of radiant sensitive area 2.65 × 2.65 mm × mm 
Rise and fall time of the photocurrent 20 ns 
 
The LEDs were placed at a distance of 7 mm from the centre of the photodiode. 
The distance between Photodiode and the LDF tip is 7 mm (note that the laser 
Doppler tip is effectively a combined emitter and detector, i.e. the photodiode on 
the probe is solely for PPG measurement). A three-dimensional concept of the 
combined probe construction is shown in Figure 7.4. 
 
 
Figure 7.4: The three-dimensional concept of the combined probe. 
 
7.2.2 Sensor construction 
Commercial software Altium Designer (Altuim limited, Sydney, Australia) was 
used to design the probe printed circuit board (PCB). Using a laser printer with 
high resolution, the desirable circuit was printed out first on a transparent sheet 
(laserstar, 895-945 Franell, 100062).  The design was chemically etched onto a 
flexible copper substrate (Pyralux, DuPont, USA). Components were then 
manually soldered onto the circuit. The full specification for the PPG system 
(probe and instrumentation) is included in Appendix A. 
!
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PPG cable 
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7.3 Combined sensor: Laser Doppler probe and monitor 
A commercial titanium laser Doppler disc probe (Moor Instruments VP8c, Moor 
Instruments Ltd., UK) was incorporated into the sensor used in this research. 
Light is delivered via a central window at a right angle to the cable. Figure 7.5 
shows a photograph of the probe. The laser Doppler probe is connected to a 
laser Doppler monitor (Moor Instruments, Ltd., U). The specification for Laser 
Doppler monitor and probe can be seen in Appendix B. 
 
Figure 7.5: The VP8c titanium disc probe (232) (a) and the laser Doppler monitor (b) 
 
Figure 7.6 shows a photograph of the completed combined probe. The probe 
connects with the instrumentation unit (Chapter 8), which interfaces with a data 
acquisition card and signals acquired using a LabVIEW virtual instrument 
(Chapter 9). The distal part of the probe connects to the instrumentation unit via a 
5-core screened cable with a length of 3.9 m.  
 
(b)
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Figure 7.6: Photograph of the probe with two LEDs, one photodiode and the laser 
Doppler probe tip of 8mm in diameter. 
 
7.4 Probe sheath 
In order to protect patients against cross contamination during measurements, a 
single-use sterile latex sheath was used to protect the surgical site from 
contamination. A custom-made probe cover made with Palmedic (Palmedic b.v., 
The Netherlands) provided a perfect fit for the combined probe during intra-
operatively measurements in the clinical trials. Figure 7.7 shows the custom-
made probe cover used. 
 
The maximum length of the sheath supplied by manufacture was 2.40 cm, which 
didn’t cover the entire length of the cables from the probe to the measurement 
unit, so a sterile camera sleeve was used to cover the rest of the cables. These 
two together were able to cover enough cable length to protect the probe from 
possible contamination. After covering the probe, the probe was placed on a 
separate trolley, which was covered with a sterile sheet. Another sterile sheet 
was placed over the combined probe to protect that from any possible 
Photodiode 
Laser Doppler  
PPG and Doppler 
cables 
IR LED Red LED 
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contamination before each use. The probe was then ready to give to the surgeon 
for measurements.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.7: The sterile probe ready to use for measurement. 
 
After each trial the probe covers were removed carefully in a dirty utility room 
adjacent to the theatre. To test for possible contamination of the probe after each 
trial, the protective sheath had to be investigated to prove it had not been 
damaged during the trial (e.g. by puncturing when inserting the probe). Since the 
probe could not be cleaned, it was recommended by infection control that the 
sheath should be inspected before use and handled with care. After use, the 
integrity of the sheath could be confirmed by gently inflating it and immersing in 
water. After confirming of the absence of bubbles the probe was ready to use for 
the next trial. If the sheath was damaged after the trial there was no way of 
decontaminating the probe and therefore it would have to be discarded, however 
this event did not occur in any of the clinical studies. 
 
7.5 Evaluation of the combined sensor 
To assess the functionality of the sensor, two volunteer studies were performed in 
the laboratory on the finger of healthy volunteers. Note that these evaluations 
were conducted with using the instrumentation and software described in 
Chapters 8 and 9 respectively. The first study was performed to evaluate the 
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system’s ability to differentiate between states of normal and compromised 
perfusion and the second study was conducted to investigate any optical 
interference between the PPG and LDF sensors. These studies were approved 
by the City University London Senate Research Ethics committee. 
 
7.5.1 First volunteer study 
This study presents evaluation of a system combining laser Doppler flowmetry 
and photoplethysmography (PPG) in a single probe for the simultaneous 
measurement of perfusion and blood flow in the finger. A cuff sphygmomanometer 
was used to partially occlude the arteries supplying the hand to investigate the 
effect of low pressure on photoplethysmographic and laser Doppler signals and 
also to calculate arterial blood oxygen saturation values (SpO2).  Red and infrared 
PPG and Doppler signals were recorded from six healthy volunteers at various 
pressures.  
 
Experimental method 
Six healthy volunteers (2F, 4M; mean age 25) who were not taking any regular 
medication and were free of any significant medical problems participated in this 
study. A pressure cuff attached to a manual sphygmomanometer was placed 
around the left arm of a volunteer while he/she was sitting on a chair. The 
experimental probe was attached to the left index finger.  One minute of 
simultaneous PPG and Doppler flux measurements were taken with the cuff 
deflated.  The cuff was then inflated in 15 mmHg steps up to 135 mmHg. 
Measurements of PPG and Doppler were acquired during one minute for each 
pressure condition.  The cuff was deflated for 30 seconds between each 
measurement to allow re-perfusion of the hand and to avoid unnecessary 
discomfort for the volunteer subjects. 
 
Data Analysis  
From the PPG signals, the peak-to-peak amplitudes of the AC red (RAC) and 
infrared (IRAC) signals were calculated for each cardiac cycle (heartbeat) and the 
mean value of these amplitudes determined for all signals during each one-
minute measurement period. DC values for red (RDC) and infrared (IRDC) 
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calculated as well. The amplitudes of laser Doppler for all six volunteers were 
also measured during the cuff inflation process for about one minute with 
calculation of peak-to-peak amplitude of the laser Doppler signals. The SpO2 
values were also calculated using the following formula:  
 
���! = 110− 25  �!  
In which, 
 
 
Results 
PPG and Doppler signals were recorded from the index finger in all volunteer 
subjects. The AC red and infrared PPG and Doppler traces in one volunteer at 
zero, 75 mmHg and 135 mmHg pressure for 10 seconds are shown in Figures 
7.8, 7.9 and 7.10 respectively. In all Figures AC infrared (IRAC) PPG is shown in 
the first graph, AC red (RAC) PPG is the middle graph and the last graph is 
related to laser Doppler. By comparing Figures 7.8, 7.9 and 7.10, it is clear that 
there are marked differences between IRAC and RAC PPG and Doppler signals at 
each of the cuff pressures represented by the graphs. In fact at 75 mmHg, the 
finger PPG signals are noticeably reduced for all subjects compared to the 
signals obtained at zero pressure and with a further increase of the cuff pressure 
to approximately 120 mmHg all signals ceased due to no blood flow to the finger 
(see Figure 7.12 at pressure 120 mmHg). In Figures 7.11, 7.12 and 7.13, the 
amplitude of AC red and infrared signals along with the Doppler signal at various 
pressures in all subjects is shown. As the cuff is gradually inflated, the brachial 
artery will be occluded gradually.  As a result, less blood reaches the finger, 
producing low amplitude signals for all measurements.  This effect is obvious in 
changes in the amplitude of IRAC and RAC PPG and Doppler signals from the 
finger probe. The IRAC and RAC amplitude reduced by 58.96% and 37.58% 
respectively at 75 mmHg compared to zero cuff pressure. The laser Doppler 
amplitude fell by 60.14% at 75 mmHg cuff pressure compared to zero cuff 
pressure. Figure 7.14 shows the calculated SpO2 at different cuff pressures.  It 
can be seen the values of SpO2 become erratic at cuff pressures greater than 75 
mmHg, with all but one subject showing apparent desaturation at high cuff 
pressures.  
RR=
R AC/R DC
IR AC/IR DC
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Figure 7.8: (a) IRAC, (b) RAC and (c) laser Doppler 
signals at zero mmHg for 10 second. 
 
 
Figure 7.11: RAC amplitude (±SD) at various pressure 
from zero to 135 mmHg. 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.9: (a) IRAC, (b) RAC and (c) laser Doppler 
signals at 75 mmHg for 10 second. 
 
 
Figure 7.12: IRAC amplitude (±SD) at various pressure 
from zero to 135 mmHg. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.10: (a) IRAC, (b) RAC and (c) laser Doppler 
signals at 135 mmHg for 10 second. 
 
 
Figure 7.13: Laser Doppler amplitude (±SD) at various 
pressure  from zero to 135 mmHg. 
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Figure 7.14: Blood oxygen saturation (SpO2) (±SD) during 
hypoperfusion from zero to 135 mmHg. 
 
Discussion and conclusion 
Finger PPG and Doppler signals were measured in six volunteers in various 
pressures from zero to 135 mmHg. Clear signals were recorded in all subjects at 
low cuff pressures; however both PPG and Doppler signals showed a gradual 
decrease in amplitude at higher pressures. During hypoperfusion the amplitude of 
the PPG and Doppler signals decreased with increasing cuff pressure as 
expected due to occlusion of the brachial artery. From the signals obtained at 
different pressures, it can be seen that the mean AC red and infrared PPG and 
Doppler amplitude is considerably reduced in states of simulated ischaemia in the 
finger tissue.  The decrease in the amplitude of the PPG signals and Doppler 
coincides with the observed changes in blood oxygen saturation in all subjects. 
These findings suggest that both PPG and LDF individually are sensitive 
indicators of ischaemia although the percentage fall in amplitude of the Doppler 
signals was greater than PPG between zero and 75 mmHg cuff pressure. This 
result suggests that PPG is more sensitive to ischemia than Doppler in peripheral 
tissue. 
 
7.5.2 Second volunteer study 
Red and infrared PPG and Doppler signals were recorded from a healthy 
volunteer in three studies at different distances between LDF and the photodiode 
in PPG. Clear photoplethysmographic (PPG) and Doppler signals were detected 
simultaneously using the probe from the skin of the finger. The influence of the 
PPG light sources on LDF measurements was investigated; also the influence of 
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the LDF light sources to the PPG measurements was studied. For this study, one 
healthy subject participated. In vivo evaluation of the PPG and Doppler system 
was done on the left index finger at rest in room temperature conditions. 
 
Experimental method 
To minimize stray light, the study was conducted in a dark room with lights off. 
Room temperature was 20–22˚C. In order to minimize motion induced artefacts 
the subjects remained silent and still during the measurement. In order to evaluate 
the effect of interference between PPG and LDF, three studies were evaluated in 
which two experiments were performed. In the first study the LDF fibre tip was 
placed 7 mm from the photodetector (the distance used in the probe design). In 
the second and third studies the LDF fibre was placed 20 mm and 40 mm from the 
photodetector respectively. 
a. First study 
For the first study, the LDF fibre tip was placed at 7 mm from the photo detector. 
The first measurement was performed to evaluate the influence from LDF on the 
PPG. This measurement was first recorded for PPG with only the PPG activated 
for 60 seconds and then with the PPG and LDF activated for another 60 seconds. 
  
To assess the influence from PPG on the LDF, the second measurement was 
performed in which LDF was switched on while PPG was off for 60 seconds and 
then with the LDF and PPG active for another 60 seconds.   
b. Second study 
All measurements in the first study were repeated with different placement for the 
LDF probe: 20 mm from the photodiode.  
c. Third study 
All measurements again were repeated but this time the LDF probe was placed 
40 mm from photodiode.  
 
Data analysis 
The mean value of the LDF was calculated for each measurement. The PPG 
amplitude was taken as the peak-to-peak value of the AC-part of the signal. A 
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custom made LabVIEW VI was used to extract the peak-to-peak value from the 
acquired PPG signals. The mean PPG amplitude of each 60-second segment 
was then calculated.    
 
Results 
Clear PPG and Doppler signals were detected from the combined probe from all 
six experiments. The results for mean value for the measurements from the first, 
second and third studies are presented in Table 7.4 (a), (b) and (c) respectively. 
 
Table 7.4: Mean value from measurements in the first study (a), second study (b) and 
in the third study (c) 
Measurement 
Average AC 
Amplitude 
(V) 
Mean DC 
(V) 
Average LDF 
Flux 
(PU) 
PPG LDF IR  R  IR  R  
ON OFF 4.560 0.683 1.502 0.391 --- 
OFF ON --- --- --- --- 38 
ON ON 4.753 0.740 1.526 0.416 43.6 
(a) 
 
Measurement 
Average AC 
Amplitude 
(V) 
Mean DC 
(V) 
Average LDF 
Flux 
(PU) 
PPG LDF IR R IR R 
ON OFF 2.738 0.460 1.081 0.301 --- 
OFF ON --- --- --- --- 51.2 
ON ON 2.799 0.469 1.220 0.330 57 
(b) 
 
Measurement 
Average AC 
Amplitude 
(V) 
Mean DC 
(V) 
Average LDF 
Flux 
(PU) 
PPG LDF IR R IR R 
ON OFF 1.774 0.329 1.088 0.322 --- 
OFF ON --- --- --- --- 38.6 
ON ON 1.778 0.334 1.127 0.338 42.4 
(c) 
The 60-second average IRAC in the first measurement in the first study increased 
slightly when the LDF was switched on.  This suggests that switching on the laser 
source results in more light being detected by the PPG photodetector, an increase 
in amplitude of 4.07% was seen. The average for RAC with PPG on and LDF off 
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increased by 7.66%.  This shows that the R PPG is affected proportionally more 
by LDF than IR PPG. The average for LDF flux was seen to increase by 14.7% 
when the PPG light sources were turned on. 
From the results of the second experiment it was found that by switching the PPG 
emitters on and off had less effect on the laser Doppler signal than the first 
experiments. The average for IRAC and RAC increased by 2.18% and 1.99% 
respectively when the LDF laser was switched on. Switching on the PPG light 
sources in the second study caused an increase of 11.3% in average laser 
Doppler flux. 
From the results of the third experiment it was found that by switching the PPG 
emitters on and off, this had the least effect on the LDF. The average for IRAC and 
RAC increased by 0.23% and 1.40% respectively. Switching on the PPG light 
sources in the second study caused an increase of 9.84% in the average laser 
Doppler flux. 
The IRDC and RDC are also affected by LDF and their amplitude increased by 
switching the LDF on between in all three measurements as it can be seen from 
the Table 7.4 (a), (b) and (c). The average for IRDC and RDC in the first study 
increased by 1.57% and 6.01% respectively. The average for IRDC and RDC in the 
second study increased by 1.14% and 8.79% respectively and the average for 
IRDC and RDC in the third study increased by 3.46% and 4.73% respectively.    
 
Discussion and Conclusion 
This study was performed to evaluate optical interference between PPG and LDF 
in a combined system. From all the results of this experiment it was found that 
the PPG is not greatly affected by LDF; in the worst case the change in AC 
amplitude when the LDF system is switched on was less than 8%. 
 
Results from this trial study showed that by increasing the distance between the 
LDF and the photodiode, the effect of optical interference from LDF on both red 
and infrared PPG signals decreased. Also it was found that R PPG is 
proportionally more affected by LDF light than IR PPG. The results also show that 
the effect on reported LDF flux from the PPG light sources is more marked. In the 
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worst case the change in LDF flux amplitude when the PPG system is switched on 
was less, just over 14.7%. Like the PPG amplitudes, it was found that increasing 
the distance between the LDF and the photodiode had the effect of reducing the 
optical interference from PPG light sources on the LDF flux values. 
 
The observed changes in AC amplitude and LDF flux were considered small 
enough to not disrupt the measurements and overall assessment of bowel 
viability. 
 
7.6 Thermal evaluation on the combined sensor 
7.6.1 Thermal Safety Testing 
The red and infrared emitters are low power components with operating currents 
of 50 mA. The laser Doppler output power is 2.5 mW and this is further affected 
by the optical fibre. All optical components are also thermally insulated from the 
tissue by the approximately 1 mm thick sterile latex sheath. Despite the fact that 
the operating current of the emitters and the output from laser Doppler was well 
below the maximum rated value, it was still necessary to confirm that these 
sources would not cause any direct thermal damage to the tissue. So 
temperature tests were performed to assess the likely thermal effect of placing 
the optical probe in contact with tissue during measurements.  
 
A thermal sensor; LM35 (National Semiconductor, USA) was used to measure 
the temperature produced by light sources while the probe was on. LM35 is a 
precision IC temperature sensor with its output proportional to the temperature 
(in °C). LM35 possesses low thermal effects and does not cause a rise above 
0.1 °C in ambient temperatures (233).  
 
To convert the output voltage to temperature, the following equation was used: 
Temp in °C = (Volt in mV) / 10 
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7.6.2 Experimental methods  
An in vivo experiment was carried out on the forearm of a female volunteer. The 
thermal sensor was placed directly adjacent to the combined probe. It was 
connected to one analogue input of a data card (USB 600, National Instruments, 
USA). Data was recorded at a rate of 100 Hz by the use of a virtual instrument 
implemented in LabVIEW (National Instruments, USA). The probe was placed on 
the forearm for 30 minutes to reach a steady thermal state.  Then the 
temperatures of the thermocouples were continuously recorded for 40 minutes 
while the circuit was switched on, so both PPG and Laser Doppler light sources 
were emitting continuously.  The drive current (as stated on the LEDs datasheet) 
used for switching the red and infrared LEDs was 50 mA using a current-limiting 
resistor of value R=220 Ω and a voltage supply of 12 V. The PPG and Laser 
Doppler light sources were then switched off and the temperatures recorded for 
another 20 minutes. In order to confirm and average out results the experiment 
was repeated twice more. 
 
7.6.3 Results  
Figure 7.15 shows a graph of changes in temperature against time. 
 
 
 
 
Figure 7.15: Graph showing changes in temperature induced on skin by the combined 
probe. 
After the light sources were switched on, the temperature increased and after 
approximately 2 minutes it reached to a steady state (mean temperature 30.2 
°C), as shown in Figure 7.15, where the temperature is plotted against time. 
Monitoring was continued for a further 38 minutes. When the light sources were 
Time (second) 
T
e
m
p
e
ra
tu
re
 (
°C
) 
Light sources on Light sources off 
  113 
switched off, again a steady state temperature was achieved after approximately 
2 minutes. The mean temperature with light sources off was 29.0 °C. See Table 
7.5. 
 
Table 7.5: Temperature change with LEDs of and on. 
LEDs status Mean Temperature 
LEDs off 30 minutes baseline 29.2 
LEDs on 40 minutes 30.2 
LEDs off 20 minutes 29.0 
 
The mean observed temperature rise was no greater than 1.2 °C with light 
sources emitting continuously. The rise in temperature would not be expected to 
result in tissue damage and therefore, it was concluded that there would be 
negligible risk of thermal injury to the tissue using the proposed probe. 
 
7.7 Sensor design and safety test summary 
Good results from the both studies along with the thermal test have determined 
that the use of this sensor for bowel operation would be very unlikely to cause 
any injury during intraoperative measurements in theatre. 
  
The following chapter describes the design and development of the 
instrumentation system for acquisition of signals from the probe. 
 
 
 
 114 
 
 
Development and Evaluation of the 
Combined PPG/LDF Measurement System 
8.1 Introduction 
The aim of this research is to develop a new system for simultaneous 
measurement of blood flow and pulsation for intraoperative evaluation of 
perfusion in intestinal tissue. This approach requires the combination of two 
different optical methods. Chapter 7 describes the design and manufacture of the 
combined photoplethysmography (PPG) and laser Doppler (LDF) sensor for the 
monitoring of pulsatile blood in bowel tissue. To drive the optical combined 
probes, a custom-made hardware PPG processing system was developed. The 
new combined PPG/LDF system was designed and developed in order to detect 
the red and infrared (AC and DC) PPG signals along with laser Doppler flowmetry 
signals. It then pre-processes the acquired signals and displays them, analysed 
and stored on a laptop computer for further analysis. Figure 8.1 shows a simple 
block diagram of the whole PPG/LDF processing system. 
 
 
Figure 8.1: A simple block diagram of the PPG/LDF processing system. 
 
8.2 Instrumentation  
As mentioned, the measurement system comprises a combined probe, PPG 
instrumentation unit (PPG unit) and laser Doppler flux monitor (LDF monitor). 
 
 
PPG-LDF 
Sensor 
(Chapter 8) 
!
!
PPG-LDF 
Processing System 
(Chapter 9) 
 
 
Laptop with 
NI LabVIEW 
(Chapter 10) 
                                                                    CHAPTER EIGHT 
 115 
PPG unit 
This unit consists of a small box (30 x 28 x 9 cm) weighing 3.44 kg, containing a 
power supply unit (two 12 V 2.2 Ah sealed lead-acid batteries), LED current 
sources and a custom-made signal processing circuit to separate the 
photoplethysmographic signals into AC (rapidly varying or ‘pulsatile’) and DC 
(slowly varying) components and to amplify each component together with the 
associated combined probe and a laptop computer (see Figure 8.2). The laptop 
computer was also powered by an internal battery comprising two 12 V 1.2 Ah 
sealed lead-acid batteries. 
 
The unit also contained a data acquisition card (National Instruments Inc., Austin, 
TX, USA) which samples (at 100 samples per second) and converts the analogue 
output of the PPG measurement system into a digital signal then feeds it to a 
notebook computer via a USB connection.  (Note: The data acquisition card also 
connects to the LDF monitor via a cable between the PPG unit and LDF monitor. 
This arrangement enables simultaneous recording of the LDF signal on the 
notebook computer). 
 
 
Figure 8.2: Instrumentation: unit containing Data acquisition card, PCB board, power 
supply unit and the connection to the computer and probe. 
 
Photographs of the front and rear panel of the monitoring system used in this 
study are presented in Figures 8.3 and 8.4 respectively. 
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PPG Connector 
 
Figure 8.3: Photograph of the rear panel of monitoring system. 
 
 
Figure 8.4: Photograph of the front panel of monitoring system. 
 
Block Diagram of the System 
This circuit contains a timer circuit, LED driver circuit, photodiode detector circuit, 
amplifier circuit, de-multiplexer (sample and hold) circuit and a filter circuit. Figure 
8.5 shows a photograph of the circuit used in this study. Figure 8.6 presents a 
block diagram of the PPG/LDF system. The block diagram consists of eight parts, 
starting from timer, multiplexer, LEDs driver, sensor, photodiode detector, 
amplifier, de-multiplexer and band pass filter circuit.  
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Figure 8.5: The circuit of PPG measurement system. 
 
The red and infrared signals, which comprise AC and DC parts (Section 4.4) are 
demultiplexed in order to separate them into two different signals; red and 
infrared. The red (AC and DC) and infrared (AC and DC) are digitised and sent to 
the notebook computer for analysis.  
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Figure 8.6: The block diagram of the PPG/LDF system. 
 
A schematic diagram of the entire measurement system is shown in Figure 8.7. 
Detailed descriptions of each segment are presented in the following sections. 
 
Timing Circuit 
In this study an NE555 timer was used to generate stable and accurate timing 
pulses. It is an 8-pin timer IC and has mainly two modes of operation: monostable 
and astable. In this study, the astable mode is used to generate a continuous 
series of pulses (monostable mode can be used to make a one-shot or 
monostable circuit). The circuit of the 555 timer used in this study is shown in 
Figure 8.8. 
 
The frequency or repetition rate of the output pulses is determined by the values 
of two resistors, R1 and R2 and the capacitor C using the Equation 8.1 and 8.2 
(234). 
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Figure 8.7: A schematic of the entire measurement system. 1
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                                                                               Equation 8.1 
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                                                               Equation 8.2 
 
T   = Time period in seconds (s)  
f    = Frequency in hertz (Hz)  
R1 = Resistance in ohms (Ω)  
R2 = Resistance in ohms (Ω)  
C = Capacitance in farads (F) 
With R1= 1 K Ω, R2= 10 K Ω and C = 100 nF = 0.1 µF: 
f = 680 Hz  
 
 
Figure 8.8: Generating the timing pulses for pulse oximeters using 555timer (235). 
 
Multiplexer/Driver of two Wavelengths 
The counter provides the timing signal for the multiplexed LED driver circuits and 
for the demultiplex circuit. In this study a dual 4-bit counter (HEF4520B, Philips 
Semiconductors) was used, see the functional and timing diagram for HEF4520B 
in Figure 8.9 (a) and (b).  By inputting a clock signal provided by the 555 timer 
(CP1), the counter produces three signals at different frequencies: half, one 
quarter and one eighth the frequency of the timer signal (Q1, Q2 and Q3 
respectively) as shown in Figure 8.10.  
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(a): Functional diagram for HEF4520B 
 
 
(b): Timing diagram 
Figure 8.9: (a) Functional and (b) timing diagram for HEF4520B. 
 
 
Figure 8.10: HEF5420B 4-bit binary counter was used in this circuit, CP1 is the clock 
signal (frequency = fCP1) as the input and counter produces three signals Q1, Q2 and 
Q3. Q1 has frequency fCP1/2, Q2 has frequency fCP1/4 and Q3 has frequency fCP1/8. 
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Figure 8.11 shows the LED driver circuit, which comprises a basic multiplexing 
logic circuit based on two AND gates, a pair of current sources consisting of a low 
power operational amplifier (TL081, Texas Instruments, Dallas, Texas, USA) and 
a NPN transistor (2N3904).  
 
The timing signal provided by HEF5420B, drives the current sources. The output 
of the first AND gate is connected to the input of the R LED driver switches on the 
R LED when Q1 and Q2 are both high, see the timing diagram in Figure 8.12.  
The output of the second AND gate is connected to the input of the IR LED driver. 
To drive the IR LED, one of the inputs of the AND gate is inverted. The IR LED is 
thus switched on when Q1 is high and Q2 is low.  The red and infrared LEDs 
therefore switch on alternately, with periods in between when both emitters are 
off. 
 
 
 
 
Figure 8.11: Schematic drawing of the LEDs current driver circuit. 
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Figure 8.12: Light source timing diagram. Q1 and Q2 are the outputs from the counter. 
The R LED switches on when Q1 and Q2 are both high while the IR LED is switched on 
when Q1 is high and Q2 is low.   
 
 
Transimpedance Amplifier 
Many biomedical and analytical applications require the detection of light. A 
photodetector is able to detect the light transmitted through the part of the target 
tissue and convert light into an electrical signal. There are several basic 
technologies including: photomultiplier tubes (PMTs), avalanche photodiodes 
(APDs), and photodiodes. Photodiodes were chosen for this project as they 
produce current linearly proportional to the intensity of the detected light. Using a 
transimpedance amplifier this current can be then converted to voltage.  
 
Positive-intrinsic-negative (PIN) photodiodes have been used in the majority of 
commercial pulse oximeters as detectors mostly due to their rapid response 
times, favourable spectral response at red and infrared wavelengths and also 
relative insensitivity to temperature variation. The photodiode used in this 
application is a silicon PIN photodiode operating with reverse bias applied to the 
p-n junction (photoconductive mode). Electron-hole pairs are created when light 
falls on the junction area of the photodiode. Due to the reverse bias, i.e. 
(increased depletion region) the hole sweeps towards the p-material and the 
electron towards the n-material. The output light current can be seen as a large 
increase in the reverse current. The photocurrent is effectively transformed into a 
voltage using the circuit shown in Figure 8.13. This circuit is known as a 
transimpedance amplifier or I-V converter. The output voltage of the circuit is 
given by:  
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where Rf is the feedback resistor and the output V0 is proportional to the light 
intensity I. 
 
A very large feedback resistance is usually required as the output current from 
the photodiode is very small (values as high as several tens of M Ω are typical). 
Note that the gain of the transimpedance amplifier is equal to the value of the 
feedback resistor in ohms. 
 
 
Figure 8.13: Transimpedance amplifier circuit. 
 
The output from the photodetector is passed into an analogue circuit in order to 
amplify and filter the signal. 
 
De-multiplexer 
The output of the transimpedance amplifier consists of mixed (multiplexed) 
signals so in order to separate the detected signals into its components, a de-
multiplexer was used. In this circuit a sample and hold circuit (LF398) was used 
to de-multiplex three signals detected from the detector circuit corresponding to 
the red, the infrared and the ambient light (measurable during periods when both 
LEDs are off). See Figure 8.14. These signals then were passed to the filters and 
the AC post-amplifier.  
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The mixed signals from the transimpedance amplifier are fed into a de-multiplexer 
to separate the signals into independent channels as shown in Figure 8.15.  The 
de-multiplexing circuit comprised of a logic circuit connected to three LF398 
sample and hold circuits. (National Semiconductor Inc., Santa Clara, CA, USA). 
The logic circuit composed of a combination of AND gates and NOR gates. The 
signals from the counter (CP1 and Q1–3) were used as the inputs for the logic 
circuit. Figure 8.16 shows a timing diagram for the de-multiplexer. As shown in 
this diagram, Q2 and Q3 determine which LF398 is triggered, while triggering 
only occurs when CP1 is low and Q1 is high. 
 
The logic circuit was designed to trigger each LF398 to sample the signals at 
appropriate times so the first LF398 samples the output signal from photodiode 
when both R and IR emitters are off (i.e. the ambient light level is sampled). The 
timing diagram (Figure 8.16) shows that the sampling time occurs at the mid-point 
of the period when the LEDs are off, thereby avoiding interference from the light 
sources in the event of switching delays. Two other LF398s were sampled when 
the infrared and red light sources were on, at the mid-points of each period of 
illumination which allows time for the LEDs to reach full brightness before 
sampling.  
 
 
Figure 8.14: Sample and hold IC pin out diagram. 
 
 
 
 126 
 
Figure 8.15: The de-multiplexer circuit. The pins on the LF398 sample-and-hold chip are: pin 
3 (photodiode output/analogue input), pin 8 (logic input) and pin 5 (analogue output). 
 
 
Figure 8.16: Timing diagram for the de-multiplexer. The dotted lines indicate the 
times when sampling of the photodetector output occurs. 
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Band-pass Filter (Low and High Pass Filter) 
The output coming from the multiplexing stages are the raw signals consisting of 
the sum of the AC and DC components.  These signals are then passed through 
an array of filters (described below) to separate the AC and DC components and 
to remove unwanted frequencies. 
 
In this study a pair of band-pass active second-order Butterworth filters  (see 
Figure 8.15) were used to separate the red and infrared (AC) 
photoplethysmographic signals from the total (DC) detected signal levels and 
remove high frequency noise. The value of the cut off frequency of the high pass 
filter stage was 0.4 Hz and for the low pass filter stage it was 19 Hz to ensure that 
the pulsatile portion of the PPG signals were preserved.  The red and infrared DC 
signals were filtered to remove high frequency noise using a low-pass second-
order active Butterworth filter  (see Figure 8.7) with cut off frequency 0.15 Hz. 
 
Amplifier 
To amplify the AC signals detected from the photodiode detector an amplifier was 
used. In this study an inverting amplifier was used with a gain of 100. Two 
amplifiers were required in this circuit, one for each of the red and infrared 
signals. 
 
8.3 Laser Doppler Monitor 
The LDF monitor is a commercial VMS-LDF laser Doppler monitor (Moor 
Instruments Ltd, Exmoor, UK), a fully certified CE-marked medical device. See 
Figure 8.17. The LDF monitor is connected to the PPG unit via a coaxial cable. 
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Figure 8.17: Photograph of Laser Doppler Flowmetry monitor. 
 
Figure 8.18 shows a photograph of the entire measurement system. As can be 
seen, the probe is connected via a Y-shaped cable to the PPG unit and the laser 
Doppler monitor.  The laser Doppler monitor is connected to the PPG unit via an 
analogue connection which represents the flux value as an analogue voltage 
where 1 V is equal to 100 perfusion units (PU).  The PPG unit is connected to a 
personal computer (a laptop computer for this clinical study) via a USB connector. 
 
 
Figure 8.18: Photograph of measurement system. Note: in the photograph the distal tip 
of the probe is being held between thumb and forefinger. 
 
 129 
The PPG signals (AC and DC), and the perfusion signal from the laser Doppler 
flowmeter were acquired and recorded with a 14-bit data acquisition card 
(USB6009, National Instruments, TX, USA) at a sampling frequency of 100 Hz 
using a specially developed LabVIEW program (National Instruments Inc. Austin, 
TX, USA). The data acquisition card is a bus-powered device; which is attached 
to a laptop computer via a USB connection. The laptop computer runs a ‘Virtual 
Instrument’ (VI) software application for acquisition and displays signals acquired 
from the probe and instrumentation, which is covered in Chapter 9. 
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Data Acquisition and Development of the 
Virtual Instrument (VIs) for Signal 
Processing, Data Storage and Display 
9.1 Introduction to LabVIEW 
A Virtual Instrument (VI) created in LabVIEW (National Instruments, Austin, 
Texas, USA), reads the digitised signals at a rate of 100 samples per second, 
displays the signals to the operator and writes them to a tab-delimited text file for 
future analysis. The processing system in this study provides six output signals 
including AC PPG (pulsatile arterial component) for red and infrared wavelengths, 
DC PPG signals (non-pulsatile PPG component from venous, skin and bone) for 
red and infrared wavelengths, ambient and also laser Doppler signals. These 
acquired PPG and LDF output signals from the sensor are digitised using a data 
acquisition card (National Instruments) incorporating an analogue to digital 
convertor (ADC). The Data acquisition (DAQ) card is connected to a computer via 
a USB cable so that the digitised PPG and LDF signals can be saved to the 
computer’s hard disk drive.  Figure 9.1 illustrates the main functions of the 
developed VI and the connection with the processing system. 
 
Figure 9.1: Block diagram of the PPG-LDF processing system and the connection with 
the VI. 
 
                                                                                         CHAPTER NINE 
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LabVIEW, which stands for Laboratory Virtual Instrument Engineering 
Workbench, is a development environment designed by National Instruments 
(National Instruments, Austin, Texas, USA).  Programs developed in LabVIEW 
are referred to as Virtual Instruments (Vis) due to their visible and functional 
resemblance to hardware instruments. LabVIEW uses a graphical programing 
language called “G”. Using a workspace known as the ‘block diagram’, a program 
can be created in G, in contrast to most other programming systems that use 
text-based lines of code. In fact, this software relies on graphical symbols instead 
of textual language to create applications. 
 
Each VI comprises three main parts, including the ‘front panel’ a graphical user 
interface for operating the VI when it is running and the block diagram 
representing the program, which contains multiple functions, some of which are 
also represented on the front panel.  
 
The front panel: The front panel may consist of controls and indicators. Controls 
are knobs, buttons, dials and other input devices, while indicators are graphs, 
LEDs and other displays. The user interfaces with the running VI via the front 
panel. 
 
The block diagram: The block diagram consists of functions connected together 
by virtual ‘wires’ represented by lines.  Functions (also known as sub-Vis) can be 
selected from a library or created by the programmer.  In this way they are similar 
to subroutines used in text-based programming languages.  All front panel 
objects are represented on the block diagram, so may be connected to other front 
panel objects (or just to block diagram objects).  Other functions used in text-
based languages are available such as while loops, for loops etc.   
 
Wires perform a similar function to variables in text-based programming and can 
be of different types including integer, floating point and string.  One or two 
dimensional array variables of these types can also be used.  Data acquired 
through a DAQ card may be processed using simple or advanced mathematical 
functions and the results displayed numerically or on a graph.  Data may also be 
read from and saved to text files. 
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9.2 Two Wavelengths and Laser Doppler Signal Acquisition VI 
In order to use the data acquisition hardware described in Chapter 8, a VI was 
created in LabVIEW (Version 8.5), shown schematically in Figure 9.2. This VI 
was designed to acquire all signals, displays AC and DC PPG, ambient and also 
LDF signals in a graphical format, calculate SpO2 value and at the end, save the 
data in a spreadsheet format for further analysis.  
 
The following sections will describe each part of this VI.  
 
NI-DAQmx is a set of drivers, which are a connection between the data 
acquisition card (DAQ) and a laptop. Figure 9.3 shows the basic DAQmx, which 
has been used in the VI developed to continuously acquire all PPG and LDF 
signals in this current study, which will be explained in detail. 
 Figure 9.2: Simple diagram of the virtual instrument (VI). 
Algorithm for the 
Acquisition of 
Analogue Data Input 
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Stop 
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Saving VI 
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Algorithm  
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Figure 9.3: Basic DAQmx functions used in the VI developed to continuously acquire 
PPG and LDF signals. 
 
DAQmx create Channel: uses the Physical Channel to create and set up an 
Analogue Input Voltage virtual channel, which has six virtual channels to measure 
the voltage output from the PPG/LDF processing system. As mentioned before 
the DAQ card used in this study (USB6009) has 8 analog inputs, six of them (ai0-
ai5) have been connected to the output of the PPG/LDF processing system, the 
virtually created channels correspond to these six physical terminals on the DAQ 
card. Maximum and minimum voltages may be set according to the requirements 
of the data acquisition but the default range is +10 v to -10 v, the input terminal 
configuration are set for RSE (Referenced Single Ended) mode. See Figure 9.4. 
 
 
Figure 9.4: Diagram of DAQmx Create Virtual Channel. 
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DAQmx Timing (Sample Clock): To controls the number of and rate at which 
samples are acquired DAQmx Timing is added. The sample mode is on the 
continuous mode, which acquires samples continuously until the VI is stopped, 
sampling rate of 100 Hz is also set. See Figure 9.5. 
 
 
 
Figure 9.5: Diagram of DAQmx Timing. 
 
DAQmx Start Task: To start and run the measurement (acquiring the samples). 
See Figure 9.6. 
 
 
 
Figure 9.6: Diagram of DAQmx Start Task. 
 
9.3 Algorithm for continuous signal display 
While-Loop: The task (acquired data) is then passed into a while-loop, which 
incorporates most of the VI’s functions, which contains a for-loop, which will be 
explained in the next section. Within the while-loop the acquisition and all codes 
will be executed continuously until a condition occurs and the user stops the 
program by pressing the stop button on the front panel of the VI, in fact it 
executes the sub diagram until the conditional terminal  receives a specific 
Boolean value (“TRUE”). As soon as the TRUE condition is received the while-
loop will finish executing all codes. The while-loop always executes at least once. 
The iteration terminal  contains the number of completed iterations. Figure 9.7 
shows the block diagram representation of a while-loop. 
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Figure 9.7: While-loop 
 
As explained, the VI is based on a repeating loop. The user sets the number of 
samples per cycle on the front panel, then during each loop the VI acquires that 
number of samples from each channel. At the end this number of acquired 
samples is written onto a spreadsheet file for further analysis, which will be 
explained later in this chapter. 
 
For-Loop: A for-loop executes a sub diagram within it, N times. A for-loop differs 
from the while-loop, as the for-loop executes at a set number of times (N) 
however a while-loop stops executing the sub diagram only if specific values at 
the conditional terminal occurs. Figure 9.8 shows the block diagram 
representation of a for-loop. As it can be seen in Figure 9.9 the DAQmx Read 
function is placed inside a for-loop, which is in turn inside a while-loop. Details of 
this function will be explained in the next section. 
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Figure 9.8: For-loop 
 
DAQmx Read: using this function inside the while-loop the signals that have 
been sampled by the DAQ card can be read for each specified channel. After the 
creation of an analogue output signal, the while-loop along with the DAQmx Read 
function generates an output voltage continuously. The DAQmx Read VI reads 
one sample from a single channel. The format of sampling is set for analogue “1D 
DBL NChan NSamp” so single samples from multiple channels can be read and 
the output is a one-dimensional array. Figure 9.10 shows a diagram of a DAQmx 
Read. 
 
The VI is designed to run continuously to obtain one sample as set in the DAQmx 
Read, so that one sample for each iteration may be acquired. The for-loop is set 
to execute continuously 200 times. Therefore, after 200 iterations of the for-loop, 
200 samples can be acquired. The while-loop continuously repeats, runs the 
process and keeps scanning the data until the conditional terminal receives the 
Boolean value corresponding to a ‘stop’ command (TRUE).  When the user 
presses the stop button on the front panel of the VI the while-loop stops acquiring 
data. 
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Figure 9.9: Algorithm for continuous signal display. 
 
 
Figure 9.10: Diagram of DAQmx Read. 
 
The output of the DAQmx Read function is fed into an “Index Array” function. 
Using this function, any of the columns representing each channel at the voltage 
data output of the DAQmx Read function may be extracted. This function can 
resize automatically when wired to an array, and displays an index input for 
For-Loop While-Loop 
!
Display Section 
of VI!
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dimension in the array. Also more elements or subarray terminal can be added by 
resizing the function (See Figure 9.11). The output of this function is six 
separated acquired channels.  
 
 
Figure 9.11: Index Array function. 
 
9.4 Estimation of the bowel tissue SpO2 
The arterial blood oxygen saturation (SpO2) values were also calculated from the 
incoming raw PPG signals using a developed VI.  To derive estimations for SpO2 
values, initially the ratio (RR) of the quotients of the AC and DC amplitudes of the 
red and infrared wavelengths are calculated using: 
 
�! =
!!"
!!"
!"!"
!"!"
                                                                                Equation 9.1 
 
The outputs of the formula are displayed on the front panel. 
 
The arterial oxygen saturation is then computed using the formula below: 
 
SpO! = 110− 25  �!                                                                    Equation 9.2 
 
A VI was designed and implemented to calculate the RR and the SpO2 of the 
bowel tissue using Equations 9.1 and 9.2. These details will be explained in the 
following section. 
 
In order to find the peak-to-peak amplitude of the pulsatile R and IR PPG 
components of the required signals, the difference between the maximum and 
minimum values of a short segment of the acquired signal is found.  Note that the 
acquisition time of two seconds ensures that at least one heartbeat is 
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represented by the acquired segment of data.  
 
Following the separation of the raw acquired signals by Index Array function, the 
output (comprising 200 samples, or 2 seconds of data) then passes outside the 
for-loop. Among them the RAC and IRAC and also RDC and IRDC signals pass 
through “Array Max and Min” functions (Figure 9.12), which returns the maximum 
and minimum values of all elements in the array.  
 
 
Figure 9.12: Array Max and Min functions. 
 
The peak-to-peak amplitude is then calculated from the difference between the 
maximum and minimum values.  
 
The mean of the values for the DC component of the PPG for both R and IR 
wavelengths is calculated using two “Mean” functions (see Figure 9.13). 
 
 
Figure 9.13: Mean function 
 
Following calculations of the amplitude of the AC PPG for both R and IR 
wavelength and also the mean values for DC PPG, all the outputs from the array 
functions are then sent into a formula node, so now the ratio of R!"  R !" and 
IR!"  IR !"
 can be obtained using “division numeric” functions. At the end another 
division numeric function needs to be used to compute the ratio-of-ratios (RR) 
value by dividing the obtained values in the Equation 9.1. The calculated RR used 
to calculate the SpO2 value using Equation 9.2. The whole block diagram for 
calculation of RR and SpO2 is illustrated in Figure 9.14. 
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DAQmxBase Clear Task VI: After the VI is stopped by pressing the STOP 
button, the VI commands the DAQ card commands to stop acquiring data using 
DAQmxBase Clear Task VI. This allows the DAQ card to clear the previous set 
up parameters and reset itself. See the diagram of DAQmxBase Clear Task in 
Figure 9.15. 
 
 
Figure 9.14: Illustration of the block diagram, used for calculating RR and SpO2 for the PPG. 
 
RR 
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Figure 9.15: Diagram of DAQmx Base Clear Task VI. 
 
9.5 VI for Data Storage 
The acquired data must be saved and stored in a text file for further analysis. All 
PPG and LDF signals are saved into a file in a tab-delimited text format.  
The ‘DAQmx Read’ VI produces a 2-dimensional array, which is then formatted 
and saved. 
 
The data in the 2D array first needs to be converted to a table in string form, 
which is accomplished with an “Array to Spreadsheet String” function (Figure 
9.16). 
 
 
 
 
 
 
Figure 9.16: Array To Spreadsheet String Function. 
 
After generating the spreadsheet string, the data is saved in the specified file, 
using a ‘Write File’ function (Figure 9.17). All the acquired data can thus be saved 
in memory continuously while the VI is running. The date and time of the 
measurement is also saved using the “Get Date/Time String” Function (Figure 
9.18). 
 
        
Figure 9.17: Write to Text File Function. 
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Figure 9.18: Get Date/Time String Function. 
 
At the end of the measurement by pressing the stop button on the front panel of 
the VI, the file is transferred to a text file saved to the computer hard disk. The VI 
used to save all the acquired analogue signals is shown in Figure 9.19. 
 
 
Figure 9.19: The VI used to save all the acquired analogue signals. 
 
9.6 Front panel of the VI 
All six signals including photoplethysmographic, laser Doppler and ambient light 
are displayed on the front panel using three chart indicators for IRAC, RAC and 
LDF, also three bar indicators for IRDC, RDC and ambient light outputs in real time. 
As mentioned before the user can observe these output signals, also their 
amplitude and morphology can be monitored during acquisition of data as a way 
of verifying the quality of the signals. Figure 9.20 shows the Front panel of the 
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Virtual Instrument, as it can be seen the first chart on the right top side of the front 
panel shows the IRAC PPG, the second chart shows RAC PPG and the third chart 
shows LDF.  In all three charts amplitude is plotted versus time in seconds. The 
waveform chart is a graphical representation of the output data to display the 
PPG and LDF signals.  
 
On the left side of the front panel there are three bar indicators for IR DC, R DC 
and ambient outputs. These three horizontal coloured bar displays, show the 
output voltages corresponding to the total detected signal level acquisition phase 
(infrared and red signal levels (AC+DC)). Bar indicators are chosen for DC 
displays since they give a quick and easy visual interpretation of DC level in the 
PPG processing signals. Also the set up parameters are placed on the left side of 
the front panel in order to control and adjust the parameters if required. All the 
controls of the system including offset control of the waveforms, sampling 
frequency of the acquisition, RR, and SpO2 are placed on the front panel of the VI 
and can be seen and controlled by the user. 
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Figure 9.20: Front panel of the Virtual Instrument. 
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Intra-operative PPG/LDF Assessment of 
Bowel Tissue Viability 
Following the design of the probe and instrumentation and the successful 
evaluation, clear PPG and LDF signals through two different volunteer studies 
were obtained in Chapter 7. The functionality of the developed PPG/LDF system 
was then discussed in Chapter 8 and the virtual instrument presented in Chapter 
9. With these three chapters, sufficient confidence was acquired to allow the 
system and probe to commence the preliminary clinical measurements. The 
recruitment process for selecting potential patients who met the inclusion criteria 
for the trial and the procedure by which the PPG and LDF signals that were 
acquired in vivo will be presented in this chapter. This chapter also explains the 
methodology used to analyse the acquired data followed by a detailed discussion 
of the results. 
 
10.1 Introduction 
The aim of this evaluation was to determine if clear PPG and LDF signals could 
be obtained from the surface of the large bowel at different stages in bowel 
resection intra-operatively, also to compare differences in PPG amplitude and 
LDF flux obtained from different stages during the operation. Arterial blood 
oxygen saturation was also estimated from the large bowel at each stage. 
 
The PPG/LDF instrumentation system was inspected by the Clinical Physics 
Department of Barts and the London, NHS Trust, London and was deemed safe 
for use on patients in the clinical environment. Ethical approval (Appendix D) was 
written and obtained for this study in June 2013 by the National Research Ethics 
Service (NRES) Research Ethics Committee London: City & East.  The study 
was approved by the Barts and Queen Mary Joint Research Office in September 
2013. 
                                                                  CHAPTER TEN 
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10.2 Methods 
10.2.1 Patients 
Written informed consent from each patient was obtained prior to recruitment to 
the study. In total, 24 patients undergoing bowel resection with/without 
anastomosis (Chapter 3) that met the inclusion criteria and were due for 
colorectal surgery at the Royal London Hospital from January 2014 to September 
2014 were entered into this study. 11 volunteers were male and 13 were female 
with average age (±SD) of 66 (±15.6) (range 33 - 91). These preliminary clinical 
measurements were performed on patients undergoing bowel resection both 
laparotomy (4 cases) and laparoscopy (20 cases). Table 10.1 summarises the 
patients’ details, which included age, sex, type of measurements and number of 
measurements obtained from each patient. It was decided by the surgeons that 
the evaluation should focus on the measurements at eight different stages during 
each operation (if possible), see Section 10.3. In order to avoid delaying the 
surgical procedure, the length of the recording for each measurement was limited 
to about one minute. A Case Report Form (CRF) was also prepared for each 
patient, where patient information such as the patient’s date of birth, weight, date 
of surgery, medical history, reason for the operation, etc. were documented. 
 
10.2.2 Measurements 
As mentioned in chapter three, the most common procedure in this study was the 
removal of a cancerous segment of the large intestine, which can be done 
through laparoscopy or laparotomy. To perform a laparoscopy, three or four small 
incisions are commonly made, (in order to prevent a large incision), to insert the 
laparoscope and small surgical tools. While in laparotomy, the operation is 
carried out through a large incision on the abdomen.  
 
After administration of general anaesthesia, the patient was intubated and  
mechanically ventilated. This research was planned so as not to interfere with the 
operation so the PPG/LDF probe was placed on a separate sterile trolley near the 
patient’s bed to be used later by the surgeon. Since this was a research study, 
care was taken to ensure that the recorded data was not available to the 
surgeons during the measurements in case it could be interpreted as a reliable 
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indicator of tissue viability and possibly contribute to clinical decision making. 
Prior to any measurements, the combined sensor was inserted into the sterile 
probe cover (Section 7.4) and was placed on the sterile covered trolley beside 
the surgeon and operating table. For each measurement, at an appropriate time, 
the processing system was switched on and the sensor was passed to the 
surgeon with caution and inserted through the Trocar 1  (size 12-mm) in 
laparoscopy and applied over the surface of the bowel or applied directly and 
gently onto the surface of the bowel in laparotomy. For each recording the 
surgeon tried to put the sensor over a suitable place on the surface of the bowel 
to obtain a clear signal but sometimes the probe position needed adjusting 
slightly by the surgeon until a clear signal could be observed on the laptop 
screen.   
 
Signal acquisition then commenced using the LabVIEW program (Chapter 9) on 
the laptop. The sensor was held as steadily as possible over the investigation site 
by the surgeon during the recording period. To ensure no interference with the 
light from the combined sensor during the measurements in laparoscopy, the 
laparoscopic light was turned off. During the laparotomy procedure, the over-
head operating theatre lights were turned off. Simultaneous AC and DC PPG and 
LDF signals were then acquired using the PPG/LDF processing system and 
recorded for approximately one minute for each measurement. 
 
Once satisfied with the signal detected from the investigation site, the signal 
acquisition was stopped and the acquired signals were saved. Any additional 
information such as surgical events, during the measurements was recorded on a 
separate notebook for future analysis, if required. In order to compare the 
recorded values obtained by custom made PPG/LDF sensor with those from 
routine commercial measurements, the data such as blood oxygen saturation, 
heart rate, systolic and diastolic blood pressures and temperature from the 
theatre monitors, were also noted right after each measurements separately. 
After each measurement the surgeon would remove the sensor from the 
measurement site (in the case of laparoscopy, the sensor would be withdrawn 
                                            
1
 A sharp-pointed surgical instrument used a means of introduction for cameras and laparoscopic hand instruments, such 
as scissors, graspers, etc., 
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from the trocar) and put back with caution on to the sterile trolley for the next 
measurement and the operation continued as planned. Sometimes the 
investigation site was in a very low location in the abdomen, this happened 
mostly for post anastomosis or over tumour measurements, so the measurement 
from these locations could not be monitored.  
 
 
Table 10.1: Details of all patients recruited to the study including the measurements for each trial. Reference; 1: Mobilisation, 2: Over Tumour, 
3: Pre Ligation, 4: Post Ligation, 5: Pre Anastomosis Proximal, 6: Pre Anastomosis Distal, 7: Post Anastomosis Proximal, 8: Post Anastomosis 
Distal measurement (Measurements will be explained in detail in the following section). 
Patient Sex Age 
Type of 
Operation 
Reason for Operation 
Measurement 
1 2 3 4 5 6 7 8 
1 M 82 Laparoscopy Tumour ✓ ✗ ✓ ✓ ✓ ✓ ✓ ✓ 
2 F 56 Laparoscopy Tumour ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✗ 
3 F 61 Laparoscopy Tumour-Right side ✓ ✓ ✓ ✗ ✓ ✗ ✓ ✗ 
4 F 54 Laparoscopy Rectal Tumour ✓ ✗ ✗ ✗ ✓ ✗ ✗ ✗ 
5 M 33 Laparoscopy Tumour-left side ✗ ✗ ✗ ✗ ✓ ✓ ✓ ✓ 
6 F 61 Laparoscopy Tumour-left side ✓ ✓ ✓ ✓ ✗ ✗ ✗ ✓ 
7 M 52 Laparoscopy Right Hemi-colectomy ✓ ✓ ✓ ✗ ✓ ✗ ✓ ✓ 
8 M 85 Laparotomy Hernia repair/closure of colostomy ✗ ✗ ✗ ✗ ✓ ✓ ✓ ✓ 
9 M 72 Laparoscopy Anterior Resection ✗ ✗ ✗ ✗ ✓ ✗ ✓ ✗ 
10 M 75 Laparoscopy Anterior Resection of rectum ✓ ✗ ✓ ✓ ✓ ✗ ✓ ✗ 
11 M 38 Laparoscopy Hemi-colectomy ✗ ✓ ✗ ✓ ✓ ✓ ✓ ✗ 
12 F 82 Laparotomy Rectum tumour ✗ ✗ ✗ ✗ ✓ ✓ ✓ ✓ 
13 F 77 Laparoscopy Anterior Resection ✓ ✓ ✓ ✓ ✓ ✗ ✓ ✗ 
14 F 61 Laparoscopy Anterior Resection ✗ ✗ ✓ ✓ ✓ ✓ ✓ ✗ 
15 F 56 Laparotomy Open Anterior Resection ✓ ✗ ✓ ✓ ✗ ✗ ✓ ✗ 
16 F 74 Laparoscopy Anterior Resection ✓ ✗ ✗ ✓ ✗ ✗ ✓ ✗ 
17 F 35 Laparoscopy Right Hemi-colectomy ✓ ✓ ✗ ✓ ✗ ✗ ✓ ✓ 
18 F 72 Laparoscopy Low Anterior Resection ✗ ✗ ✓ ✓ ✓ ✗ ✓ ✓ 
19 M 80 Laparoscopy Hartmann’s ✓ ✓ ✓ ✓ ✓ ✗ ✓ ✗ 
20 F 91 Laparoscopy Tumour-left side ✓ ✗ ✗ ✓ ✗ ✗ ✗     ✗ 
21 M 59 Laparoscopy Anterior Resection ✓ ✗ ✗ ✓ ✓ ✓ ✓ ✓ 
22 F 81 Laparoscopy Anterior Resection ✓ ✗ ✗ ✓ ✗ ✗ ✗ ✗ 
23 M 72 Laparoscopy Anterior Resection ✓ ✗ ✓ ✓ ✗ ✗ ✓ ✓ 
24 M 68 Laparoscopy Anterior Resection ✗ ✗ ✗ ✗ ✗ ✗ ✗ ✗ 
N= --- --- --- --- 15 7 11 16 16 7 18 10 
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10.3 Intraoperative Measurements 
With the agreement by the surgeon, intraoperative measurements were made 
through eight measurements made at the following times: 
 
1. Mobilisation 
2. Over tumour 
3. Pre- Ligation 
4. Post-Ligation 
5. Pre-Anastomosis, Proximal 
6. Pre-Anastomosis, Distal 
7. Post-Anastomosis, Proximal 
8. Post-Anastomosis, Distal 
Each measurement is explained in brief below. 
 
10.3.1 Mobilisation 
The first surgical step in bowel resection is mobilisation of the colon and its 
mesentery, i.e. separation of the colon from the wall of the bowel. Once 
mobilisation is complete, the first measurement can be performed as 
explained. In total, 15 mobilisation measurements were performed. 
 
10.3.2 Over Tumour 
The second measurement was planned to be performed on the tumour, in 
which the probe was placed over the cancerous site, although in many cases 
the tumour was very small or located very low and couldn’t be monitored. In 
total, seven measurements over tumours were acquired. 
 
10.3.3 Pre-Ligation 
After mobilisation of the bowel vascular ligation takes place, in which the 
blood vessels, which are providing blood supply to the area, must be stapled 
in order to stop feeding the region of colon to be removed. In this step of the 
operation the appropriate recipient vessels must be identified in the area by 
the surgeon in preparation for clamping. Before ligation, a measurement (‘pre-
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ligation’) was performed. In total, 11 pre-ligation measurements were 
performed. 
 
10.3.4 Post-Ligation 
Following vascular ligation, post ligation measurement could be carried out.  
In total, 16 post-ligation measurements were performed. 
 
10.3.5 Pre Anastomosis Proximal and Distal  
After ligation of the blood vessel in the area to be removed, the cancerous 
segment is ready to be removed followed by anastomosis of the healthy 
segments. At this point of the procedure in laparoscopy a section of colon that 
includes the cancerous segment is passed through one of the small incisions 
(which needs to be enlarged to 3–4 cm) (Chapter 3), so anastomosis is 
performed while the colon is out of the abdomen (Figure 10.1). Anastomosis 
is performed by joining the edges of the healthy parts together along with 
rejoining the arterial and venous blood vessels of the proximal sites of the 
anastomosis area. Pre-anastomosis measurements were made before 
rejoining two segments together. The measurements were performed on the 
proximal and distal ends of the anastomosis edge. In total, 16 pre-
anastomosis proximal and seven pre-anastomosis distal measurements were 
performed. After the anastomosis, the colon was then placed back into the 
abdomen. 
  
10.3.6 Post Anastomosis, Proximal and Distal 
After the anastomosis, in order to capture the reperfusion of the anastomosis 
site, PPG amplitude, LDF flux and arterial blood oxygen saturation 
measurements at the proximal and distal ends of the anastomoses were 
performed. In total, 18 post-anastomosis proximal and ten post-anastomosis 
distal measurements were performed. Figure 10.1 shows a picture of the 
PPG/LDF recording at an anastomosis measurement in which the surgeon 
applied the sensor on the surface of the colon, outside of the abdomen.  
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Figure 10.1: In vivo monitoring for anastomosis measurement during 
laparoscopy. 
 
At the end of the surgery, after construction of the anastomosis, the abdomen 
was then closed with sutures.  
 
The total numbers of measurements in all investigated sites was 100 (15 
mobilisation, 7 over tumour, 11 pre-ligation, 16 post-ligation, 16 pre-
anastomosis proximal, 7 pre-anastomosis distal, 18 post anastomosis 
proximal and 10 post anastomosis distal investigations). To facilitate the 
comparison between the results obtained with the combined sensor, the 
results were divided into four groups: mobilisation, over tumour, ligation and 
anastomosis. 
 
10.4 Methods of Analysis of Acquired Data 
In the 24 patients; 20 anastomosis and 4 non-anastomosis, 100 recordings 
were made. Clear red and infrared PPG and laser Doppler signals were 
acquired in most attempts from various measurements: mobilisation (n=15), 
PPG/LDF 
sensor Bowel surface 
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over tumour (n=7), Pre-ligation (n=11), post-ligation (n=16), Pre-anastomosis-
proximal (n=16), pre–anastomosis-distal (n=7), post-anastomosis-proximal 
(n=18) and post-anastomosis distal (n=10).  The PPG signals on the laptop 
screen appeared to show morphology typical of PPGs measured in other sites 
(71). As mentioned, it was planned to get all the eight measurements in each 
trial but this wasn’t possible in all subjects for one or more of the following 
reasons: 
 
• The operation didn’t include anastomosis, resulting in fewer 
measurements. 
• The measurement site was very low in the bowel or in a place that 
wasn't easy to access  
• The surgeon was too busy (or forgot) to take the measurement 
• The surgeon decided that there was insufficient time to complete the 
measurements without unacceptably delaying the operation. 
• The processing system failed to detect clear PPG or LDF signals due 
to poor contact with tissue surface, or other technical reason.  
 
In the next section, the results will be presented and compared between 
measurement sites. 
  
In each group (mobilisation, over tumour, ligation and anastomosis) typical 
samples of acquired signals from one patient are shown. Also a table with the 
mean normalised amplitude for ac PPG for both red and infrared and also the 
mean LDF flux values for each patient in all measurements is included. An 
explanation of the normalisation method is given in Section 10.4.1.  At the 
bottom of the table, the mean amplitude and flux averaged for all patients, and 
standard deviation (±SD) in all measurements is shown. Data analysis for the 
calculation of the average amplitude for ac PPG and LDF fluxes and the mean 
DC PPG were computed using LabChart 7 software (ADInstruments). The 
mean peak-to-peak amplitude of the AC PPG was automatically calculated 
and displayed by the software. The mean of the DC PPG and LDF flux 
selected data were also calculated automatically by the software. 10 to 20 
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second periods of each measurement were selected for the data analysis. For 
this calculation, periods with the fewest artefacts for three signals (R and IR 
PPGs and LDF) simultaneously were chosen, identified by visual inspection. 
A 43 second period is shown in Figure 10.2 from which a 10 second part was 
selected for the data analysis. In some measurements the acquired data 
couldn't be analysed and was excluded from the data analysis process.  
These cases were due to insufficient duration of clear signals as a result of 
motion artefacts caused by the surgeon while holding the sensor over the 
surface of the colon.  
 
 
Figure 10.2: Selected period of the data for analysis. 
 
The average laser Doppler flowmeter signal for the corresponding time, which 
was calculated by LabChart, then converted to conventional perfusion units 
(PU; 1 PU=10 mV) (66), values are given as mean PU (±SD) in the table 
along with the PPG values for each measurement.  
 
10.4.1 Filtering and Normalisation of the Acquired Signals 
To perform the analysis, the raw detected signals firstly had to be filtered to 
remove and eliminate the unwanted noise using LabChart. All detected 
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signals were filtered before any data analysis. In order to filter AC and DC a 
band-pass filter with a cut-off at 0.2 and 10 Hz and a low-pass filter at cut-off 
at 0.125 Hz were used respectively. Figure 10.3 shows a sample of signal 
before and after filtering. 
 
The red and infrared AC PPG signals were normalised to remove the effect of 
non physiological variables from the signal. Normalisation is performed by 
dividing each AC component by its respective DC component (235).  This 
removes the effect of variations in light intensity emitted by the LEDs, 
differences in sensitivity of the photodiode to each of the two PPG 
wavelengths and other non-physiological effects.  Normalisation thus allows 
more meaningful comparison between measurements from different subjects. 
 
(a) 
 
(b) 
Figure 10.3: Raw signals with noise artefact (a) and after filtering (b). 
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10.5 Results of Analysis of Acquired Data 
10.5.1 Mobilisation Measurements 
Figure 10.4 illustrates a typical 10-second sample of the infrared and red AC 
PPG along with LDF signals obtained at mobilisation from one patient. Table 
10.2 shows the mean normalised amplitudes for the red and infrared AC PPG 
and the mean flux for LDF from all patients at mobilisation (both values 
averaged over each measurement period).  The mean (±SD) values averaged 
for all patients also are presented. In total, 15 measurements in mobilisation 
were acquired, among them 13 measurements for IR, 10 R and 11 LDF were 
included in the analysis (two measurements for IR, five for R and four from 
LDF were excluded from the analysis due to insufficient duration of clear 
signals). The mean (±SD) IR and R AC amplitudes averaged for all subjects 
were 433 (±238) mV and 409 (±255) mV respectively, and the mean LDF flux 
averaged for all subjects was 80.8 (±76.3) PU. 
 
 
 
Figure 10.4: 10-second sample of red and infrared AC PPGs and LDF obtained at 
typical mobilisation measurements (case No. 6). 
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Table 10.2: Mean normalised AC PPG amplitudes and LDF flux from all subjects at 
mobilisation. 
Patient 
 
AC IR normalised 
(mV) 
AC Red normalised 
(mV) 
LDF 
(PU) 
1  --- --- --- 
2  --- --- --- 
3  224 507 --- 
4  523 247 --- 
5  ---- --- --- 
6  326 379 21.3 
7  458 372 23.3 
8  --- --- --- 
9  --- --- --- 
10  494 --- 11.3 
11  --- --- --- 
12  --- --- --- 
13  466 --- 22 
14  ---- --- --- 
15  222 220 20.3 
16  339 289 30.6 
17  --- --- --- 
18  --- --- --- 
19  995 --- 92 
20  230 260 175 
21  575 673 129 
22  94 151 232 
23  687 991 130 
24  --- --- --- 
Mean 433 409 80.8 
±SD 238 255 76.3 
 
10.5.2 Over Tumour Measurements 
Figure 10.5 shows a typical 10-second period measurements of the infrared, 
red PPG and LDF signals obtained in an over tumour measurement from one 
patient. Table 10.3 shows the mean normalised amplitudes for the red and 
infrared AC PPG and the mean flux for LDF from all patients from the over 
tumour measurements; the mean (±SD) values averaged for all patients are 
also presented. In total, seven measurements over tumour were acquired, 
among them six measurements for IR, three R and seven LDF were included 
in the analysis. The mean IR AC amplitude was 550 (±361) mV, for R it was 
431 (±218) mV and 32.4 (±31.5) PU for LDF, averaged for all subjects. 
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Figure 10.5: 10-second sample of typical red and infrared AC PPGs and 
LDF obtained at over tumour measurements (case No. 7). 
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Table 10.3: Mean normalised PPG AC amplitudes and LDF flux from all subjects at 
over tumour. 
Patient 
 
AC IR normalised 
(mV) 
AC Red normalised 
(mV) 
LDF 
(PU) 
1  --- --- --- 
2  --- --- --- 
3  177 192 0.52 
4  --- --- --- 
5  ---- --- --- 
6  --- --- --- 
7  547 620 15 
8  --- --- --- 
9  --- --- --- 
10  --- --- 14.9 
11  424 --- 36 
12  --- --- --- 
13  467 --- 15.7 
14  ---- --- --- 
15  --- --- --- 
16  --- --- --- 
17  442 481 51.9 
18  --- --- --- 
19  1.24 --- 92.9 
20  --- --- --- 
21  --- --- --- 
22  --- --- --- 
23  --- --- --- 
24  --- --- --- 
Mean 550 431 32.4 
±SD 361 218 31.5 
 
10.5.3 Pre and Post Ligation Measurements 
Figures 10.6 and 10.7 show a typical 10-second sample of the infrared, red 
PPG and LDF signals obtained in pre and post ligation from one patient. 
Table 10.4 shows the PPG AC normalised amplitudes and the mean flux LDF 
from all patients at pre and post ligation and the mean (±SD) values averaged 
for all subjects. In total, 27 measurements at pre and post ligation, among 
them 26 measurements for IR, 18 R and 20 LDF were performed. The mean 
IR AC amplitude in pre-ligation was 394 (±152) mV, for R it was 349 (±265) 
mV and 80.4 (±71.1) PU for LDF. The mean IR AC in post ligation was 293 
(±161) mV, for R it was 286 (±152) mV and 71.2 (±49.2) PU for LDF. 
 
Figure 10.8 is a bar graph of the mean (±SD) normalised AC amplitudes for 
red and infrared averaged for all patients at pre and post ligation. 
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Figure 10.6: 10-second sample of typical red and infrared AC PPGs and 
LDF at pre ligation measurements (case No. 6). 
 
 
Figure 10.7: 10-second sample of typical red and infrared AC PPGs and LDF at post 
ligation measurements (case No. 6). 
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Table 10.4: Mean normalised PPG AC amplitudes and LDF flux from all subjects at 
pre and post ligation. 
Patient 
 
Pre Ligation Post Ligation 
AC IR 
normalised 
(mV) 
AC Red 
normalised 
(mV) 
LDF 
(PU) 
AC IR 
normalised 
(mV) 
AC Red 
normalised 
(mV) 
LDF 
(PU) 
1  --- --- --- --- --- --- 
2  --- --- --- 329 196 37.1 
3  302 858 --- 213 268 --- 
4  --- --- --- --- --- --- 
5  --- --- --- --- --- --- 
6  302 224 29.7 103 180 21.4 
7  458 372 --- --- --- --- 
8  --- --- --- --- --- --- 
9  --- --- --- --- --- --- 
10  674 --- 28.9 763 688 --- 
11  --- --- --- 294 --- 81.2 
12  --- --- --- --- --- --- 
13  466 --- --- 139 --- 89 
14  427 --- 74.1 471 --- 28.9 
15  119 109 57.9 168 132 16.9 
16  --- --- --- 124 171 --- 
17  --- --- --- 352 --- 31.4 
18  295 223 25.5 270 235 43.2 
19  525 --- 127 291 --- 108 
20  --- --- --- 217 260 146 
21  --- --- --- 267 306 135 
22  --- --- --- 202 369 39.5 
23  372 304 220 402 336 148 
24  --- --- --- --- --- --- 
Mean 394 349 80.4 293 286 71.2 
±SD 152 265 71.1 161 152 49.2 
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(a)                                                                      (b) 
Figure 10.8: Mean (±SD) of normalised AC IR PPG amplitudes averaged for all 
patients for (a) pre-ligation IR (n=10), post-ligation IR (n=16), (b) pre-ligation R (n=6), 
and post-ligation R (n=12). 
 
10.5.4 Pre and Post Anastomosis Measurements 
Figures 10.9 to 10.12 depict AC PPGs and LDF signals for a 10 second 
sample at pre and post anastomosis, at proximal and distal sites from one 
patient. Tables 10.5 and 10.6 show the mean normalised amplitudes for the 
red and infrared AC PPG and the mean flux for LDF from all patients at pre 
and post anastomosis measured from the proximal end, and pre and post 
anastomosis measured from the distal end respectively; the mean (±SD) 
values averaged for all patients were also presented. In total 51 
measurements at pre and post anastomosis were acquired, among them 43 
measurements for IR, 30 R and 42 LDF were included in the analysis. The 
mean IR AC in pre anastomosis at the proximal site was 300 (±149) mV, for R 
it was 333 (±174) mV and for LDF it was 69.1 (±49.3) PU. The mean IR AC 
amplitude at post-anastomosis from the proximal site for IR, R, and LDF was 
350 (±230) mV, 325 (±189) mV and 44.1 (±4.7) PU respectively. These values 
for pre anastomosis at the distal site for IR, R and LDF were 351 (±168) mV, 
583 (±389) mV and 48.0 (±37.2) PU respectively. The mean IR AC amplitude 
at post-anastomosis from the distal site was 432 (±244) mV, for R it was 361 
(±91) mV and 66.1 (±69.8) PU for LDF. A bar graph of the mean (±SD) 
amplitude at pre and post anastomosis from both sites for R and IR has been 
illustrated in Figures 10.13 and 10.14 respectively.  
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Figure 10.9: 10-second sample of typical PPG and LDF signals at pre anastomosis 
measurement at the proximal end (case No. 5). 
 
 
 
Figure 10.10: 10-second sample of typical PPG and LDF signals at pre-anastomosis 
measurement from the distal end (case No. 5). 
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Figure 10.11: 10-second sample of typical PPG and LDF signals at post-
anastomosis measurement from the proximal end (case No. 21). 
 
 
 
 
Figure 10.12: 10-second sample of typical PPG and LDF signals at post-
anastomosis measurement from the distal end (case No. 21). 
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Table 10.5: Mean normalised PPG AC amplitudes and LDF flux from all subjects at 
pre and post anastomosis (proximal). 
Patient 
 
Pre-Anastomosis 
Proximal 
Post-Anastomosis 
Proximal 
AC IR 
normalised 
(mV) 
AC Red 
normalised 
(mV) 
LDF 
(PU) 
AC IR 
normalised 
(mV) 
AC Red 
normalised 
(mV) 
LDF 
(PU) 
1  --- --- --- --- --- --- 
2  247 243 --- --- --- --- 
3  213 268 --- --- 262 --- 
4  705 --- --- --- --- --- 
5  492 640 96.5 120 162 10.3 
6  238 321 147 242 320 11.1 
7  --- --- --- 214 646 17.1 
8  461 307 162 191 175 16.4 
9  226 --- 26 229 --- 19.4 
10  351 --- 24.1 154 298 5.7 
11  294 --- --- 289 --- 45.9 
12  355 --- 18.7 889 --- 40 
13  259 --- 75.9 495 --- 68.3 
14  193 --- 68.1 482 --- 24.7 
15  --- --- --- 390 442 24.9 
16  124 171 49 129 295 139 
17  --- --- --- 732 575 28.6 
18  156 163 23.9 --- --- 11.1 
19  165 --- 105 --- --- 92 
20  --- --- --- --- --- --- 
21  262 610 33.9 352 360 151 
22  --- --- --- --- ---  
23  --- --- --- --- --- --- 
24  --- --- --- --- --- --- 
Mean 300 333 69.1 350 325 44.1 
±SD 149 174 49.3 230 189 45.7 
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Table 10.6: Mean normalised PPG AC amplitudes and LDF flux from all subjects at 
pre and post anastomosis (distal). 
Patient 
 
Pre-Anastomosis 
Distal 
Post-Anastomosis 
Distal 
AC IR 
normalised 
(mV) 
AC Red 
normalised 
(mV) 
LDF 
(PU) 
AC IR 
normalised 
(mV) 
AC Red 
normalised 
(mV) 
LDF 
(PU) 
1  --- --- --- --- --- --- 
2  --- --- --- --- --- --- 
3  --- --- --- --- --- --- 
4  ---- --- --- --- --- --- 
5  549 655 77.5 354 355 9.22 
6  --- --- --- --- --- --- 
7  --- --- --- 287 330 22.1 
8  316 224 9.45 215 172 13.4 
9  --- --- --- --- --- --- 
10  --- --- --- --- --- --- 
11  --- --- --- 449 --- 165 
12  393 --- 10.1 959 --- 22 
13  ---- --- --- --- --- --- 
14  --- --- 89.5 --- --- --- 
15  146 --- --- --- --- --- 
16  --- --- --- --- --- --- 
17  --- --- --- 597 391 191 
18  --- --- --- 126 431 14.5 
19  --- --- --- --- --- --- 
20  --- --- --- --- --- --- 
21  --- 996 53.5 498 427 59.8 
22  --- --- --- --- --- --- 
23  --- --- --- 405 417 97.6 
24  --- --- --- --- --- --- 
Mean 351 583 48.0 432 361 66.1 
±SD 168 389 37.2 244 91 69.8 
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Figure 10.13: Mean (±SD) for normalised AC IR PPG amplitudes averaged for all 
patients in pre-anastomosis-proximal (n=16), pre–anastomosis-distal (n=4), post 
anastomosis-proximal (n=14) and post-anastomosis distal (n=9). 
 
 
Figure 10.14: Mean (±SD) for normalised AC R PPG amplitudes averaged for all 
patients in pre anastomosis-proximal (n=10), pre–anastomosis-distal (n=3), post 
anastomosis-proximal (n=10) and post-anastomosis distal (n=7). 
 
 
 
10.6 Comparison of PPG amplitude between all 
measurements 
In order to provide an indication of how PPG amplitudes differ between 
different measurements in all patients, a bar graph of mean (±SE) for IR and 
R PPG amplitudes for all 24 patients are presented graphically in Figure 
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10.15. Figure 10.16 presents the percentage change from baseline (with 
measurement made during mobilisation) for normalised IR PPG amplitudes 
across all measurements. 
 
Figure 10.15: Standard error of the mean normalised R and IR across all the measurements averaged for all patients. 
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Figure 10.16: Percentage change for IR PPG amplitudes for all measurements 
in all patients. Reference; 1: Mobilisation, 2: Over Tumour, 3: Pre-Ligation, 4: 
Post-Ligation, 5: Pre-Anastomosis Proximal, 6: Pre-Anastomosis Distal, 7: 
Post-Anastomosis Proximal, 8: Post-Anastomosis Distal. 
 
The percentage change in all measurements for R amplitude is presented in 
Figure 10.17, and in Table 10.7 the values for the percentage change between R 
and IR was compared. 
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Figure 10.17: Mean R PPG amplitudes with the percentage change for all measurements 
in all patients. Reference; 1: Mobilisation, 2: Over Tumour, 3: Pre-Ligation, 4: Post-
Ligation, 5: Pre-Anastomosis Proximal, 6: Pre Anastomosis Distal, 7: Post-Anastomosis-
Proximal, 8: Post-Anastomosis Distal. 
 
Table 10.7: The percentage change in all measurements for R and IR. Reference; 1: 
Mobilisation, 2: Over Tumour, 3: Pre-Ligation, 4: Post-Ligation, 5: Pre-Anastomosis 
Proximal, 6: Pre-Anastomosis Distal, 7: Post-Anastomosis Proximal, 8: Post-Anastomosis 
Distal. 
Measurement 1 2 3 4 5 6 7 8 
Percentage 
change 
IR 0 +27.0 −9.01 −32.3 −30.7 −18.9 −19.2 −0.23 
R 0 +5.38 −14.7 −30.1 −15.9 +42.5 −20.5 −11.7 
 
Figure 10.18 illustrates the percentage change in R and IR amplitude in pre and 
post ligation. The reduction at post-ligation in both R and IR is apparent: the 
amplitude of IR fell by -25.6% and the amplitude for R PPG fell by -18.0% from 
pre ligation. 
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Figure 10.18: Percentage change in amplitude for (a) normalised IR and (b) 
normalised R PPG in pre and post ligation. 
 
In Figure 10.19 the percentage change in amplitude for normalised IR PPG in pre 
and post anastomosis in both proximal and distal sites can be observed. Values 
at post-anastomosis from the proximal site for IR PPG increased by 17% from 
pre anastomosis, and by 23% for the distal site.  
 
Figure 10.19: Percentage change in amplitude for normalised IR PPG in pre 
and post anastomosis in proximal and distal site. 
 
At the proximal site, the amplitude of the R PPG decreased by 6% from pre to 
post-anastomosis as shown in Figure 10.20.  At the distal site there was a 
decrease of 38% from pre- to post-anastomosis.  
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Figure 10.20: Percentage change in amplitude for normalized R PPG in pre and post 
anastomosis in proximal and distal site. 
 
Figure 10.21 shows the amplitude of DC IR in all measurements, which is an 
indicator of blood volume, the lower value of DC IR indicates greater blood 
volume, due to higher absorption of light due to increased haemoglobin density 
(236). As can be seen, the lowest DC IR value is observed for the over tumour 
measurements, which also shows the largest PPG amplitude (Figure 10.15). 
 
Figure 10.21: Amplitude of DC IR in all measurements showing the blood 
volume. 
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10.7 Comparison of LDF Flux between all measurements 
The laser Doppler signal was more sensitive to artefact than PPG, as several 
spikes were observed across most of the measurements, an example of that can 
be seen in Figure 10.22.  These are most likely due to motion of the probe 
relative to the tissue. 
 
 
Figure 10.22: Detected signals, showing that LDF was more sensitive to motion 
artefacts than PPG. 
 
The mean (±SD) LDF flux was obtained and in order to show how the values 
change between measurements, a bar graph is illustrated in Figure 10.23.  
 
As can be seen in Figure 10.23 at mobilisation, the mean flux has the lowest 
value (31.6 PU) of all the measurements. Also the flux at pre-ligation (80.4 PU) 
decreases at post-ligation (71.2 PU). Figure 10.23 also shows that the LDF flux 
before and after the anastomosis for both proximal and distal ends changed. As 
Figure 10.23 shows, an increase from pre-anastomosis to post-anastomosis in 
the flux at the distal end (48.0 PU to 66.1 PU) is observed. In contrast, the flux 
values are reduced at the proximal site from 69.1 PU to 44.1 PU after 
anastomosis. 
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The percentage change from baseline in all measurements for LDF flux is 
presented in Figure 10.24. 
 
 
Figure 10.23: Mean (±SD) LDF flux for all measurements averaged for all 
patients. 
 
 
Figure 10.24: Percentages change in PU across all the measurements. 
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10.8 Arterial Blood Oxygen Saturation (SpO2) Estimations  
As explained in Chapter 8, using AC and DC components for both red and 
infrared PPG signals, blood arterial oxygen saturation can be estimated from the 
various periods of measurements, which can be an indicator of the system’s 
ability to estimate arterial blood oxygen saturation. Preliminary estimated SpO2 
values were estimated for each measurement and the results are presented in 
the Table 10.8.  
 
Table 10.8: The estimated SpO2 values in all measurements. Reference; 1: Mobilisation, 
2: Over Tumour, 3: Pre Ligation, 4: Post Ligation, 5: Pre Anastomosis Proximal, 6: Pre 
Anastomosis Distal, 7: Post Anastomosis Proximal, 8: Post Anastomosis Distal. 
Patient 
No. 
Measurement 
1 2 3 4 5 6 7 8 
1  --- --- --- --- --- --- --- --- 
2  --- --- --- 95.1 --- --- --- --- 
3  53.4 82.9 39.1 78.5 78.5 --- --- --- 
4  98.2 --- --- --- 100 --- --- --- 
5  --- --- --- --- 77.4 85.9 76.5 84.9 
6  80.9 --- 91.5 66.2 76.3 --- 106  
7  89.7 81.7 89.7 --- --- --- 34.5 81.2 
8  --- --- --- --- 93.4 92.3 87.1 90.1 
9  --- --- --- --- --- --- --- --- 
10  --- --- --- 87.5 --- --- 61.5 --- 
11  --- --- --- --- --- --- --- --- 
12  --- --- --- --- --- --- --- --- 
13  --- --- --- --- --- --- --- --- 
14  --- --- --- --- --- --- --- --- 
15  85.2 --- 87.1 90.4 --- --- 81.6 --- 
16  88.7 --- --- 75.5 75.5 --- 52.8 --- 
17  --- 82.8 --- --- --- --- 90.3 93.6 
18  --- --- 91.1 88.2 83.8 --- --- 24.4 
19  --- --- --- --- --- --- --- --- 
20  81.8 --- --- 80.1 --- --- --- --- 
21  80.8 --- --- 81.4 51.7 --- 84.4 88.6 
22  69.7 --- --- 78.4 --- --- --- --- 
23  73.9 --- 89.6 89.1 --- --- --- 84.2 
24  --- --- --- --- --- --- ---  
Mean 80.2 82.5 81.3 82.8 79.6 89.1 75.0 78.2 
±SD 12.4 0.69 20.7 8.2 14.4 4.52 19.4 24.0 
 
In order to provide an indication of how SpO2 values change between different 
measurements in all patients, the mean (±SD) SpO2 values is presented in a bar 
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graph in Figure 10.25. As mentioned before, the commercial SpO2 values 
obtained from the finger were recorded manually immediately after each 
measurement in all the trials.  The mean SpO2 was calculated and the results are 
shown in Figure 10.25 along with SpO2 values obtained from the bowel. 
 
 
Figure 10.25: Mean (±SD) SpO2 estimated values by sensor from bowel compared to the 
values measured with the commercial device, from the finger for all measurements 
averaged for all patients. 
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10.16, however these results did not reveal any statistically significant difference 
between different measurements although a marked change in the amplitudes of 
PPGs was observed in some measurements (e.g. between pre and post ligation) 
(Figure 10.18). The reason for the lack of significance is probably because of 
inadequate data since the study group was too small for any statistically 
significant differences to be detected. 
 
Table 10.9: Paired t-test between pre and post ligation for AC R and IR amplitudes. 
Paired t-test Pre ligation R Post ligation R Pre ligation IR Post ligation IR 
Pre ligation R  0.397   
Post ligation R 0.397    
Pre ligation IR    0.172 
Post ligation IR   0.172  
 
Table 10.10: Paired t-test between pre and post anastomosis in proximal and distal for AC 
IR amplitudes. 
Paired t-test 
Pre 
anastomosis 
proximal  
Post 
anastomosis 
proximal  
Pre 
anastomosis 
distal  
Post 
anastomosis 
distal  
Pre 
anastomosis 
proximal  
 0.720 
0.636 
 
0.473 
Post 
anastomosis 
proximal  
0.720  
0.764 
 
0.117 
Pre 
anastomosis 
distal  
0.636 
 
0.764 
 
 
0.743 
 
Post 
anastomosis 
distal  
0.473 0.117 
0.743 
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Table 10.11: Paired t-test between pre and post anastomosis in proximal and distal for AC 
R amplitudes. 
Paired t-test 
Pre 
anastomosis 
proximal  
Post 
anastomosis 
proximal  
Pre 
anastomosis 
distal  
Post 
anastomosis 
distal  
Pre 
anastomosis 
proximal  
 0.107  0.730  0.540 
Post 
anastomosis 
proximal  
0.107   0.175  0.621 
Pre 
anastomosis 
distal  
 
0.730 
 
0.175   0.323 
Post 
anastomosis 
distal  
0.540  0.621  0.232   
 
Table 10.12: Paired t-test between pre and post ligation for DC R and IR amplitudes. 
Paired t-test Pre ligation R Post ligation R Pre ligation IR Post ligation IR 
Pre ligation R  0.524   
Post ligation R 0.524    
Pre ligation IR    0.576 
Post ligation IR   0.576  
 
Table 10.13: Paired t-test between pre and post anastomosis in proximal and distal for DC 
IR amplitudes. 
Paired t-test 
Pre 
anastomosis 
proximal  
Post 
anastomosis 
proximal  
Pre 
anastomosis 
distal  
Post 
anastomosis 
distal  
Pre 
anastomosis 
proximal  
 0.904 0.183 0.890 
Post 
anastomosis 
proximal  
0.904  0.072 0.914 
Pre 
anastomosis 
distal  
0.183 0.072  0.224 
Post 
anastomosis 
distal  
0.890 0.914 0.224  
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Table 10.14: Paired t-test between pre and post anastomosis in proximal and distal for DC 
R amplitudes. 
Paired t-test 
Pre 
anastomosis 
proximal 
Post 
anastomosis 
proximal 
Pre 
anastomosis 
distal 
Post 
anastomosis 
distal 
Pre 
anastomosis 
proximal 
 0.299  0.414  0.442 
Post 
anastomosis 
proximal 
0.299   0.516  0.503 
Pre 
anastomosis 
distal 
0.414 
 
0.516   0.402 
Post 
anastomosis 
distal 
0.442  0.503  0.402   
 
Table 10.15: Paired t-test between pre and post ligation for LDF flux. 
Paired t-test Post ligation  
Pre ligation  0.171 
 
Table 1.16: Paired t-test between pre and post anastomosis in proximal and distal for LDF 
flux. 
Paired t-test 
Pre 
anastomosis 
proximal  
Post 
anastomosis 
proximal  
Pre 
anastomosis 
distal  
Post 
anastomosis 
distal  
Pre 
anastomosis 
proximal  
 0.146 0.379 0.187 
Post 
anastomosis 
proximal  
0.146  0.409 0.207 
Pre 
anastomosis 
distal  
0.379 0.409  0.564 
Post 
anastomosis 
distal  
0.187 0.207 0.564  
 
The discussion, conclusion and future work will be discussed in the next chapter. 
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Discussion, Conclusions and Future Work 
 11.1 Discussion and Conclusions 
The aim of this research was to assess bowel viability using 
photoplethysmography (PPG) and laser Doppler flowmetery (LDF) in patients 
undergoing bowel resection utilising custom-made combined sensors and 
instrumentation. Reflectance mode PPG along with LDF sensors have been 
successfully designed, constructed and tested for thermal safety (Chapter 7) and 
placement on the bowel tissues allowing monitoring of perfusion in the tissue. In 
order to verify the suitability of the probe for use in a clinical environment, 
volunteer studies were performed in which clear PPGs and LDF signals were 
obtained from the fingers (Section 7.5).  
 
Clinical trials were performed at the Royal London Hospital, London, UK for 
patients undergoing bowel resection to monitor changes in PPG amplitude and 
LDF flux during surgery. Eight stages of surgery including; mobilisation, over 
tumour, pre and post ligation, pre and post anastomosis for both proximal and 
distal ends, were investigated during each trial (unless measurements were not 
technically possible or were not performed by the surgical team for any reason). 
For each measurement, PPG and LDF signals where acquired simultaneously for 
approximately one minute. It was shown that clear PPG and LDF signals could 
be obtained in most cases.  
 
The total number of measurements in all investigated sites was 100 (15 
mobilisation, 7 over tumour, 11 pre-ligation, 16 post-ligation, 16 pre-anastomosis 
proximal, 7 pre-anastomosis distal, 18 post anastomosis proximal and 10 post 
anastomosis distal investigations). Data analysis was conducted on all acquired 
signals to examine the difference in AC and DC PPG amplitude and also LDF flux 
between different signals acquired from different measurements. Blood arterial 
oxygen saturation (SpO2) was calculated from the AC and DC components of the 
                                                               CHAPTER ELEVEN 
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PPG signal for both red and infrared for all measurements and compared to the 
values obtained from a commercial device.  
 
The results from the data analysis were presented in the previous chapter. 
Figures 10.8, 10.13 and 10.14 show that there were large standard deviation 
values across all the measurements, due to a large variability in PPG amplitudes 
for all patients. The reason for this variability was possibly due to differences in 
the density of blood vessels beneath the probe from one patient to another.  This 
variability highlights the need to take baseline measurements from which 
subsequent measurements may be compared.  Although special care was taken 
to try to place the probe in the same position for each measurement, this was 
often difficult in the conditions of the operating theatre.  Furthermore, differences 
in surgical procedures also prevented subsequent measurements from the same 
location.  
 
As can be seen in Figure 10.15, the PPG amplitude (R and IR) from the over 
tumour measurement had the highest normalised amplitude (550 mV for IR and 
431 mV for R) of all the measurements.  This was possibly due to a higher 
concentration of blood vessels in tumour tissue compared to healthy tissue. Since 
cancer cells have a high oxygen requirement (as their metabolic rate is high), 
large tumors generate their own vasculature, a process known as angiogenesis 
(237). These blood vessels differ from normal blood vessels, in fact, they are 
highly irregular, chaotic, and leaky leading to uneven delivery of oxygen (238). 
This could explain the non-typical shape of the PPG waveforms, an example is 
shown in Figure 10.5. Also there was a large standard deviation for IR (±361 mV) 
compared to other measurements (Tables 10.2−10.6), possibly also due to the 
different vascular structure within the tumour. 
 
Furthermore, it is obvious from Figure 10.15 that there was a considerable 
difference in IR AC amplitude between pre-ligation (394 mV) and post-ligation 
(293 mV). After ligation a noticeable reduction in amplitude was observed, and a 
similar decrease was seen in the R AC signal (349 mV and 286 mV).  This was 
expected due to the reduction in blood supply in the area as a result of vascular 
ligation. 
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Figure 10.15 shows that the PPG amplitude before and after the anastomosis for 
both proximal and distal ends had changed. An increase in amplitude (300 mV to 
350 mV for IR in proximal end and 351 mV to 432 mV for IR in distal end) was 
observed after anastomosis. This increase in amplitude after anastomosis was 
expected as the blood vessels had been rejoined and the blood volume most 
likely increased in this area. The increase of amplitude could thus be an 
indication of improved blood volume to the area after anastomosis. 
 
The equivalent increase was not seen in R PPG amplitude at both proximal and 
distal sites after anastomosis, as seen in Figure 10.20, probably due to 
insufficient sample size (measurements for pre anastomosis at distal site totaled 
only three). 
 
The percentage change in amplitude for IR PPG from baseline in mobilisation at 
both pre and post anastomosis seen in Figure 10.16 was greater at the proximal 
compared to the distal sites.  This was expected since the removal of a tissue 
segment can impair the local blood flow at the edge of the anastomoses 
(proximal end). Less effect was seen on the distal ends. 
 
Also as it can be seen in Figures 10.15, the amplitude of IR PPG in post-
anastomosis  (432 mV) was similar to the amplitude of mobilisation (433 mV) 
suggesting that the blood volume after post-anastomosis (last step of the 
procedure) was recording the same value as that during mobilisation (first step of 
the procedure), this result suggests that this sensor has the capability to show 
changes in blood perfusion in the tissue intraoperatively. 
 
By observing Figure 10.23 which shows a bar graph of mean flux for all the 
measurements, it can be seen that the flux at post-ligation decreased from pre-
ligation by 11%, which was expected due to the reduction in blood flow in the 
area as a result of vascular ligation. However this decrease in flux after ligation, 
seen in Table 10.15, is not significant (P=0.171), possibly due to the high 
sensitivity of LDF to motion. As can be seen in Figure 10.23 an increase of 38.0% 
in flux at the distal end after anastomosis was observed. This could be an 
indication of improved blood flow to the area after anastomosis. The equivalent 
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increase was not seen however at the proximal site. In fact after anastomosis the 
flux reduced by 36.0%, possibly due to the removal of tissue segments which 
may have impaired the local blood flow at the edge of the anastomoses (proximal 
end). The changes in flux measured by LDF during each surgical stage did not 
follow the pattern of the changes seen in PPG amplitude, and were more difficult 
to interpret in terms of expected physiological changes.  This is possibly due to 
the high sensitivity to movement of the LDF. As mentioned in Section 10.7, the 
LDF signals showed significant artefact that was attributed to movement (see 
Figure 10.22) and explains the large standard deviations observed in the LDF 
measurements (Figure 10.23).  Although PPG is also sensitive to movement, 
such artefacts were not seen on the simultaneously recorded PPG signals.  
 
By comparing the differences between the commercial and estimated SpO2 
values presented in Figure 10.25, it can be seen that across all the 
measurements, the mean of SpO2 values obtained with the custom combined 
probe from the bowel area underestimated the arterial blood oxygen saturation 
compared to the commercial SpO2 values from the finger. The values were found 
to be lower than those obtained simultaneously from the commercial device: 
between 13.4% lower in pre anastomosis distal and 31.1% lower in post 
anastomosis distal. Also the obtained standard deviations between 
measurements appeared to be large (Figure 10.25). These differences may be 
due to a number of reasons: firstly the algorithm used for calculating oxygen 
saturation was based on one derived from measurements using a finger probe in 
volunteer subjects and was intended for calibrating commercial finger probes.  
The composition of bowel tissue differs from finger tissue in terms of the relative 
abundance of different absorptions as well as the density of blood vessels, and 
the geometry of the reflectance probe differs from commercial finger probes.  
 
Statistical analysis showed that there was no significant difference between pre 
and post ligation for IR (P = 0.172) and pre and post ligation for R (P = 0.397). 
The results for all other measurements are presented in Tables 10.9 to 10.17. As 
can be seen these results did not reveal any statistically significant difference 
between different measurements. Although an evident change in the amplitudes 
of PPGs was observed in some measurements (e.g. between pre and post 
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ligation) (Figure 10.18). 
 
In conclusion, the results from this preliminary in vivo investigation demonstrated, 
that a combined PPG and LDF system is capable of acquiring clear PPG and 
LDF signals from the surface of the bowel intraoperatively in laparoscopy or 
laparotomy in bowel resection operations in most cases.  
 
The results have confirmed that the custom made PPG/LDF system and sensor 
might has the potential to be used as an alternative technique for monitoring 
perfusion in various stages of the bowel operation, and may provide a useful tool 
for surgeons during the bowel resection.  
 
The results form the in vivo investigation has indicated that there is a difference 
between PPG and LDF signals acquired from different stages. Obtaining the 
same amplitude at the last step of operation (post anastomosis), as the value of 
the first step of the operation (mobilisation) suggests that the probe can assist the 
surgeon’s decision making in critical anastomosis. This could lead to a reduction 
in anastomotic leak thus having an important impact on the clinical outcome in 
bowel resection.  
 
11.2 Future Work 
This pilot study aimed to evaluate the feasibility of the proposed probe and 
system to acquire LDF and PPG signals simultaneously. The signals were 
interpreted to see if there was any correlation between changes from baseline in 
the results from the eight measurements in each patient and predictions made for 
each of them by the surgeon.  
 
Subject to funding availability, the next stage (‘Initial study’) will be to evaluate if 
the probe and system can detect any compromise in blood supply and therefore 
possibly predict anastomotic leak. As mentioned in Section 6.1 the most 
important surgical complications following bowel resection with anastomosis are 
anastomotic leaks. Major consequences of the anastomotic leakage are 
postoperative morbidity and mortality (239). Therefore detecting the anastomotic 
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leak intraoperatively has a significant impact on improving the outcome of 
operations. The initial study aims to achieve further meaningful information from 
the signals in order to identify the possible relation between the acquired signals 
and the results of the operation (anastomotic healing/failing). The influence of 
anaesthetic and analgesic drugs (including those epidurally administered) will 
also be considered to see how these factors might cause intestinal hyperaemia or 
hypoperfusion. 
 
The ‘Follow-up Study’ will be considered after the initial study. Once enough 
information from the initial study has been obtained, the probe will be used to 
detect possible complications and leakages in specific diseases. 
 
The last stage is the ‘Final Study’, which will focus on bowel ischaemia and to 
utilise the probe to detect early diagnosis of ischaemia in the small or large 
intestine.  
 
Each part of the proposed future study will be explained in the following sections. 
 
A: Initial Study 
1. Longitudinal Study: the next clinical study will be initially a longitudinal study, 
which will include taking measurements from a number of patients (approximately 
50), then following the patients’ progress post operatively. It would explore long 
term data to see how many patients had complications and whether this was 
predicted by the probe. This exploration could draw conclusions as to the 
correlation between anastomotic healing or anastomotic failing and the results 
from the probe measurements.  
 
2. Temperature sensing: knowledge of temperature differences between a 
tumour and the surrounding area may be valuable. It has been suggested that 
tumours have a different temperature in comparison to their surrounding area. It 
is proposed that tumours tend to be higher in temperature, possibly because of 
the need for more blood supply to them and also the fact that tumours 
continuously reproduce. Such a process continuously draws and releases energy 
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leading to an increase in local temperature (240). Therefore, designing a sensor 
with the ability to measure temperature may be of some value towards a better 
understanding of the tumour and possible diagnose of its existence.  
 
3. A Larger Pool of Candidates: more laparotomy cases would be needed to 
obtain the correlation between laparoscopy and open surgery (laparotomy) (in 
this pilot study there were only 4 laparotomy cases).  
 
4. More Data Regarding LDF Signals: since the LDF was found to be very 
sensitive to artefect in the first study, future work is needed to confirm whether 
the system could improve post-operative patient outcome.  
 
5. A New Design for the Probe: providing a measurement tool that is impervious 
to motion artefacts would be an advantage. It has been suggested by the surgical 
team that if the probe could be inserted in a hard thin tube, that the fibreoptic LDF 
cable would not be subject to bending and therefore this might result in a greater 
reduction in motion artefacts. 
 
B: Follow-up Study 
1. Colon Interposition for Oesophageal Replacement and Gastric Pull-up: this is 
where the colon or gastric is used as an oesophageal substitute in patients with 
malignant oesophageal disease. The outcome of this operation depends strongly 
on the maintenance of adequate perfusion between the colon and the 
oesophagus. Currently there is no easy to use device available to show the 
viability of the tissue at the edge of the anastomosis. Using the combined probe 
could be of great value and help to reduce possible complications and leakages. 
 
2. Colon Pull-through: in patients undergoing tumour resection of the rectum, the 
large intestine often needs to be replaced and reattached to the pelvis and 
anastomosis with the distal end of the rectum or anal canal has to be performed. 
The most common cause of the anastomotic failure is ischaemia at the edge of 
anastomosis. Using the combined probe for monitoring the viability of the tissue 
at the edges of anastomosis may help to reduce possible complications and 
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anastomosis leakages.  
 
C: Final Study 
Bowel Ischaemia: Surgery to remove sections of ischaemic bowel is a necessary 
and life-saving operation. Monitoring of the circulation intraoperatively is a very 
important issue especially at early diagnosis and the start of the treatment. The 
probe can monitor the process and give a prediction of the blood perfusion in the 
area possibly leading to an early diagnosis of the ischaemic tissue. 
 
Other future work 
Other alternative future work could be planned in the following areas: intraluminal 
measurements, Crohn’s Disease, perineal blood supply and measuring the 
stiffness of the tumour and the surrounding tissues, pre and post treatment. 
These pathologies have specific and involved treatments, and monitoring is not 
fully developed, so further research is needed to improve diagnosis, guide 
therapy and improve prognosis. 
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Appendix A 
Technical Specifications for Photoplethysmographic system  
A: Custom-made Probe 
Manufacturer Biomedical Engineering Research Group, 
School of Engineering and Mathematical 
Sciences, City University London 
Optoelectronics:  
Sources 
1 x 628 nm (red) LED (SMT), max power 
output = 25 mW 
1 x 880 nm (infrared) LED (SMT), max power 
output = 20 mW 
Optoelectronics: 
Photodetector 
1 x 1mm2 PIN Photodiode (SMT) 
Connections 3.9 m 5-core coaxial cable to locking DIN-
style 8-pin plug 
Dimensions 29(L) x 12(W) x 1.5(D) mm 
 
B: Instrumentation unit 
Manufacturer Biomedical Engineering Research Group, 
School of Engineering and Mathematical 
Sciences, City University London 
Measurement Parameters† perfusion index PI (ratio or %) 
arterial oxygen saturation SpO2 (%) 
tissue oxygenation index (TOI%) 
Change in deoxyhaemoglobin concentration 
(∆Hb) 
Change in oxyhaemoglobin concentration 
(∆O2Hb) 
Change in total functional haemoglobin (∆Hb 
+ ∆O2Hb) 
Signal Processing Bandwidth: 
High pass 0.4 Hz 
Low pass 16 Hz 
Sample rate: 100-400 Hz 
Output USB connection to PC 
LabVIEW™ virtual instrument displaying red 
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and infrared PPG signal, Doppler signal and 
calculated parameters (†see above).   
Anonymous raw data saved to tab-delimited 
text file. 
Safety features Battery power, low voltage 
Splash proof case 
On-off switch on front panel 
Power supply 2 x 12 V 1.2 Ah lead-acid cells 
External connections Inputs: Probe connection (8 pin locking DIN-
style plastic); Laser Doppler analog BNC. 
Outputs: USB type-B data 
Dimensions 30(L) x 28(W) x 9(D) cm 
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Appendix B  
Technical Specifications for laser Doppler monitor and probe 
A: Specifications for monitor: moor VMS-LDF 
Quality Control 
Moor Instruments is certified to ISO 13485: 2003. 
The moor VMS-LDF is CE certified. 
Measurement Parameters 
Flux (tissue perfusion). 
Conc* (blood cell concentration). 
DC (mean intensity). 
Temperature. 
Measurement Channels Moor VMS-LDF2 Dual channel. 
Reliability 
Assured by our 3 year basic warranty or 5 year 
extended warranty for the 
Moor VMS-LDF modules. 
Optics 
Temperature stabilised output laser diode; 
785nm. 
Maximum output power 2.5mW. 
Laser Safety Classification 
Class 1 per IEC 60825-1:2007. 
Class 1 per 21 CFR 1040.10 and 1040.11. 
Laser Doppler Signal Processing 
Bandwidth: 
High pass 20Hz. 
Low pass 3kHz*, 15kHz, 22kHz*. 
Flux smoothing time constants: 0.1s*, 0.5s*, 1.0s, 
3.0s* and unfiltered*. 
Automatic gain control and zeroing. 
Output 
 
LCD screen providing display of flux, DC and 
temperature. 
USB Interface for connection to PC. 
Analogue outputs: BNC sockets, 0-5V. 
Moor VMS-LDF2 2x flux, 2x temperature/DC 
(selectable). 
All outputs have independent user selectable 
scaling. 
Classification 
Medical devices directive 93/42/EEC: Class IIa, 
Active device for diagnosis. 
Laser classification: Class 1 per IEC 60825-
1:2007. 
Type of protection against electric shock: Class I. 
Degree of protection against electric shock: Type 
BF applied parts. 
Protection against harmful ingress of water: IPX0 
(not protected). 
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Not suitable for use in an oxygen rich 
atmosphere. 
Not suitable for use in the presence of flammable 
anaesthetics. 
Safety standards 
Complies with: 
IEC 60601-1:2005, IEC 60601-1-2:2007, IEC 
60825-1:2007. 
ISO 10993-1:2003, Medical devices directive 
93/42/EEC. 
FDA Laser Notice No. 50; dated July 26, 2001. 
Temperature Measurement  
Range: 5ºC to 50ºC. 
Resolution: 0.1ºC, accuracy +/- 0.3ºC. 
General 
Power source: Universal voltage, 100-230V AC, 
30VA, 50 to 60Hz. 
Dimensions: W x H x D mm, Weight: Kg 
Moor VMS-LDF2: 235 x 80 x 200, 1.5kg. 
Operating environment: Clinic or laboratory, 
excluding domestic. 
Operating temperature: 15-30ºC. 
References 
A.P. Shepherd, P. Å. Öberg, Laser-Doppler 
Blood Flowmetry, 1990, 
ISBN 0-7923-0508-6, Kluwer Academic 
Publishers. 
 
B: Specification for Probe: moor VMS-LDF probe, VP8C 
Probe Low profile disk probe  
 
General The VP8c titanium disc probe has a 
2.1mm outside diameter flexible nylon 
sleeve with a titanium disc probe head 
 
The probe head 8mm outside diameter and 2.5 mm 
high 
 
 
Moor Instruments – Millwey, Axminster, Devon. EX13 5HU 
Telephone +44 (0) 1297 35715 
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NRES Committee London-City & East 
Bristol Research Ethics Committee Centre 
Whitefriars 
Level 3, Block B 
Bristol 
BS1 2NT 
Telephone:01173421386 
Facsimile:01173420445 
!
14 May 2013 
 
Dr Justin Phillips 
Senior Lecturer in Biomedical Engineering City University London 
Northampton Square London  
EC1V 0HB 
 
Dear Dr Phillips 
 
 Study title:                  Evaluation of a combined laser Doppler and   
                       photoplethysmographic system for intra-operative 
                                    monitoring of bowel tissue viability. 
REC reference:           13/LO/0738 
Protocol number:       BERG-ZA-13/01 
IRAS project ID:         130982 
 
The Research Ethics Committee reviewed the above application at the meeting held on 02 
May 2013. Thank you for attending to discuss the application. 
 
Issues Discussed 
 
• The Committee requested you to confirm that all the cases in the study will 
be planned routine cases and no emergency cases will be included. You 
agreed to provide a written confirmation for the same. 
 
• The Committee advised that the surgeons involved in the study 
should be blinded to all the data collect during the study. You 
agreed to comply. 
 
Ethical opinion 
The members of the Committee present gave a favourable ethical opinion of the above 
research on the basis described in the application form, protocol and supporting 
documentation, subject to the conditions specified below. 
 
We plan to publish your research summary wording for the above study on the NRES 
website, together with your contact details, unless you expressly withhold permission to do 
so. 
Publication will be no earlier than three months from the date of this favourable opinion 
Appendix C: 
Ethical Approval Confirmation 
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letter. Should you wish to provide a substitute contact point, require further information, or 
wish to withhold permission to publish, please contact the Co-ordinator Mr Rajat Khullar, 
nrescommittee.london-cityandeast@nhs.net. 
 
Ethical review of research sites 
 
NHS Sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the 
start of the study (see “Conditions of the favourable opinion” below). 
 
Non NHS sites 
 
The Committee has not yet been notified of the outcome of any site-specific assessment 
(SSA) for the non-NHS research site(s) taking part in this study. The favourable opinion 
does not therefore apply to any non-NHS site at present. I will write to you again as soon 
as one Research Ethics Committee has notified the outcome of a SSA. In the meantime 
no study procedures should be initiated at non-NHS sites. 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the 
start of the study. 
 
 
!
You should notify the REC in writing once all conditions have been met (except for 
site approvals from host organisations) and provide copies of any revised 
documentation with updated version numbers. The REC will acknowledge receipt 
and provide a final list of the approved documentation for the study, which can be 
made available to host organisations to facilitate their permission for the study. 
Failure to provide the final versions to the REC may cause delay in obtaining 
permissions. 
 
Management permission or approval must be obtained from each host organisation 
prior to the start of the study at the site concerned. 
 
Management permission (“R&D approval”) should be sought from all NHS 
organisations involved in the study in accordance with NHS research governance 
arrangements. 
! !!!!
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System or at http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and referring 
potential participants to research sites (“participant identification centre”), guidance 
should be sought from the R&D office on the information it requires to give 
 
1. Please provide confirmation that all the cases in the study will be planned 
routine cases and no emergency cases will be included. 
 
2. The surgeons involved in the study should be blinded to all the data collect 
during the study. 
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permission for this activity. 
 
 
For non-NHS sites, site management permission should be obtained in accordance with 
the procedures of the relevant host organisation. 
Sponsors are not required to notify the Committee of approvals from host organisations 
 
It is responsibility of the sponsor to ensure that all the conditions are complied with 
before the start of the study or its initiation at a particular site (as applicable). 
 
Approved documents 
 
The documents reviewed and approved at the meeting were: 
Document Version Date 
Covering Letter ! 25 April 2013 
Evidence of insurance or indemnity ! 17 August 2012 
Investigator CV - Justin Phillips ! !
Other: Peer Review - Rupert Pearse ! 11 September 2012 
Participant Consent Form: Consent Form 1 23 April 2013 
Participant Information Sheet 1 23 April 2013 
Protocol 1 23 April 2013 
REC application ! 24 April 2013 
 
 
Membership of the Committee 
 
The members of the Ethics Committee who were present at the meeting are listed on 
the attached sheet. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
!
After ethical review 
 
Reporting requirements 
 
The attached document “After ethical review – guidance for researchers” gives detailed 
guidance on reporting requirements for studies with a favourable opinion, including: 
 
•  Notifying substantial amendments 
•  Adding new sites and investigators 
•  Notification of serious breaches of the protocol 
•  Progress and safety reports 
•  Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the light 
of changes in reporting requirements or procedures. 
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Feedback 
 
You are invited to give your view of the service that you have received from the National 
Research Ethics Service and the application procedure.  If you wish to make your views 
known please use the feedback form available on the website. 
 
Further information is available at National Research Ethics Service website > After 
Review 
 
!
!
!
We are pleased to welcome researchers and R & D staff at our NRES committee 
members’ training days – see details at http://www.hra.nhs.uk/hra-training/ 
 
With the Committee’s best wishes for the success of this project. 
 
Yours sincerely 
pp Dr Arthure T. Tucker 
   Chair 
 
Email: nrescommittee.london-cityandeast@nhs.net 
 
Enclosures: List of names and professions of members who were 
present at the meeting and those who submitted 
written comments 
“After ethical review – guidance for researchers” 
 
Copy to: Ms Anna Ramberg 
Mr Gerry Leonard, Barts Health - QMUL Joint Research 
Management Office 
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
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Evaluation of the optical interference in a combined measurement 
system used for assessment of tissue blood flow 
Zahra Abdollahi, Panayiotis A. Kyriacou, Senior Member, IEEE and Justin P. Phillips, Member, IEEE 
 
Abstract— A dual-wavelength pulse oximetry system 
combined with laser Doppler was developed for the assessment 
of perfusion. Red and infrared PPG and Doppler signals were 
recorded from a healthy volunteer in three studies at different 
measurement sites to investigate the interference between PPG 
and laser Doppler flowmetry (LDF). Good quality 
photoplethysmographic (PPG) and Doppler signals were 
detected simultaneously using this combined probe from the 
skin of the finger. The influence of the PPG light sources on 
LDF measurements was investigated; also the influence of the 
LDF light sources to the PPG measurements was studied. 
 
I.   INTRODUCTION 
Assessment of tissue perfusion can be achieved with 
various techniques including photoplethysmography and 
laser Doppler flowmetry (LDF). In photoplethysmography, 
changes in transmission of light through tissue due to 
pulsation of small arteries can be monitored while in laser 
Doppler flowmetry (LDF) microcirculatory blood cell 
velocity and flux can be studied [1]. 
The results presented here are part of a wider study in 
which a combination of LDF and PPG methods is used for 
assessment of perfusion in bowel tissue for patients 
undergoing bowel resection. Determination of bowel viability 
following bowel resection is essential in gastrointestinal 
surgery [1, 2, 3]. Monitoring blood flow in abdominal 
surgery especially intra and post-operatively would be a 
valuable tool for prevention of intestinal ischemia and 
necrosis, often requiring surgical re-exploration, resulting in 
significant postoperative morbidity and increased length of 
hospital stay. Although various monitoring techniques have 
been proposed to assess intestinal viability, none of these 
techniques have been proven reliable enough to replace 
visual observation [4]. The aim of the main study is to 
combine the established techniques, laser Doppler flowmetry 
(LDF) and Photoplethysmography (PPG), into one flexible 
probe intended for assessment of perfusion in abdominal 
tissue during bowel operation. Such a probe could alert the 
surgeon immediately of any compromise in blood flow so 
further investigation and if necessary, therapeutic steps can 
be applied immediately to prevent severe consequences. 
However in the present study, evaluation of optical 
interference between the two measurements was investigated. 
B. Photoplethysmography  (PPG) 
Photoplethysmography, (PPG) a non-invasive electro-optical 
technique used mainly to determine and register  the 
variation in blood volume or blood flow in the body caused 
by cardiovascular pulsations in the bed of tissue [5–6]. 
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A photoplethysmographic signal is obtained by 
illuminating a region of tissue containing a vascular bed and 
acquiring either the reflected or transmitted light. 
Photoplethysmography (PPG) involves two basic 
optoelectronic components: an emitter such as a light 
emitting diode (LED) which illuminates the tissue and a 
photodiode for collecting the backscattered or transmitted. 
The intensity of light that reaches the photo detector can be 
measured which represent blood volume changes 
synchronous with the cardiac cycle [7]. 
The PPG signal consists of two components: a pulsatile 
(‘AC’) part, which is modulated by pulsations of (primarily) 
arterioles and a static (‘DC’) part which represents the light 
scattered from non-pulsing arterial blood, the venous and 
capillary blood and other static tissues. Two main PPG 
operational configurations include transmission and 
reflection mode. In transmission mode operation the tissue 
sample (e.g. fingertip) is placed between the source and 
detector while in reflection mode the LED and detector are 
positioned adjacently [8]. 
 
 
C. Laser Doppler flowmetry (LDF) 
LDF is an optical and non-invasive method for 
monitoring microvascular blood flow and is currently used in 
a variety of fields in medicine [7], assessment of burn wound 
depth [9], skin tumor characterization [8], amputation level 
determination [10,11], neurosurgery [12], and breast 
reconstruction [13]. It has been used also for ocular, cerebral, 
cutaneous, auricular, splanchnic, and renal blood flow in a 
wide range of laboratory animal species (14). 
Laser Doppler flowmetry (LDF) and 
photoplethysmography (PPG) are both well-established non- 
invasive optical methods for measuring blood flow changes 
in skin [12]. As they register perfusion effects at different 
tissue layers, application of both these methods infers a 
useful overall assessment of perfusion. Laser Doppler 
flowmetry can investigate the more superficial blood flow 
[13] while PPG can assess vessel pulsation deeper in the 
tissue [14]. Therefore the combination of LDF and PPG 
techniques into a single probe for estimating the degree of 
perfusion at different depths simultaneously would provide a 
new, improved method of assessing tissue viability. 
 
 
II. MATERIALS AND METHODS 
A. Evaluation of the system 
Three main parts of the measurement system were 
developed and used in this study. These include the probe, 
instrumentation and a data acquisition system. A custom- 
made signal processing circuit separates the 
photoplethysmographic signals into its AC and DC 
components and amplifies each component.  The AC PPG 
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Abstract— this study presents evaluation of a system 
combining laser Doppler flowmetry and photoplethysmography 
(PPG) in a single probe for the simultaneous measurement of 
perfusion and blood flow in the finger. A cuff 
sphygmomanometer was used to partially occlude the arteries 
supplying the hand to investigate the effect of low pressure on 
photoplethysmographic and laser Doppler signals and also on 
calculated arterial blood oxygen saturation values (SpO2). Red 
and infrared PPG and Doppler signals were recorded from six 
healthy volunteers at various pressures. Good quality signals 
were recorded in all subjects at low cuff pressures; however 
both PPG and Doppler signals showed a gradual decrease in 
amplitude at higher pressures. SpO2 values calculated from the 
PPG signals showed higher deviation from measurements made 
on the contralateral hand using a commercial pulse oximeter at 
higher cuff pressures. 
I. INTRODUCTION 
Blood oxygen saturation level is very important in clinical 
physiological monitoring. In medicine, oxygen saturation 
indicates the percentage of haemoglobin binding sites in the 
bloodstream occupied by oxygen [1]. Various techniques 
measure the skin blood flow including 
Photoplethysmography and laser Doppler flowmetry (LDF). 
Photoplethysmography is a method of monitoring changes in 
transmission of light through tissue due to pulsation of small 
arteries while laser Doppler flowmetry (LDF) measures 
microcirculatory blood cell velocity and flux [2]. 
The results presented here are part of a wider study to 
combine LDF and PPG into a surface probe intended for 
evaluation of peripheral blood flow in abdominal tissue 
during bowel operations. Bowel viability assessment is 
essential in gastrointestinal surgery, and must be evaluated 
frequently during and after abdominal operation otherwise it 
can be lead to intestinal ischemia and necrosis associated 
with an increased length of hospital stay, significant 
postoperative morbidity and mortality. Although numerous 
techniques of intraoperative bowel viability assessment like 
pulse oximetry, Polarographic measurement of oxygen 
tension, near-infrared and visible light spectrophotometry 
(NIRS & VLS) and intravital microscopy are available, only 
a few are applicable in bowel surgery. The majority of 
methods are still far from ideal [2]. Combination of these 
methods can be advantageous for bowel  viability 
assessment. An optical sensor for assessment of  the 
perfusion of the bowel has been proposed which may be 
placed on the bowel allowing the perfusion status and blood 
oxygen level before and after rejoining two parts of bowel 
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together to be assessed. The sensor could indicate the 
presence and magnitude of the circulation so allow early 
warning of ischaemia to the surgeon before damage occurs. 
A. Photoplethysmography  (PPG) 
Photoplethysmography, (PPG) a non-invasive electro- 
optic method provides information on the blood volume 
changes in the body caused by cardiovascular pulsations in 
the bed of tissue [3]. A photoplethysmogram is obtained by 
illuminating a part of the body of interest and acquiring either 
the reflected or transmitted light. Photoplethysmography 
(PPG) involves two basic forms of optoelectronic which one 
for emitting monochromatic light into tissue and the other for 
collecting the light reflected back, or through, and not 
absorbed by tissue and blood. The intensity of light from 
emitter, which reaches the photodiode detector, will be 
measured to determine the blood volume changes. Variation 
in the signal correlates to several parameters of which 
pulsative changes in blood flow and blood volume are 
regarded as most important [4]. Typically PPG is a non- 
invasive technique and operates at red and infrared 
wavelength [5]. 
The PPG signal consists of two types of waveforms 
including a dominating DC-part and a pulsatile AC-part. AC 
component is a pulsatile waveform, which represents the 
pulsing of the blood in the arteries while DC component is a 
comprised of the absorption from the non-pulsing arterial 
blood, the venous and capillary blood. The AC-part is usually 
filtered out and amplified. 
There are two main PPG operational configurations; the 
first one is transmission mode operation where the tissue 
sample (e.g. fingertip) is placed between the source and 
detector. And the second one is reflection mode operation 
where the LED and detector are placed side-by- side [6]. 
B. Laser Doppler flowmetry (LDF) 
The Doppler Effect is utilised in laser Doppler flowmeters 
for measuring microvascular blood flow. In brief, a beam of 
laser light, carried by a fiber-optic probe attached to or 
inserted into the investigated tissue, interacts with moving 
components of tissue such as red blood cells [7] and is 
Doppler shifted while light interacting with static objects is 
unchanged. The light is then scattered and partly absorbed by 
the tissue to be investigated. The light is picked up by a 
returning fiber, converted into an electrical signal that is 
processed to provide an estimation of blood flow, called flux, 
which is the product of the velocity and the number of red 
cells in the volume of tissue interrogated by the probe [8]. 
Laser Doppler flowmetry (LDF) and photoplethysmography 
(PPG) are both well-established non-invasive optical methods 
for measuring changes in skin blood flow [9]. Through 
application of both these methods, the tissue blood flow in 
different tissue layers can be inferred. As laser Doppler 
flowmetry can study the more superficial blood flow [10] and 
